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1 Abstract
The neurodegenerative disease frontotemporal lobar degeneration (FTLD) is charac-
terized by a progressive loss of neurons in the frontal and temporal lobes leading to
behavioural abnormalities and language impairment. Granulin (GRN), a secreted
glycoprotein, is genetically linked to FTLD with cytosolic TAR-DNA-binding protein
43 (TDP-43) and ubiquitin-positive deposits. FTLD patients carry heterozygously a
loss of function mutation in GRN and interestingly, homozygous mutation carrier that
lack GRN completely, develop neuronal ceroid lipofuscinosis (NCL), a lysosomal storage
disorder and neurodegenerative disease. Despite great efforts in the last years, the role
of GRN in health and disease is still largely elusive.
To unravel GRN’s physiological function, this study aimed to establish a zebrafish GRN
loss of function animal model. I generated mutants in both zebrafish GRN orthologues,
granulin a (grna) and granulin b (grnb), using the zinc finger nuclease technology for
genome editing. I confirmed that all grna and grnb mutant alleles generated result in a
strong reduction of mRNA expression and a complete loss of protein.
Grna and Grnb single and double knock out (KO) zebrafish are viable and fertile,
lack obvious morphological phenotypes, and develop normally. Examination of the
mutants for previously reported knock down phenotypes did not confirm spinal motor
neuron axonopathies or a reduced number of myogenic progenitor cells. Moreover, there
are no signs of phenotypic alterations in the developing vasculature. Analysing the
Grna;Grnb double KO zebrafish for disease-related phenotypes and molecular changes
known from FTLD patients or Grn-deficient mice like neurodegeneration, microgliosis,
lipofuscinosis, lysosomal dysfunction, or behavioural phenotypes did not reveal any
phenotypic or molecular alterations in the mutants. Like mammalian GRN, zebrafish
granulins are increased after an injury, but despite this increase, the regeneration as
well as the immune response after tail fin amputations were not affected in Grna;Grnb
KO zebrafish larvae.
In summary Grna and Grnb loss of function mutants were successfully generated.
Phenotypes described in Grna or Grnb morphants as well as GRN-deficient mammals
and patients were absent in Grna;Grnb KO zebrafish. Investigations of injured, adult
Grna;Grnb-deficient zebrafish brains might suggest a novel physiological function of
Grna and Grnb.
1
1 Abstract
2
2 Zusammenfassung
Die neurodegenerative Erkrankung Fronto-Temporal-Lappen-Degeneration (FTLD)
zeichnet sich durch einen progressiven Verlust von Neuronen im Frontal- und Temporal-
Lappen aus. Dies führt zu Verhaltensauffälligkeiten und Sprachstörungen. Granulin
(GRN ), ein sezerniertes Glykoprotein, wird genetisch mit einer Form der FTLD in
Verbindung gebracht, die sich durch TAR-DNA-bindendes Protein 43 (TDP-43) sowie
Ubiquitin-positive Ablagerungen im Zytosol auszeichnet. Patienten mit FTLD tragen
heterozygot eine Funktionsverlust (KO)-Mutation in ihrem Genom. Interessanterweise
entwickeln homozygote Träger einer KO-Mutation, die lysosomale Speicherkrankheit
neuronale Zeroidlipofuszinose, die auch eine neurodegenerative Erkrankung ist. Trotz
intensiver Forschung in den letzten Jahren ist die Rolle von GRN im gesunden Menschen
und bei den genannten Erkrankungen noch weitgehend unklar.
Das Ziel dieser Arbeit war es, ein GRN defizientes Zebrafisch-Tiermodell zu entwi-
ckeln und die physiologische Funktion von GRN zu ermitteln. Zur Generierung GRN
defizienter Zebrafishmutanten habe ich die Orthologen von GRN, granulin a (grna)
und granulin b (grnb), mit Hilfe der Zinkfinger Nuklease Technologie gezielt genetisch
modifiziert. Ich konnte zeigen, dass alle generierten mutierten Allele zu einer starken
Reduktion der mRNA und zum Verlust des jeweiligen Proteins führen.
Die Grna und Grnb Einzel- wie auch Doppelmutanten sind lebens- und vermehrungs-
fähig, und sie entwickeln keine offensichtlichen morphologischen Auffälligkeiten. Nach
einem partiellen, temporären Funktionsverlust (KD) beschriebene Phänotypen, wie ein
verändertes Auswachsen der Motoneuronaxone oder eine reduzierte Anzahl von Muskel-
vorläuferzellen, konnten bei Untersuchungen in den Einzel- und Doppelmutanten nicht
bestätigt werden. Auch die Struktur der Blutgefäße ist nicht verändert. Phänotypische
und molekulare Veränderungen, die in FTLD Patienten und Grn-defizienten Mäusen
beschrieben wurden, wie Neurodegeneration, Mikrogliose, Lipofuszinose, lysosomale
Dysfunktion und Verhaltensveränderungen, treten in den Grna;Grnb KO-Mutanten
nicht auf. Wie auch in Säugetieren werden die Zebrafisch granuline nach einer Verletzung
verstärkt exprimiert. Trotz dieses Anstiegs ist die Regeneration und die Immunantwort
nach einer Schwanzflossenamputation in Grna;Grnb Doppelmutanten nicht verändert.
Im Rahmen dieser Doktorarbeit wurden erfolgreich Grna und Grnb KO-Mutanten gene-
riert. Bereits in Patienten, Grn-defizienten Mäusen und KD Zebrafischen beschriebene
Phänotypen treten in diese KO-Mutanten nicht auf. Untersuchungen in Gehirnen von
erwachsenen Grna;Grnb Doppelmutanten nach Verletzung deuten jedoch auf eine bisher
unbekannte physiologische Funktion von Grna und Grnb hin.
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Neurodegenerative diseases like Alzheimer’s disease (AD) and frontotemporal lobar
degeneration (FTLD) are characterized by a progressive loss of neurons leading to a
loss of memory or changes in behaviour, respectively. Amongst the main risk factors
to develop neurodegenerative diseases is ageing. According to a collaborative analy-
sis by Alzheimer Europe, the prevalence to be diagnosed with a neurodegenerative
disease is 0.6% for people between 60-64 years of age and 41.0% in the age group of
90-94 (http://www.alzheimer-europe.org/Research/European-Collaboration-on-Demen-
tia/Prevalence-of-dementia/Prevalence-of-dementia-in-Europe) . Therefore, all ageing
societies are facing a tremendous medical, social, and economical burden, as the rate
of neurodegenerative disease incidence rises in the decades ahead. For 2008 it was
estimated that 10.11 million people in Europe suffered from dementia generating total
costs of illness estimated to 177 billion euro (Wimo et al., 2011). The awfulness of
neurodegenerative diseases and the increasing financial burden urge scientists and
societies all over the world to learn more about these, so far incurable diseases, to find
treatments and one day a cure.
Understanding the underlying pathomechanisms is of tremendous importance when
seeking for a cure. To understand what is happening in patients suffering from a disease
model systems are used. Amongst these animal models, with all cell types present, fill a
major gap between cell culture model systems and human patients. In the past animal
models have proven to provide useful insights in disease pathomechanisms (e.g.Gutierrez
et al., 2014; Mahmood et al., 2013a; Partanen et al., 2008; Ralph et al., 2005). Moreover,
they offer the opportunity to disclose possible adverse events upon pharmacological
treatment also in body tissues that are not directly affected by the disease (e.g.Strähle
and Grabher, 2010). A unique feature of (neuro)degenerative diseases is the progressive
degradation of the affected tissue precluding a detailed examination at the time of death.
Therefore, animal models that mimic disease progress, disease-related phenotypes, and
biochemical changes are of vital importance in understanding triggers and courses of
neurodegenerative diseases in humans.
3.1 Aim of the project
The aim of this PhD thesis is to establish an animal model for the neurodegenerative
diseases FTLD and neuronal ceroid lipofuscinosis (NCL) providing a model to decipher
pathomechanisms and identify drugs that ameliorate or cure these diseases. FTLD
and NCL have in common that they are both genetically linked to loss of function
mutations in Granulin (GRN ) (Baker et al., 2006; Cruts et al., 2006; Shankaran et al.,
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2008; Smith et al., 2012). To mimic the partial loss of GRN-function in FTLD and the
complete loss of function in NCL, I will generate a GRN loss of function animal model.
I will work in this study with the zebrafish a frequently used vertebrate model organism
that is genetically modifiable and due to the high number of offspring very suitable for
large-scale compound screens (Esterberg et al., 2013; Gutierrez et al., 2014). To provide
a basis for this study, tools for the detection of zebrafish Granulin e.g. zebrafish specific
antibodies should be developed. A basic characterization of the expression pattern
of zebrafish granulin should follow. Thereafter, zebrafish Granulin loss of function
mutants should be generated by genome editing using the zinc finger nuclease technology.
After successful generation of loss of function mutants, these should be analysed for
phenotypical and biochemical alterations. Thereby the focus will be on the validation of
phenotypes and molecular changes that were previously reported from patients suffering
from FTLD or NCL with underlying GRN mutations or other GRN-deficient animal
models. Moreover, the expression pattern of zebrafish granulin should be considered in
the analysis of the mutants. Apart from being an animal model for FTLD and NCL
caused by GRN-deficiency, these zebrafish mutants will also provide insights in the
physiological function of zebrafish Granulin.
In the following the two neurodegenerative diseases important for this project, FTLD and
NCL, are briefly described. Then the protein central to this study, GRN, is introduced
and data available from GRN-deficient patients and model organisms is summarised.
Thereby, the data provided by the literature about (zebra)fish Granulin will be explained
in detail. Subsequently, the immune cells present during zebrafish development and
available transgenic zebrafish lines as well as wounding assays performed in this study
are introduced. Finally, genome editing technologies in zebrafish are described.
3.2 Frontotemporal lobar degeneration
The term FTLD summarises brain atrophies in the frontal and temporal lobes that
can manifest in heterogeneous clinical symptoms including behaviour and language
dysfunction (Premi et al., 2012). FTLD accounts for 5-15% of all dementias and in
individuals younger than 65 it is the second most common cause of dementia after
AD (Pan and Chen, 2013; Rademakers et al., 2012). Duration of illness depends mostly
on the underlying pathologies and varies from 2-20 years (Hodges et al., 2003; Pan and
Chen, 2013). Until today there is no cure for FTLD. Treatment of patients with FTLD
symptoms involves a combination of symptomatic pharmacological therapy with e.g.
behavioural and physical modification techniques (Seltman and Matthews, 2012).
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3.2.1 FTLD clinical classification and characteristics
Clinically the FTLD syndrome is divided into the following subtypes: behavioural
variant frontotemporal dementia (bvFTD), progressive nonfluent aphasia (PNFA), and
semantic dementia (SD) (Premi et al., 2012; Seltman and Matthews, 2012). Additionally,
FTLD and motor neuron diseases (MND) / amyotrophic lateral sclerosis (ALS) (FTLD-
MND or FTLD-ALS) as well as extrapyramidal movement disorders (parkinsonism or
corticobasal syndrome) show a significant clinical, pathological, and genetic overlap
with FTLD (Rademakers et al., 2012; Seltman and Matthews, 2012). The most common
variant amongst all FTLD cases is bvFTD. Patients show progressive changes in
personality and behaviour e.g. disinhibition and decline in executive function. The
atrophy in bvFTD occurs predominantly in the frontal lobe. In PNFA and SD, which
can be summarised by the umbrella term primary progressive aphasia (PPA), atrophy
occurs primarily in the temporal lobe and is at first asymmetrical. Patients diagnosed
with PNFA have difficulties expressing themselves using language and/or motor speech
deficits, but language comprehension is largely retained. In SD cases, the latter is
impaired, whereas speech production remains unaffected. A clear clinical classification
of bvFTD, PNFA, and SD can be difficult due to considerable overlap, especially in
advanced stages of the disease (Pan and Chen, 2013; Seltman and Matthews, 2012).
3.2.2 FTLD neuropathology and associated genes
The aggregation of specific proteins is a common feature of neurodegenerative diseases
and allows to distinguish different neurodegenerative diseases sometimes not possible
after a clinical examination only. FTLD can also be subclassified into categories
according to the proteins that are predominantly found in pathological brain deposits.
These proteins are microtubule-associated protein tau (MAPT), TAR-DNA-binding
protein 43 (TDP-43), and the FET family proteins, Fused in sarcoma (FUS), Ewing’s
sarcoma (EWS), and TATA-binding protein-associated factor (TAF15). Accordingly,
the corresponding categories are: FTLD-TAU, FTLD-TDP, and FTLD-FET/FTLD-
FUS (Pan and Chen, 2013; Seltman and Matthews, 2012). 25-50% of FTLD cases
present a positive family history (Rademakers et al., 2012) and the proteins aggregating
correlated with the underlying genotype. Mutations in MAPT were the first identified
to cause FTLD. They account for 5-20% of familial FTLD and patients carry tau
aggregates in their brain, which are toxic to the cell (Hardy and Rogaeva, 2013;
Rademakers et al., 2012). Interestingly, tau deposits are also found to aggregate in
the brain of AD patients (Selkoe, 2011). A haploinsufficency in GRN accounts for
5-20% of familial and 1-5% of sporadic FTLD cases (Baker et al., 2006; Cruts et al.,
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2006; Rademakers et al., 2012). In these patients ubiquitin-positive TDP-43 deposits
are characteristic (Neumann et al., 2006). Rare missense mutations or truncations
are also found in valosin-containing protein-1 (VCP), chromatin-modifying protein 2B
(CHMP2B), sequestosome 1 (SQSTM1 ) (p62), optineurin (OPTN ) and ubiquilin 2
(UBQLN2 ) (Deng et al., 2011; Holm et al., 2007; Ito et al., 2011; Kamada et al., 2013;
Le Ber et al., 2013; Rubino et al., 2012; Watts et al., 2004). Mutations is all these
genes lead, like mutations in GRN, to TDP-43 and/or ubiquitin binding protein p62-
positive aggregates and the pathomechanism is likely linked to autophagy or lysosomal
pathways (Hardy and Rogaeva, 2013; Pikkarainen et al., 2008; Rademakers et al., 2012).
TDP-43 is a nuclear DNA/RNA binding protein that shuttles between the nucleus and
the cytosol. In healthy patients TDP-43 is predominantly found in the nucleus (Dormann
and Haass, 2011). Under pathological conditions some cells, however, show abnormal
TDP-43 deposits in the cytosol combined with a nuclear clearance of TDP-43 (Neumann
et al., 2006, 2009). Additionally, it was demonstrated that pathological TDP-43 is
hyperphosphorylated, ubiquinated, and N-terminally truncated (Dormann and Haass,
2011; Neumann et al., 2006). Until today it is not completely solved how mutations in
such diverse genes can result all in the same neuropathology, namely TDP-43 deposits.
In 2011, two groups reported independently that a GGGGCC hexanucleotide repeat
expansion in the non-coding region of C9ORF72 is a disease-causing alteration on
chromosome 9p21 in ALS and FTLD (Dejesus-Hernandez et al., 2011; Renton et al.,
2011). C9ORF72 repeat expansions account for 21% of familial and 6% of sporadic
FTLD cases and are, together with mutations in GRN, the most common genetic cause
of FTLD (Rademakers et al., 2012). As possible disease-causing mechanisms of the
C9ORF72 repeat expansion, several hypotheses are currently discussed. One possibility
is a toxic gain of function by the sequestration of RNA binding proteins in RNA
foci (Dejesus-Hernandez et al., 2011; Lee et al., 2013) or repeat-associated non-ATG
(RAN) translation of the GGGGCC expansion in dipeptide-repeat (DPR) proteins (Ash
et al., 2013; Mori et al., 2013). The other possibility is a loss of function mechanism,
as the C9ORF72 mRNA is reduced to 50% in mutation carrier (Dejesus-Hernandez
et al., 2011). Besides genes, which carry mutations that are causative for FTLD, there
are also mutations in genes that increase the risk to develop FTLD. Among these are
mutations in transmembrane protein 106B (TMEM106b) a protein that localises to
late endosomes/lysosomes (Lang et al., 2012; van der Zee et al., 2011) and the recently
identified mutations in the triggering receptor expressed on myeloid cells 2 (TREM2 )
gene, which is involved in the immune response (Borroni et al., 2014; Guerreiro et al.,
2013).
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3.3 Neuronal ceroid lipofuscinosis
Besides FTLD-TDP loss of function mutations in GRN were also identified to cause
NCL. In contrast to FTLD-TDP patients with GRN mutations (FTLD-TDP/GRN ),
NCL patients carrying a mutation in GRN (NCL/GRN ) are homozygous for the loss
of function mutation (Smith et al., 2012).
The term NCL summarises a group of inherited disorders that are on the one hand
characterized by neuronal loss in brain and retina, and on the other hand by the
accumulation of intracellular lipopigments. In childhood NCL is the most frequent
neurodegenerative and lysosomal disease, whereas in adulthood it accounts for only a
minor amount of these two diseases (Anderson et al., 2013). Until today there is no
cure for NCL and therapies for NCL patients are so far only palliative (Schulz et al.,
2013).
3.3.1 NCL clinical classification and characteristics
Previously, NCL was classified depending on the disease onset into congenital, infantile,
late infantile, juvenile, and adult NCL or according to the person who first described it
e.g. Batten disease (Schulz et al., 2013; Warrier et al., 2013). Since it became more and
more obvious that NCL is genetically quite heterogeneous, the current nomenclature
considers the mutated gene and the disease onset (Schulz et al., 2013). The main
symptoms are visual failure, dementia, motor deterioration, and epilepsy, due to the
massive neuronal loss, leading finally to premature death (Schulz et al., 2013; Warrier
et al., 2013). The order of symptom occurrence is variable and depends on the genes
involved as well as the disease onset (Schulz et al., 2013).
3.3.2 NCL neuropathology and associated genes
One of the hallmarks of NCL is the accumulation of intracellular, autofluorescent storage
material that resembles the lipopigments ceroid and lipofuscin. These storage bodies
contain subunit c of mitochondrial ATP synthase (SCMAS) or sphingolipid activator
proteins (Saposin) A and D as well as lipids of lysosomal/endosomal origin (Palmer
et al., 2013). Since storage bodies do also occur in extracerebral tissues, storage
bodies in biopsies from NCL patients are visualized by microscopy for diagnosis and
characterization (Anderson et al., 2013). NCL is mostly inherited in an autosomal
recessive manner (Warrier et al., 2013). The genes known that carry mutations that are
causative for NCL are: palmitoyl protein thioesterase 1 (PPT1 ), tripeptidyl peptidase 1
(TPP1 ), ceroid-lipofuscinosis, neuronal 3 (CLN3 ), DnaJ homolog subfamily C member 5
(DNAJC5 ), CLN5, CLN6, major facilitator superfamily domain containing 8 (MFSD8 ),
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CLN8, cathepsin D (CTSD), GRN, ATPase type 13A2 (ATP13A2 ), cathepsin F
(CTSF ), and potassium channel tetramerization domain containing 7 (KCTD7 ). These
genes code for proteins that are very heterogenous in their functions. For example
PPT1, TPP1, CTSD, and CTSF are lysosomal enzymes and CLN3, CLN6, CLN7, and
CLN8 code for transmembrane proteins. How these genetic defects in genes coding
for such diverse proteins can lead to such similar clinical manifestation, is still not
understood. Despite the identification of NCL causing genes the disease mechanisms
underlying NCL remain to be solved (Palmer et al., 2013; Schulz et al., 2013; Warrier
et al., 2013).
3.4 Granulin and its diverse functions
The protein central to this study is GRN, a pleiotrophic protein that was discovered
independently in several processes in the early 1990s. Therefore, it is also known as
proepithelin, progranulin, 88kDa glycoprotein, and PC cell-derived growth factor (Bate-
man et al., 1990; Kleinberger et al., 2013). The 593 amino acid secreted glycoprotein
with seven and a half granulin domains is encoded by the GRN gene on chromosome
17 (De Muynck and Van Damme, 2011). Due to complex glycosylation it migrates
in a denaturing gel electrophoresis at 75-90kDa, which is higher than the calculated
molecular weight (MW) of 68.5kDa (Kleinberger et al., 2013). The unique nature of
the granulin domains is their 10-12 cysteine-containing motif (X2−3 CX5−6 CX5 CCX8
CCX6 CCX5 CCX5 CX5−6 CX) (Nguyen et al., 2013). GRN is a proprotein that can be
cleaved in the linker regions between the granulin domains into individual granulin pep-
tides by proteases, like neutrophil elastase, proteinase 3, and matrix metallopeptidases
(e.g. MMP-9). This proteolytic processing can be inhibited by binding of secretory
leukocyte protease inhibitor (SLPI) or high density lipoprotein (HDL)/apolipoprotein
A-I (ApoA-I) (Okura et al., 2010). It is believed that GRN and the granulin peptides are
both functional (De Muynck and Van Damme, 2011; Kleinberger et al., 2013; Nguyen
et al., 2013). It was shown, for example, that GRN exhibits anti-inflammatory, whereas
the granulin peptides exhibits pro-inflammatory properties (Zhu et al., 2002).
Even though altered GRN levels are reported from several pathologic conditions, e.g. can-
cer, inflammation, or neurodegeneration (Baker et al., 2006; Cruts et al., 2006; Ong
and Bateman, 2003; Toh et al., 2011), its exact role and signaling mechanisms are still
elusive. An overview of the diverse possible functions of GRN is given below.
3.4.1 GRN in neurodegenerative diseases
Genetic linkage studies comparing case and control groups, genetically linked mutations
in GRN to FTLD. Haploinsufficiency was suggested as the underlying disease mechanism
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since all FTLD patients are heterozygous for loss of function mutations in GRN (Baker
et al., 2006; Cruts et al., 2006; Shankaran et al., 2008). A total of 149 mutations,
distributed over the whole GRN gene, were identified so far. 69 of these mutations
are documented loss of function mutations that lead to FTLD (http://www.molgen.
ua.ac.be/ADMutations/default.cfm?MT=0&ML=0&Page=Home) (Cruts et al., 2012).
FTLD-TDP/GRN patients show ubiquitin-positive TDP-43 inclusions in affected brain
regions (Neumann et al., 2006). Another linkage analysis identified a previously described
loss of function mutation in GRN in two siblings suffering from NCL. In contrast to
the FTLD-TDP/GRN patients, the NCL/GRN patients were homozygous for the
loss of function mutation in GRN (Smith et al., 2012). Moreover, it was shown that
some missense mutations in GRN increase the risk to develop AD and maybe also
ALS (Brouwers et al., 2008; Del Bo et al., 2011; Lee et al., 2011; Sleegers et al., 2008).
Despite vast efforts in the last years, it is still unclear how less or no GRN can cause
neurodegenerative diseases. On the contrary, GRN is upregulated in activated microglia
in a number of neurodegenerative diseases including Creutzfeldt-Jakob disease, MND,
multiple sclerosis, and AD (Baker and Manuelidis, 2003; Baker et al., 2006; Malaspina
et al., 2001; Vercellino et al., 2011). The reasons for that and if this increase has an
influence on disease progress are still unknown.
3.4.2 GRN a mitogenic and neurotrophic growth factor
Also many tumor types including liver, renal, brain, breast, prostate, ovarian, and
colorectal cancer have in common that the GRN expression is elevated (DeMorrow,
2013; He and Bateman, 2003). GRN was shown to have an influence on cell survival,
invasiveness, and aggressiveness of the tumor (Frampton et al., 2012; He et al., 2002;
Monami et al., 2006). Since increased GRN levels in the plasma correlate with an
increased recurrence risk and a decreased overall survival, GRN is discussed as a
potential prognostic biomarker in cancer research (Carlson et al., 2013; Han et al.,
2011; Serrero et al., 2012). Moreover, it was demonstrated that GRN can stimulate cell
growth in the absence of insulin-like growth factor 1 (IGF-1) receptor, confirming that
GRN is a potent mitogenic growth factor (Zanocco-Marani et al., 1999). Although it
is unclear which receptor mediates GRN signaling in this respect, it was shown that
GRN promotes its growth factor activities via the common cell proliferation signaling
pathways including mitogen activated protein kinase (MAPK)/extracellular regulated
kinase (ERK) and phosphatidyl inositol-3 kinase (PI3K) pathways (Cenik et al., 2012).
Despite the numerous studies that observed elevated GRN levels in many tumor types,
the reasons remain elusive.
It was furthermore demonstrated in neuronal cell culture that GRN and also some
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granulin peptides enhance neurite outgrowth and branching as well as overall neuronal
survival (De Muynck et al., 2013; Gass et al., 2012; Van Damme et al., 2008). These
neurotrophic activities of GRN that seem to be independent of the possible GRN-
receptor Sortilin 1 (SORT1) are mediated via the MAPK/ERK, PI3K/Akt, and glycogen
synthase kinase-3 β (GSK-3β) signaling pathways (De Muynck et al., 2013; Gao et al.,
2010; Gass et al., 2012; Nedachi et al., 2011; Xu et al., 2011). Additionally, GRN is
secreted at the synapse in an activity-dependent manner, thereby regulating synapse
number and structure (Petoukhov et al., 2013; Tapia et al., 2011). Whether especially
the last function of GRN plays a role in FTLD-TDP/GRN or NCL/GRN and whether
the increased GRN levels in AD are beneficial because of GRNs neurotropic potential
remain to be solved.
3.4.3 GRN an anti-inflammatory factor
Amongst other tissues, granulin peptides, the processed form of GRN, were initially
purified from human immune cells suggesting roles in inflammation, wound repair, and
tissue remodeling (Bateman et al., 1990). Several studies demonstrated that GRN
is upregulated after acute or in chronic inflammation in the central nervous system
(CNS) and in the periphery (Jian et al., 2012; Lim et al., 2012; Moisse et al., 2009;
Naphade et al., 2010; Qiu et al., 2013; Qu et al., 2013; Tanaka et al., 2012; Ungurs
et al., 2014; Wang et al., 2011; Youn et al., 2009). These elevated GRN levels are
largely assigned to an increase in expression in macrophages or microglia (Moisse
et al., 2009; Naphade et al., 2010; Tanaka et al., 2012). Analysis of neurons after an
axotomy revealed a slight decrease in GRN levels (Moisse et al., 2009). Administration
of GRN to the injured or wounded tissue did improve wound healing and reduced
the scar size (Egashira et al., 2013; Guo et al., 2012; He et al., 2003; Kojima et al.,
2009). Reduced Grn levels cause, in contrast, an exaggerated inflammatory response
and increased levels of the proinflammatory cytokine interleukin 6 (IL-6) (Bossù et al.,
2011; Yin et al., 2010a). Moreover, the inflammatory response to a traumatic brain
injury in Grn-deficient mice is augmented, when compared to wildtype animals and
fractured bones heal slower (Tanaka et al., 2012; Zhao et al., 2013). The strengthened
inflammatory boost in injured brains from Grn knock out (KO) mice seems to be caused
by an increased lysosomal biogenesis in CD68-positive activated microglia (Tanaka
et al., 2012, 2013). Additionally, it was shown that macrophages from Grn KO mice
are more phagocytic and Grn-deficient microglia were more toxic to neurons in cell
culture, which is probably due to the increased release of pro-inflammatory cytokines
of these microglial cells (Kao et al., 2011; Martens et al., 2012). The GRN proprotein
was demonstrated to have anti-inflammatory properties, whereas the granulin peptides
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have the attribute to be pro-inflammatory. Shifting the equilibrium to one side, has
therefore a direct effect on wound healing (Kessenbrock et al., 2011; Ungurs et al., 2014;
Zhu et al., 2002). GRN is also capable of blocking tumor necrosis factor α (TNFα)
signaling (Okura et al., 2010; Tang et al., 2011; Zhao et al., 2013; Zhu et al., 2002).
Whether this is mediated by direct binding to TNF receptor (TNFR) 1 and 2 or indirect
is discussed controversially, since the direct binding of GRN to TNFR1 or TNFR2 was
not reproduced so far (Chen et al., 2013b; Etemadi et al., 2013; Jian et al., 2013; Tang
et al., 2011). It is conceivable that anti-inflammatory and pro-inflammatory properties
of GRN and the granulin peptides, respectively, play a role in FTLD-TDP/GRN and
NCL/GRN but how this occurs is still elusive.
3.4.4 GRN an angiogenic factor
Besides being a mitogenic growth factor and involved in inflammation, administration
of Grn to transcutaneous wounds did increase the size and number of blood vessels
in the wound. Therefore, it was concluded that GRN has angiogenic properties (He
et al., 2003). An anti-GRN antibody was demonstrated to reduce the number of
microvessels in a hepatocellular tumor model (Ho et al., 2008) indicating an influence in
tumor vessel growth. During development Grn is expressed in the developing cerebral
microvasculature, but apparently not in established blood vessels (Daniel et al., 2003;
Petkau et al., 2010). Grn KO mice were shown to be more susceptible to disruptions
of the blood brain barrier (BBB) and it was suggested that this is due to cardinal
alterations in the microvasculature (Jackman et al., 2013). Even though there are several
indications that link GRN to the vasculature, the exact role of GRN in angiogenic
processes and vessel stability remain to be clarified. In respect to FTLD-TDP/GRN
and NCL/GRN it is of special interest to learn more about the role of GRN in the
microvasculature of the brain and the exact role of GRN on BBB function.
3.4.5 GRN involved in lysosomal function?
Apart from the finding that a lack of GRN in humans leads to NCL/GRN (Smith et al.,
2012), it was shown that Grn expression and protein levels are increased in mouse
models of two other lysosomal storage disorders, CLN10 and mucopolysaccharidosis I
and IIIB (Götzl et al., 2014; Ohmi et al., 2003). Treating cells with compounds that
alkalise the pH of the lysosome or inhibition of the vacuolar ATPase, increased GRN
levels, too (Capell et al., 2011). A lysosomal function of GRN was also indicated in
other studies. GRN showed up in a proteom analysis for mannose 6-phosphate (M6P)
containing lysosomal matrix proteins but a direct binding of GRN to M6P-receptor
(M6PR) was not confirmed (Kollmann et al., 2005). These findings are supported
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by a second proteom analysis that did indicate a possible binding of GRN to the
cation independent M6PR (CIM6PR) (Qian et al., 2008). Interestingly, this CIM6PR
also mediates endocytosis of the secreted protein insulin-like growth factor II from
the bloodstream (MacDonald et al., 1988). Moreover, a lysosomal function of GRN
was proposed in a function prediction model and it was demonstrated that GRN
overexpression leads to enlarged lysosomes (Belcastro et al., 2011). The Grn promoter
region contains two coordinated lysosomal expression and regulation (CLEAR) binding
motifs and Grn expression is induced upon translocation of transcription factor EB
(TFEB) to the nucleus, a key regulator of lysosomal biogenesis (Belcastro et al., 2011;
Sardiello et al., 2009; Tanaka et al., 2013). Moreover, it was shown that GRN binds
to sortilin (SORT1), a cell surface clearance receptor of neurons, also involved in
intracellular protein trafficking (Willnow et al., 2008). It was suggested that upon
binding, GRN is endocytosed, and targeted to the lysosomes (Hu et al., 2010; Nykjaer
and Willnow, 2012; Zheng et al., 2011). Recent data reveals that lysosomal gene
expression and protein levels are increased in Grn KO mice (Götzl et al., 2014; Tanaka
et al., 2013), especially after traumatic brain injury (Tanaka et al., 2013). It was
postulated that GRN is a negative regulator of excessive lysosomal biogenesis and the
following mechanism was suggested: GRN is targeted to the lysosome via SORT1-
mediated endocytosis, where it activates mammalian target of rapamycin complex 1
(mTORC1). Thereby, TFEB is phosphorylated and can not translocate to the nucleus.
Consequently, lysosomal gene expression is not induced (Tanaka et al., 2013). In
neuronal dentrites and axons GRN colocalises with dense-core vesicles, lysosome-related
organelles and it was shown that GRN levels have an influence on the secretory vesicle
density at the synapse (Marks et al., 2013; Petoukhov et al., 2013; Tapia et al., 2011).
Despite the increasing evidence that GRN seems to have a lysosomal function, the exact
role of GRN in lysosomal biology and its contribution to the diseases FTLD-TDP/GRN
or NCL/GRN still has to be clarified.
3.5 GRN deficiency in men and mice
If an animal model should be generated to model a human disease as much information
from the human pathology as possible is advantageous and also a comparison to
phenotypes published in other model systems is of importance in validating the animal
model. In the following the phenotypes and biochemical alterations found in GRN-
deficient men and mice are summarised.
14
3.5 GRN deficiency in men and mice
3.5.1 Neuropathology of GRN-deficient FTLD-TDP and NCL patients
In humans partial GRN deficiency leads to FTLD-TDP and a complete GRN deficiency
results in NCL. These two distinct neurodegenerative diseases were not connected until
recently. Now there is increasing evidence that also in FTLD-TDP/GRN a lysosomal
dysfunction is involved the manifestation of pathology (Götzl et al., 2014; Smith et al.,
2012).
Patients with FTLD-TDP/GRN present clinically a quite heterogenous group with
much phenotypic variation of the FTLD symptom spectrum and sometimes overlap
of symptoms that are distinctive of other neurodegenerative diseases. Least common
features are a frequently asymmetric disease onset and a more pronounced atrophy
in the frontal cortex (Kleinberger et al., 2013; van Swieten and Heutink, 2008). Neu-
ropathologically FTLD-TDP/GRN patients are characterized by extensive micro- and
astrogliosis as well as ubiquitin-positive TDP-43 cytoplasmatic inclusions (Götzl et al.,
2014; Mackenzie, 2007; van Swieten and Heutink, 2008). In one study it was shown,
that the number of synaptic vesicles at the synapse was increased in the hippocampus of
FTLD-TDP/GRN patients (Tapia et al., 2011). Frontal cortex sections from mutation
carriers revealed an upregulation of Saposin D, CTSD, and lysosomal-associated mem-
brane protein 1 (LAMP1) in neurons and glia, and an upregulation of SCMAS as well as
TMEM106B in neurons. Interestingly, all of these are lysosomal proteins (Chen-Plotkin
et al., 2012; Götzl et al., 2014). Biochemical studies revealed additionally that filamin
C (FLNC ) and signal transducer and activator of transcription 3 (STAT3 ) expression
were increased in brain samples from FTLD-TDP/GRN patients and protein levels of
FLNC, phospho-TDP-43, Saposin D, LAMP1, LAMP2, and TMEM106B were elevated
(J. Banzhaf-Strathmann and J. Janssens, unpublished; Chen-Plotkin et al., 2012; Götzl
et al., 2014). The latter are all lysosomal proteins, which indicates lysosomal dysfunction
and provides a link to the lysosomal storage disorder NCL.
Clinically the two NCL/GRN patients presented typical NCL symptoms and an elec-
tron micrograph of a skin biopsy revealed the typical fingerprint profile of intracellular
storage material (Smith et al., 2012). In NCL extracerebral tissue is frequently used for
diagnosis, as lysosomes throughout the body are dysfunctional and lead to an accumu-
lation of lipofuscin deposits in all cells of the body. Brain samples from NCL/GRN
patients for neuropathological analysis are not available (Smith et al., 2012).
3.5.2 Phenotypes and biochemical alterations in Grn KO mice
To learn more about FTLD-TDP/GRN and NCL/GRN and the underlying pathome-
chanisms, several Grn KO mouse models have been generated independently (Kao
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et al., 2011; Kayasuga et al., 2007; Petkau et al., 2012; Wils et al., 2012; Yin et al.,
2010a). The mouse orthologue, Granulin (Grn), codes for a 602 amino acid protein
with 7 granulin domains and 79% sequence identity to GRN (Petkau et al., 2012).
It was demonstrated that Grn is expressed in epithelia, especially in these with a
high proliferation rate, and immune cells. In the murine brain it is expressed at high
levels by activated microglia and specific neurons, including pyramidal cells of the
hippocampus, some cerebral cortical neurons, and cerebellar Purkinje cells, and at
low levels in astrocytes and ependymal cells (Ahmed et al., 2007, 2010; Daniel et al.,
2000; Petkau et al., 2010). All Grn KO mice are viable, fertile, and produce offspring
according to the Mendelian rules (Kleinberger et al., 2013). A reduced lifespan in aged
mice was observed in some studies (Ghoshal et al., 2012; Wils et al., 2012), but was not
confirmed in other Grn KO mice (Petkau et al., 2012; Yin et al., 2010a). FTLD-related
behavioural phenotypes were addressed by behavioural tests. The observed phenotypes
in the different KO mice were, however, not consistent (Kleinberger et al., 2013). Some
studies agreed on a reduced social interaction in Grn KO mice (Ghoshal et al., 2012;
Petkau et al., 2012; Yin et al., 2010b) and it was shown that they have a slightly
poorer performance in tests for motor function (Ghoshal et al., 2012; Petkau et al.,
2012; Wils et al., 2012). Neuropathological examinations of the different mouse lines
revealed more overlap. A pronounced micro- and astrogliosis and the accumulation
of ubiquinated proteins as well as increased lipofuscinosis were described in several
studies (Ahmed et al., 2010; Ghoshal et al., 2012; Petkau et al., 2012; Wils et al., 2012;
Yin et al., 2010a,b). In contrast to human FTLD-TDP/GRN patients no cytosolic
TDP-43 aggregates were observed in Grn KO mice, but two groups described enhanced
phospho-TDP-43 immunoreactivity (Ahmed et al., 2010; Wils et al., 2012; Yin et al.,
2010a,b). Furthermore, only one study did observe neurodegeneration in aged Grn
KO mice (Ahmed et al., 2010), this was, however, not confirmed in others (Ghoshal
et al., 2012; Petkau et al., 2012; Wils et al., 2012). In cortical, hippocampal, as well as
thalamic sections from Grn KO mice, neurons and glia were labeled more intensely for
Ctsd, Saposin D, and SCMAS (neurons only) (Götzl et al., 2014). Biochemically, Grn
homozygous but not Grn heterozygous KO mice had increased Ctsd, Stat3, and Flnc
mRNA expression levels and increased Flnc, Saposin D, Ctsd, and TMEM106b protein
levels (J. Janssens, unpublished; Götzl et al., 2014; Wils et al., 2012). The accumulation
of lysosomal proteins - Saposin D, Ctsd, and TMEM106b - as well as the stronger
staining for lysosomal proteins on sections points towards a lysosomal dysfunction
typical for NCL models (Götzl et al., 2014). Interestingly, Flnc, Stat3, Ctsd, Grn, and
Sort1 were also identified to be upregulated or differentially spliced in a mouse model,
where TDP-43 was depleted in the adult brain (Polymenidou et al., 2011), and filamin
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Ca (Flnca) and Stat3 were upregulated in TAR DNA binding protein (tardbp); tardbp
like (tardbpl) double mutant zebrafish (Schmid et al., 2013). Indicating that a lack of
functional TDP-43, which is partially trapped in aggregates in FTLD-TDP/GRN, might
enhance the biochemical alterations in the patients. All observations from Grn KO
mice have in common, that they become more pronounced with ageing. Furthermore,
neuropathological and biochemical changes were only observed in homozygous Grn KO
mice, so far, and not in heterozygous Grn KO mice (Filiano et al., 2013; Götzl et al.,
2014). The reasons for the discrepancies between heterozygous FTLD-TDP/GRN loss
of function carrier and the heterozygous Grn KO mice are still elusive but the fact
that human beings become older might play a role. The only observations that were
consistent in homozygous and heterozygous Grn KO mice are age-dependent social
and emotional deficits (Filiano et al., 2013). Taken together, the homozygous Grn
KO mice model some aspects of NCL/GRN and it remains to be clarified, if they are
also a powerful model for FTLD-TDP/GRN. The most recent studies indicate that
also in FTLD-TDP/GRN a lysosomal dysfunction contributes to the pathology (Götzl
et al., 2014; Tanaka et al., 2013), but further studies are needed to clarify the exact
pathomechanisms and a model suitable for medium- to high-throughput compound
screens is still missing.
3.6 GRN in zebrafish and other non-mammalian models
Since GRN is a secreted protein, it is of great interest to study GRN in the context of
multi-cellular model organisms. Mice are the most commonly used model organism to
study human diseases, but zebrafish for example are much more suitable for large-scale
compound screens, due to their high number of offspring that can be produced from one
spawning and their small size. Moreover, zebrafish larvae are translucent and a great
model to analyse processes by in vivo imaging. GRN has evolved early during evolution
and genes encoding proteins with granulin motives have been described in commonly
used model organisms besides Mus musculus, like Xenopus leavis, Caenorhabditis elegans
(C. elegans) and Danio rerio (Bucan et al., 1996; Cadieux et al., 2005; Kao et al., 2011;
Pera et al., 2005).
3.6.1 Phenotypes of GRN-deficient C. elegans
The C. elegans genome encodes for one GRN, pgrn-1, with three granulin domains.
Mutants lacking pgrn-1 produce less progeny and have fewer apoptotic corps. This
seems to be due to a more rapid clearance of dying cells (Kao et al., 2011). Moreover,
the same mutants are more resistant to osmotic, heat, and endoplasmic reticulum (ER)
stress, whereas their response to oxidative or genotoxic stress and pathogen exposure is
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not altered (Judy et al., 2013). The mechanisms for that and the translation of these
findings to FTLD-TDP/GRN or NCL/GRN are pending.
3.6.2 GRN and possible functions in fish
In teleost fish granulin-like peptides, which contain 11
2
granulin domains, were isolated
for the first time from haematopoietic tissue of carp (Cyprinus carpio) (Belcourt et al.,
1993). One of them, granulin-1, was shown to be produced and to be elevated in carp
and goldfish macrophages/monocytes of spleen, head kidney, and peripheral tissues,
involved in host defence (Belcourt et al., 1995). Moreover, granulin was identified
to be a candidate involved in goldfish macrophage haematopoiesis and macrophage
development in vitro. The growth factor, granulin, is expressed at high levels during
the proliferative phase and was suggested to be a positive modulator of macrophage
differentiation (Barreda et al., 2004; Hanington et al., 2006). Additionally, in vitro
treatment of carp head kidney cells with immunostimulants led to increased levels of
granulin-like peptides (Sakai et al., 2005).
3.6.2.1 Four GRNs in Danio rerio
In contrast to carp and goldfish, the zebrafish (Danio rerio) genome harbors four
zebrafish granulins (zf-grns), two short ones, granulin 1 (grn1 ) and granulin 2 (grn2 ),
and two long ones, granulin A (grna), granulin B (grnb), of which the latter are the
orthologues of the human and rodent GRN (see Fig. 5.1). It was shown that grna
and grnb are maternally provided and expressed throughout development. grn1 and
grn2 seem not to be maternally provided and expression was only detectable from
30 hours post-fertilization (hpf) onward (Cadieux et al., 2005). All four zf-grns are
expressed in all adult tissues analysed (Cadieux et al., 2005). In situ hybridisation
demonstrated that the zf-grns are expressed in several tissues of the endoderm and
each of them shows a distinct expression pattern (Cadieux et al., 2005). In the CNS,
grna seems to be expressed around 24hpf at the midbrain-hindbrain boundary, in the
tectum, in some structures in the eye (Cadieux et al., 2005) and at 27hpf also by caudal
primary motoneurons (Chitramuthu et al., 2010). At these stages and later grnb is
strongly expressed in forebrain, midbrain, hindbrain, and the eyes and was described
to resemble the murine Grn expression pattern in the brain (Cadieux et al., 2005).
grna, grn1, and grn2 but not grnb expression can be detected in haematopoietic tissues,
like the intermediate cell mass, the pronephric ducts, and leukocytes (Cadieux et al.,
2005). grna expression is furthermore elevated in cells of the myeloid lineage including
microglia when compared to non-myeloid cells (Craig et al., 2008; Zakrzewska et al.,
2010). Therefore, grna was also used as a microglia specific marker (Huang et al., 2012).
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3.6.2.2 A function of zf-grns in injury and infection?
grna might be involved in regenerative processes after injuries since it is upregulated after
ventricular resection of the adult zebrafish heart (Lien et al., 2006), retinal injury (Craig
et al., 2008), and tail fin amputation in zebrafish larvea (Mathew et al., 2009). In adult
zebrafish Mycobacterium marinum- and Streptococcus equi ssp zooepidemicus-infection
models, a granulin was strongly increased but it remains unclear, which of the four
zf-grns (Borst et al., 2013; Meijer et al., 2005). All these studies have in common that
they describe an upregulation of one or more zf-grns after injury or infection but none
of them did further address the role of zf-grns, especially grna, in those processes. These
findings clearly indicate a possible function of zf-grns in injury, infection, or wound
healing and therefore need to be considered in the analysis of the zf-Grn loss of function
mutants.
3.6.2.3 Phenotypes of transient zf-Grn deficiency
Several knock down (KD) studies using grna or grnb morpholinos (MO) are published in
zebrafish (Chitramuthu et al., 2010; De Muynck et al., 2013; Laird et al., 2010; Li et al.,
2010, 2013; Shankaran et al., 2008). Table 3.1 provides an overview of the transient KD
studies published so far. KD of Grnb did not lead to an obvious morphological phenotype
and Tardbp/Tardbpl were not mislocalised to the cytosol in injected embryos (Shankaran
et al., 2008). Two groups reported independently, that a KD of Grna as well as
Grnb results in spinal motor neuron (SpMN) axonopathy (Chitramuthu et al., 2010;
De Muynck et al., 2013; Laird et al., 2010). In one of the studies it was stated that the
SpMN axons also show premature branching and that grna MO-injected embryos have
swimming defects in a touch response assay. Interestingly, overexpression of grna did
also stimulate SpMN axon branching (Chitramuthu et al., 2010). These studies suggest,
that especially Grna is required for proper SpMN axon development. Futhermore, KD
of Grna decreased the trunk muscle size and the number of myogenic progenitor cells
(MPCs) in embryos. Grnb KD decreases the number of embryonic MPCs, too, but
to a lower extent. Additionally, muscle-specific overexpression of Grna did increase
the myofibre size and enhanced MPCs activation after toxin-induced muscle injury
in zebrafish larvae (Li et al., 2013). A KD of Grna results also in an impaired liver
morphogenesis (Li et al., 2010). The latter studies suggested that Grna signals via the
hepatocyte growth factor receptor, also known as met proto-oncogene (Li et al., 2010,
2013).
Taken together, only the studies describing an hepatic or a muscular phenotype addressed
underlying molecular pathways. Signaling mechanisms were not approached in the
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Table 3.1 – Overview of GRN deficient zebrafish models and phenotypes described.
Publication Modification
(control of KD)
Phenotype Rescue by over-
expression
Shankaran
et al., 2008
Grnb KD, splice grip
(RT-PCR)
- no morphological phenotype
- no mislocalisation of Tardbp or
Tardbpl
n.d.
Li et al.,
2010
Grna KD, 5’UTR MOs
(control MO, reporter
construct, protein
expression)
- reduced liver size
- reduced proliferation and
enhanced apoptosis of liver cells
- hepatic MET signaling reduced
Yes
- grna
Laird et al.,
2010
- Grna KD, ATG and
5’UTR MO
- Grnb KD, ATG and
5’UTR MO
- Grna and Grnb KD,
ATG MOs
(control MO)
- reduced length of SpMN axons
- no mislocalisation of TDP-43
Yes (Grna KD)
- human GRN
Chitramuthu
et al., 2010
- Grna KD, ATG and
5’UTR MO
- Grnb KD, 5’UTR MO
(Grna: control MO,
protein expression)
Grna KD:
- neuronal structures in the head
disrupted
- reduced length of SpMN axons
- extended branching of SpMN
axons
- swimming defects
Grnb KD:
- severe phenotype
- reduced head size
Yes (Grna KD)
- grna
- human GRN
only SpMN
truncation
Li et al.,
2013
- Grna KD, 5’UTR
MOsLi et al., 2010
- Grnb KD, n.a.
(Grna: control MO,
protein expression)
Grna KD:
- impaired muscle growth
- reduced number of MPCs
- impaired proliferation and
enhanced apoptosis of MPCs
Grnb KD:
reduced number of MPCs
Yes
- grna
De Muynck
et al., 2013
Grna KD, 5’UTR MO,
Laird et al., 2010
(control MO)
reduced length of SpMN axons No
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studies that characterised a SpMN axonopathy. As these studies are only descriptive,
the underlying molecular pathways still await to be discovered. In line with the
expression pattern of zf-Grns it is suggested to consider also possible immunological or
regenerative phenotypes in zebrafish deficient for zf-Grns, which has not been done so
far. Unfortunately, KD approaches are limited to early development and all phenotypes
in GRN-deficient patients suffering from FTLD-TDP or NCL are medium to late onset
and progressive. These kind of phenotypes can only be revealed in stable KO mutants
in zebrafish, since only stable mutants allow an analysis in late larval stages and in
aged adult zebrafish. Therefore the generation of stable zf-Grn loss of function mutants
modeling FTLD-TDP/GRN and NCL/GRN is urgently needed and of high relevance.
3.7 Zebrafish - a model to study inflammation and regeneration
The expression pattern of zf-grns (Borst et al., 2013; Cadieux et al., 2005; Craig et al.,
2008; Lien et al., 2006; Mathew et al., 2009; Meijer et al., 2005; Zakrzewska et al.,
2010) and data from other teleost fish (Barreda et al., 2004; Belcourt et al., 1993, 1995;
Hanington et al., 2006; Sakai et al., 2005) indicate a possible function of zf-Grns in
inflammation, wound healing, or regeneration. Moreover, it is known that activated
microglia in the mouse brain show elevated Grn levels (Moisse et al., 2009; Naphade
et al., 2010; Tanaka et al., 2012). Mammalian and zebrafish immunity have many aspects
in common. For example, the crucial genes in haematopoiesis and blood/immune cell
types are highly similar, making zebrafish an ideal organism to study the inflammatory
response (Jing and Zon, 2011; Renshaw and Trede, 2012). However, in contrast to
mammals the zebrafish has, like other non-mammalian vertebrates, the potential to
regenerate tissues, like fin, brain, or heart, even as an adult organism. Therefore,
zebrafish is an ideal model organism to learn more about the regenerative capacity of
vertebrates (Gemberling et al., 2013; Yoshinari and Kawakami, 2011). Zebrafish-specific
tools and assays to study the inflammatory response after an injury and the subsequent
regeneration are established and some will be introduced here later.
3.7.1 The development of zebrafish immune cells
Blood cells and immune cells are not present during the first hours of the life of a
zebrafish embryo. These arise gradually from haematopoietic stem cells (HSCs) in a
process termed haematopoiesis, which is defined as the generation of cellular blood
from HSCs. Like in mammals, zebrafish haematopoiesis occurs in consecutive waves
- the primitive, transient-definitive, and definitive wave (Fig. 3.1). In contrast to
mammalian vertebrates, the sites of haematopoiesis are distinct. HSCs in mammals
reside, for example, in the bone marrow, whereas HSCs in zebrafish reside in the
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Figure 3.1 – Graphic illustration of the timeline of haematopoiesis in zebrafish. The
consecutive waves of zebrafish haematopoiesis are illustrated. Haemangioblasts (white),
erythroid cells (red), myeloid cells (blue), definitive HSCs (grey), thromboid cells (yellow),
lymphoid progenitor cells (light green), and lymphoid cells (green). ALM: anterior lateral
plate mesoderm. PLM: posterior lateral plate mesoderm. PBI: posterior blood island.
AGM: dorsal aorta in the aorta-gonad-mesonephros. Modified from Jing and Zon (Jing
and Zon, 2011)
kidney marrow, the main haematopoietic tissue in zebrafish (Jing and Zon, 2011;
Sood and Liu, 2012). All haematopoietic cells in zebrafish are of mesodermal origin
(Fig. 3.1, grey box). Primitive haematopoiesis starts around 12hpf in the lateral plate
mesoderm (LPM). Uni-potent haemangioblasts populate the anterior LPM, which later
becomes the rostral blood island (RBI), and the posterior LPM, which gives later
rise to the intermediate cell mass (ICM) (Fig. 3.2, 24hpf). Haemangioblasts in the
anterior LPM/RBI differentiate predominantly into primitive macrophages and those
in the posterior LPM/ICM differentiate predominately into primitive erythrocytes
(Fig. 3.1, red boxes) (Ellett and Lieschke, 2010; Jing and Zon, 2011; Kanther and
Rawls, 2010; Sood and Liu, 2012). From 16hpf to 48hpf multi-potential erythromyeloid
progenitors (EMPs) can be detected in the posterior blood island (PBI) and in the caudal
haematopoietic tissue (CHT) (Fig. 3.2, 48hpf). EMPs of the transient-definitive wave
can differentiate into erythroid and myeloid cells (Fig. 3.1, purple box) (Jing and Zon,
2011; Kanther and Rawls, 2010; Xu et al., 2012). In parallel, definitive haematopoiesis
starts from approximately 26hpf onwards. Haemogenic endothelial cells from the ventral
wall of the dorsal aorta in the aorta-gonad-mesonephros (AGM) differentiate into HSCs.
These HSCs first colonize the CHT, a transient haematopoietic tissue in zebrafish
embryos, and can differentiate to erythroid, myeloid, and thromboid cells (Ellett and
Lieschke, 2010; Jing and Zon, 2011; Xu et al., 2012). From 2 days post-fertilization
(dpf) HSCs finally populate the kidney, where they give rise to erythroid, myeloid, and
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thromboid cells as well as eosinophiles (Fig. 3.2, 6dpf) (Jing and Zon, 2011; Kanther and
Rawls, 2010). Lymphopoiesis starts from 3dpf when lymphoblasts colonize the thymus
(Fig. 3.1, blue boxes; Fig. 3.2, 48hpf/6dpf) (Jing and Zon, 2011; Kanther and Rawls,
2010). However, the adaptive immune system in zebrafish seems to become functional at
approximately 4 weeks post-fertilization (wpf), only. Heretofore, the zebrafish relies on
its innate immune system, which makes zebrafish larvae an ideal organism to study the
innate immune response in the absence of adaptive immunity (Ellett and Lieschke, 2010;
Kanther and Rawls, 2010; Sood and Liu, 2012). Microglia, the resident phagocytes
Figure 3.2 – Graphic illustration of the spatial distribution of haematopoietic tissues
during zebrafish development. Rostral blood island (RBI): light blue. Intermediate cell
mass (ICM): purple. Dorsal aorta in the aorta-gonad-mesonephros (AGM): blue. Posterior
blood island (PBI) and caudal haematopoietic tissue (CHT): grey. Pronephros and kidney:
red. Thymus: green. Modified from Kanther and Rawls (Kanther and Rawls, 2010)
in the brain, derive from primitive macrophages from the yolk sac and colonize the
larval brain from 60hpf onwards (Herbomel et al., 2001; Shiau et al., 2013). During
development they pass a morphological transition from highly motile amoeboid cells to
mature ramified microglia (Svahn et al., 2013).
3.7.2 Visualizing the immune response - zebrafish transgenic lines
A big advantage of zebrafish compared to other model organisms is their transparency
during development providing the potential to visualize processes like the immune
response in vivo. Additionally stable, inheritable labeling of specific cells by the
expression of fluorescent proteins driven by cell-specific promoters is possible. To
visualize and examine the immune cell behaviour after an inflammatory stimulus such
transgenic zebrafish lines were generated. In these transgenic lines specific immune
cell populations are selectively labeled using immune cell specific promoters. Apart
from in vivo imaging in larvae, these transgenic lines allow also fluorescence-activated
cell sorting (FACS) of zebrafish immune cells. In the following a few transgenic
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lines available to label immune cells are briefly described. Zebrafish myeloid lineage
precursors express spleen focus forming virus (SFFV) proviral integration oncogene
spi1b (spi1b) (Bennett et al., 2001; Lieschke et al., 2002). Therefore, the spi1b promoter
drives myeloid-specific expression in transgenic zebrafish (Ward et al., 2003). Since
microglia derive from spi1b-positive cells, they are together with myeloid precursor
cells, macrophages, and neutrophils, green fluorescent protein (GFP)-positive in the
transgenic line Tg(spi1b:Gal4/UAS:EGFP) (Herbomel et al., 2001; Peri and Nüsslein-
Volhard, 2008). Neutrophils in zebrafish express myeloid-specific peroxidase (mpx ) an
orthologue to the mammalian myeloperoxidase (Bennett et al., 2001; Lieschke et al.,
2001). In the transgenic line Tg(mpx :GFP) neutrophils are GFP-positive (Mathias
et al., 2006; Renshaw et al., 2006). Interestingly, low levels of mpx are expressed
by some inflammatory macrophages, too. Therefore, these are also labeled in the
Tg(mpx :GFP) (Mathias et al., 2009). The antibacterial enzyme lysozyme (Lyz) was
proposed to be a macrophage-specific protein (Liu and Wen, 2002). However, a more
precise evaluation of the Tg(lyz :EGFP) revealed that GFP is expressed initially in
macrophages and neutrophils but at later stages GFP expression is more or less restricted
to neutrophils (personal communication A. Meijer; Feng et al., 2010; Hall et al., 2007).
A microarray approach to identify genes that are specifically expressed by macrophages
identified macrophage-expressed gene 1 (mpeg1 ). The transgenic line using the mpeg1
promoter, Tg(mpeg1 :mCherry), shows mCherry expression in macrophages but also in
microglia, making it a great transgenic line to study these two cell types (Ellett et al.,
2011; Svahn et al., 2013; Zakrzewska et al., 2010). In situ hybridization in zebrafish
larvae demonstrated that apolipoprotein Eb (apoeb) is a marker for microglia in zebrafish,
but in the transgenic line Tg(apoeb:lynEGFP) microglia and additionally some radial
glia cells are positive for GFP (Herbomel et al., 2001; Peri and Nüsslein-Volhard, 2008).
The set of transgenic lines described here labels the myeloid lineage, macrophages,
neutrophils, and microglia and provides great tools to study the immune response by in
vivo imaging.
3.7.3 Assays to study wound healing and regeneration in zebrafish
Immune cells are present in healthy, uninjured models but for the examination of
an immune cell response an injury or other inflammatory stimulus is needed that
triggers an inflammatory response. After an injury, for example, a wound is repaired by
diverse processes that take place simultaneously and involve various cell types. First,
cutaneous wounds are sealed. Then, chemotactic signals from the wound lead to an
inflammatory response, recruiting neutrophils and macrophages or microglia to the lesion
site. Neutrophils quickly infiltrate the damaged tissue and phagocytose, degranulate,
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produce and release reactive oxygen species (ROS), or participate in the formation
of extracellular nuclear traps. Macrophages follow the neutrophils to the wound site.
They ingest foreign substances and apoptotic debris, but they also secret chemotactic
substances like chemokines. Moreover, macrophages play a role in tissue rearrangement
and regeneration (Deng and Huttenlocher, 2012; Ellett et al., 2011; Li et al., 2012). In
the brain microglia fulfil the role of peripheral macrophages (Schlegelmilch et al., 2011;
Sieger and Peri, 2013). After the recruitment of immune cells, the wound is repaired by
various processes, the inflammation is resolved, and either the tissue is regenerated or a
scar is formed. In contrast to mammals, where scar formation is the usual outcome,
zebrafish have a very high regenerative capacity. They can regenerate injuries in the
brain and amputations of appendices in size and shape without the formation of a scar,
even as an adult organism (Gemberling et al., 2013; Murawala et al., 2012; Yoshinari and
Kawakami, 2011). To analyse the inflammatory response and regeneration in zebrafish
various assays in larvae and adult zebrafish have been established.
3.7.3.1 Larval injury and wounding assays
In zebrafish larvae tail fin amputation or laser ablation of cells in the periphery or
the larval brain are often used to study inflammatory processes and regeneration
(Fig. 3.3) (Cvejic et al., 2008; Sieger et al., 2012; Yoshinari and Kawakami, 2011).
After tail fin amputation in embryos or larvae the epithelial cells contract and seal the
Figure 3.3 – Schematic illustration of the tail fin amputation and regeneration in zebrafish
embryo/larvae. After amputation of the tail fin at 48hpf, the epithelial cells contract and
seal the wound (wound epithelium). Then a blastema forms and cells start to proliferate.
By 72 hours post amputation the tail fin has recovered. Modified from Yoshinari and
Kawakami (Yoshinari and Kawakami, 2011).
wound (wound epithelium) (Yoshinari and Kawakami, 2011). In parallel, a hydrogen
peroxide (H2O2) gradient forms, which is required for the recruitment of neutrophils and
macrophages to the wound (Niethammer et al., 2009). By in vivo imaging it was shown
that neutrophils arrive first at the wound site and that they migrate faster to the wound,
but with less directionality than macrophages. Macrophages arrive at the wound from 6
hours post amputation (hpa) onwards and persist longer at the wound margin. A lack
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of neutrophils enhances regeneration slightly, whereas a lack of macrophages impairs the
regenerative process (Ellett et al., 2011; Li et al., 2012). After approx. 12hpa a blastema
forms next to the stump surface. Proliferating cells from this region differentiate into
all kinds of cell types, needed to regenerate the finfold in size and shape and by 72hpa,
the larval fin is restored (Kawakami et al., 2004; Li et al., 2012; Yoshinari et al., 2009).
Mechanical induction of wounding/injuries is time-consuming and a rate-limiting step.
This makes tail fin amputation assays not suitable for medium- to high-throughput
screens. To circumvent this a chemically induced inflammation (ChIn) assay was estab-
lished. Zebrafish larvae are soaked in copper sulfate (CuSO4) solution. This treatment
causes rapidly cell death of sensory hair cells in the lateral-line system. Neutrophils
respond to the cell death and are quickly recruited to the damaged neuromasts. This
migration can be visualized in transgenic neutrophil-labeled zebrafish lines, also by au-
tomated imaging. Therefore, this assay is suitable for high throughput pharmacological
and genetic screens (d’Alençon et al., 2010; Wittmann et al., 2012).
3.7.3.2 Adult zebrafish injury models
Zebrafish larvae and embryos are suitable for a whole range of experiments but sometimes
an issue precludes an analysis during developmental stages. If, for example, the
regenerative potential in adult zebrafish should be addressed it is apparent that injury
experiments in adult zebrafish are more suitable (Gemberling et al., 2013). Due to its
simplicity and accessibility the amputation of the tail fin is a frequently used regeneration
assay in adult zebrafish. It was shown that the fin is reconstituted in size and shape
within approx. 10 days after amputation (Yoshinari and Kawakami, 2011). Despite
some differences in the larval and adult finfold, the cellular and molecular mechanism
involved seem to be similar (Kawakami et al., 2004).
Another regeneration assay that gained interest in the recent years is the stab wound
injury in the adult zebrafish telencephalon, a model for traumatic brain lesions (Ayari
et al., 2010; Baumgart et al., 2012; Kroehne et al., 2011; März et al., 2011). Soon
after the injury a strong inflammatory response can be observed. The number of
microglia and leukocytes increases in the injured hemisphere and the expression levels
of proinflammtory cytokines are elevated. After only a few days the acute inflammatory
response is resolved. Cells of radial glia origin from the ventricular zone populate
the lesion site and differentiate into functional neurons. In contrast to mammals, no
permanent glial scarring can be observed, highlighting the regenerative potential of the
zebrafish brain (Kroehne et al., 2011; Kyritsis et al., 2012; März et al., 2011). In future,
a detailed knowledge of the mechanisms involved as well as a possible transfer into
therapies for patients suffering from neurodegenerative diseases might be of fundamental
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importance.
For both assays the morphological changes and cells that participate in inflammation and
regeneration have been described. Nevertheless, the complex processes of regeneration
are still poorly understood and only a few signaling molecules involved are described so
far (Gemberling et al., 2013; Yoshinari and Kawakami, 2011).
3.8 Generation of loss of function zebrafish
When modeling the effect of disease-related mutations in a model organism it is very
useful to carefully evaluate beforehand if the disease might be triggered by a loss of the
functional protein or by the aggregation of an aberrant protein. These reflections should
have a direct impact on the approach chosen for the generation of the model. In both
FTLD-TDP/GRN and NCL/GRN the mutations result in a reduction or depletion of
GRN, respectively (Baker et al., 2006; Cruts et al., 2006; Shankaran et al., 2008; Smith
et al., 2012). Therefore, a zebrafish GRN model should be a loss of function model,
too. In the following, targeted genome editing, which was used for the generation of
the zebrafish GRN mutants, is discussed in the context of earlier strategies to perform
mutagenesis in zebrafish, as targeted genome editing became feasible only a few years
ago.
3.8.1 History of forward and reverse genetics in zebrafish
To gain insights into gene function in vivo, one can either mutate a specific gene of interest
and analyse the organism for resulting phenotypes (reverse genetics), or one observes a
phenotype and searches for the mutated gene responsible for the observed phenotype
(forward genetics) (Fig. 3.4). In the early days of molecular genetics forward genetics
using mutagens was the state-of-the-art since tools to perform reverse genetics were
still lacking. In zebrafish unbiased forward genetic screens were performed using e.g. γ-
irradiation, retroviruses, or chemicals like N-ethyl-N-nitrosouresa (ENU) as mutagens.
Depending of the breeding scheme the F2 or F3 generation was analysed for phenotypes,
followed by the identification of the causative mutation (Fig. 3.4A) (Lawson and Wolfe,
2011). In contrast to other organisms reverse genetics using targeted mutagenesis was
not feasible in zebrafish due to a lack of zebrafish embryonic stem cell cultures. For
some years the solution was either to perform a targeted KD or to do a forward random
mutagenesis screen. For the first approach, the anti-sense KD, e.g. MO that inhibit
either translation or splicing of a gene of interest can be used. This technology is very
popular, cheap, and quick. Nevertheless, it often leads only to a partial and transient
loss of the protein of interest (Bill et al., 2009) and suffers sometimes from off-target
effects or toxicity. One of the first approaches used for reverse genetics in zebrafish
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was TILLING (targeted induced local lesions in genomes) (Wienholds et al., 2002).
TILLING combines random mutagenesis by e.g. ENU in the whole genome with specific
screening for mutations in a previously selected gene of interest in the F1 generation
(Fig. 3.4B). This approach provides an inheritable loss of function mutation, but is time,
labor, and cost intensive (Moens et al., 2008). In 2008 zinc finger nucleases (ZFNs)
were shown to be functional in zebrafish and the introduction of targeted, inheritable
lesions in the zebrafish genome became possible for the first time (Fig. 3.4C) (Doyon
et al., 2008; Meng et al., 2008).
Figure 3.4 – Forward and reverse genetics in zebrafish. There are three possible approaches
to link a phenotype to a gene. A: In forward genetics, first random mutagenesis is
performed, then phenotypic alterations are identified, and finally the genome is analysed
for the causative mutation. B: In for example TILLING, random mutagenesis is performed
and offspring are screened for mutations in a gene of interest. Mutation carriers are then
analysed for phenotypic alterations. C: Targeted mutagenesis or genome editing induces
mutations in pre-selected genes. The offspring are then analysed for phenotypic alterations.
Modified from Schier (Schier, 2013).
3.8.2 Targeted mutagenesis in zebrafish by genome editing
ZFN, transcription activator-like effector nucleases (TALENs), and the clustered reg-
ularly interspaced short palindromic repeats/CRISPR-associated 9 (CRISPR/Cas9)
system (Gaj et al., 2013), induce double-strand breaks (DSB) in the genome, which
are either repaired by homology-directed repair (HDR) or non-homologous end joining
(NHEJ) (Schmid and Haass, 2013). NHEJ is in comparison to other cellular repair mech-
anisms error-prone and induces insertions, deletions, or a combination of both, which
can lead to loss of function mutations in the selected gene of interest (Fig. 3.5) (Schmid
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Figure 3.5 – Graphic illustration of genome editing and possible results - integration,
deletion, and insertion. Nucleases induce double-strand breaks at a pre-selected target
sequence. The nucleases are targeted to their target site by sequence-specific DNA binding
elements. The DSB can either be repaired by homology directed repair (HDR), which
can lead to the integration of foreign DNA, when the DNA is flanked by homologous
sequences, or by non-homologous end joining (NHEJ), an error-prone repair mechanism
that can generate deletions or insertions.
and Haass, 2013). Potential loss of function mutations are mutations that cause a
shift in the reading frame of the targeted gene of interest. If a premature translation
termination (preTT) codon is introduced by the mutation, the aberrant mRNA is most
likely recognised and efficiently degraded by the cell’s own nonsense-mediate mRNA
decay (NMD) machinery resulting in a loss of protein (Vicente-Crespo and Palacios,
2010; Wittkopp et al., 2009). In the last years several genome editing technologies
emerged, which are summarised herein.
3.8.2.1 Zinc finger nucleases
ZFNs, which were the first technology to perform genome editing in zebrafish, are
composed of an engineered tandem array of DNA binding Cys2His2 zinc-finger (ZF)
fused to the nuclease domain of a type IIS FokI endonuclease (Kim et al., 1996). The
DNA-binding ZF moiety of the chimeric ZFN guides the nonspecific nuclease moiety to
a specific, pre-selected target site in the DNA (Cathomen and Joung, 2008; Hafez and
Hausner, 2012). ZF DNA-binding domains consist of three to six ZFs, each recognizing
three DNA base pairs (bp) (Hafez and Hausner, 2012; Urnov et al., 2010). Since the
FokI nuclease domain is only enzymatically active as a dimer, two ZFN monomers
need to recognize their 9bp to 18bp target sequence in the DNA in close vicinity to
form an active dimer. ZFN monomers are designed to bind the DNA in a tail-to-tail
conformation to form a nuclease dimer, which is able to induce a DSB in the 4bp
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to 6bp nucleotide spacer between the ZFN binding sites (Fig. 3.6) (Cathomen and
Joung, 2008; Porteus and Carroll, 2005). Site-specific DNA DSBs are then repaired by
the cell endogenous repair mechanisms NHEJ or HDR (Fig. 3.5) (Urnov et al., 2010).
One challenge with ZFNs is the construction and evaluation of the ZF DNA-binding
Figure 3.6 – Graphic illustration of ZFNs binding to DNA enabling DNA cleavage. Two
ZFNs with four ZFs (multi-coloured) bind sequence specific to the DNA on the forward
and the reverse strand allowing the FokI nucleases to form a heterodimer (yellow and
black) and cleave the DNA.
domains, as the binding affinities of a single ZF moiety is context dependent. ZFNs and
ZF DNA-binding domains can either be generated in-house by the modular assembly
method, which has a low success rate, or by a combinatorial selection of engineered
multifinger proteins, which requires some expertise and is labor-intensive. Another
option is to outsource the generation of the whole ZFNs to e.g. Sigma-Aldrich with
their proprietary ZF design platform. This is cost-intensive but was shown to produce
very efficient ZFNs (Cathomen and Joung, 2008; Leong et al., 2011). To date ZFNs
were used successfully in cell culture systems and in many model organisms for gene
disruption, correction, and addition (Urnov et al., 2010). In zebrafish, ZFNs were so far
only used for gene disruption, since HDR is a very rare event in this context (Doyon
et al., 2008; Meng et al., 2008). The on- to off-target ratio of ZFN-induced lesions
is high. Nevertheless, there are possibilities to enhance the specificity of ZFNs. By
using obligatory heterodimeric FokI nucleases a DNA binding and cleavage of two
identical (e.g. forward only) ZFNs is prevented (Miller et al., 2007) and also an increased
number of ZFs reduces the amount of potential off-target sites in the genome (Gupta
et al., 2011). Moreover, decreasing the injection dose is reducing off-target induced
toxicity in zebrafish (Doyon et al., 2008; Gupta et al., 2011). Additionally, it was shown
in one of the first publications that in outcrossing of ZFN-injected zebrafish (P0) no
off-target lesions could be identified in the F1 generation (Gupta et al., 2011). Therefore,
extensive, time-consuming outcrossings that were necessary after ENU mutagenesis are
no longer required using this technology.
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3.8.2.2 Transcription activator-like effector nucleases
The second genome editing technology is similar to ZFNs. Like ZFNs, TALENs
are composed of a DNA binding domain and a nuclease domain. The DNA binding
domain, transcription activator-like effector (TALE), was identified in the plant pathogen
Xanthomonas and in contrast to ZF each of the tandem repeats (as many as 30) binds
to 1bp in the DNA target site via two hypervariable amino acids (Boch et al., 2009;
Moscou and Bogdanove, 2009). When fusing the TALE with a FokI nuclease domain
(TALEN), two TALENs can induce DSB like it was previously reported for ZFNs
(Fig. 3.7) (Christian et al., 2010). Soon after the description that TALENs were
Figure 3.7 – Graphic illustration of TALENs binding to DNA enabling DNA cleavage.
Two TALENs bind with their TALEs (multi-coloured) sequence specific to the DNA on
the forward and the reverse strand allowing the FokI nucleases to form a heterodimer
(yellow and black) and cleave the DNA. TALE array (multi-coloured).
effectively used in human cell culture for targeted genome editing, TALENs were also
used for targeted genome editing in zebrafish (Huang et al., 2011; Miller et al., 2010;
Sander et al., 2011). The big advantage of TALENs is that the generation of the DNA
binding domain is faster and easier than that of the ZF DNA-binding domains of ZFNs.
Contrary to ZFs, TALE binding is not context dependent and DNA binding is easier to
predict. Therefore, TALE DNA-binding domains can be done in-house by more or less
simple cloning. Moreover, TALENs are equally or more mutagenic than ZFNs (Chen
et al., 2013a; Moore et al., 2012). Additionally, TALENs and single-stranded DNA
oligonucleotides or linearized donor DNA were used for precise targeted insertions in the
zebrafish genome by HDR, which was not achieved before with this efficiency (Bedell
et al., 2012; Zu et al., 2013). Another advantage of TALENs is that the nuclease-
associated toxicity of TALENs is lower than that of ZFNs (Mussolino et al., 2011).
TALENs are now preferred over ZFNs for targeted genome editing.
3.8.2.3 CRISPR/Cas9 system
The latest tool for genome editing, the CRISPR/Cas9 system, differs from ZFNs and
TALENs in the facts that the DNA is recognized by Watson-Crick base pairing by a
guide RNA (gRNA) and that the RNA-guided endonuclease (RGEN), Cas9, functions
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as a monomer (Cho et al., 2013; Schmid and Haass, 2013). The CRISPR/Cas system is
derived from bacteria and archaea and is used as an adaptive immune system, protecting
them from infections by viruses and plasmids (Bhaya et al., 2011). There are at least
three types of those prokaryotic CRISPR/Cas systems and of these the type II systems
are best established for RGEN genome editing. Among these the CRISPR/Cas9 system
of Streptococcus pyogenes is the best studied. Originally it requires a CRISPR RNA
(crRNA), a trans-activating crRNA (tracrRNA), and the endonuclease Cas9. The
crRNA is binding with its 5’ end to a 20 nucleotide DNA sequence, next to a NGG
protospacer adjacent motif (PAM) on the opposite strand. The tracrRNA base-pairs
Figure 3.8 – Graphic illustrations of the CRISPR/Cas9 system. A: The original
CRISPR/Cas9 system. a crRNA (blue) base-pairs sequence specific to a selected DNA
sequence. The only requirement is a nearby NGG protospacer adjacent motif (PAM)
on the opposite strand. tracrRNA (red) is binding to the crRNA and the complex is
recognised by the nuclease Cas9 (green), which can induce a DSB upon binding. B: The
modified CRISPR/Cas9 system. Instead of a crRNA a gRNA (purple) that is a fusion of
the crRNA and the tracrRNA binds to the DNA. This DNA-gRNA complex is recruits
the Cas9 (green) to the DNA.
with the crRNA and both form a specific structure, that is recognized by the Cas9
endonuclease, which is then inducing DSBs (Fig. 3.8A). To reduce the complexity of the
system the two RNAs, tracrRNA and crRNA, were engineered to a single RNA chimera,
termed gRNA, which is still efficiently recruiting Cas9 for site-specific DNA cleavage
(Fig. 3.8B) (Jinek et al., 2012). The CRISPR/Cas9 system was quickly applied in
eukaryotic cells for targeted genome editing. To enhance the nuclear localisation of Cas9
and improve the efficiency, a nuclear localisation sequence was added to Cas9 (Cong
et al., 2013; Jinek et al., 2013; Mali et al., 2013). In zebrafish the CRISPR/Cas9 system
was also used successfully to induce mutations at a selected genomic locus and for
knock in by HDR (Chang et al., 2013; Hruscha et al., 2013; Hwang et al., 2013a,b;
Xiao et al., 2013). Like all genome editing technologies, the CRISPR/Cas9 system can
induce mutations at off-target sites, too. The advantage of this genome editing system
is, however, that the off-target sites are easier to predict as they rely on Watson-Crick
base pairing as well (Cho et al., 2014). The on- to off-target ratio of the CRISPR/Cas9
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system seems to be comparable to ZFNs and TALENs and targeting off-targets can
be reduced in zebrafish by using lower mRNA concentrations of Cas9 (Cho et al.,
2013; Fujii et al., 2013; Hruscha et al., 2013). Compared to ZFNs and TALENs, the
CRISPR/Cas9 system is less time- and cost-consuming, but still displays comparable
efficiencies (Schmid and Haass, 2013). Therefore, the CRISPR/Cas9 system is now
widely used for genome editing in cell culture as well as in animal and plant models
and still offers many applications and modifications to be discovered.
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4 Material and Methods
4.1 Material
4.1.1 Zebrafish lines
The zebrafish lines used in this study are listed below. ZFN mutants were generated by
injections into the wildtype-line AB.
Zebrafish line Origin (Reference)
wildtype-line AB G. Streisinger, Institute of Neuroscience, University
of Oregon, Eugene, USA
wildtype-line TLF C. Nüsslein-Volhard, MPI for Developmental Biology,
Tübingen, Germany
Tg(apoeb:lynEGFP)zf147Tg F. Peri, EMBL, Heidelberg, Germany (Peri and
Nüsslein-Volhard, 2008)
Tg(fli1a:EGFP)y1Tg J. Bussmann, MPI for Molecular Biomedicine, Mün-
ster, Germany (Lawson and Weinstein, 2002)
Tg(kdrl :HRAS-mCherry)s896Tg P. Hammerl, Helmholtz Center Munich, Munich, Ger-
many (Chi et al., 2008)
Tg(lyz :EGFP)nz117Tg A. Mahagaonkar, Molecular Medicine and Pathology,
University of Auckland, Auckland, New Zealand (Hall
et al., 2007)
Tg(mpeg1 :mCherry) used in the laboratory of A. Meijer, Institute of Bi-
ology, Leiden University, Leiden, Netherlands (gen-
erated in the laboratory of George Lutfalla, unpub-
lished)
Tg(mpx :GFP)i114Tg used in the laboratory of A. Meijer, Institute of Biol-
ogy, Leiden University, Leiden, Netherlands (Renshaw
et al., 2006)
Tg(spi1b:Gal4/UAS:EGFP)zf149Tg F. Peri, EMBL, Heidelberg, Germany (Peri and
Nüsslein-Volhard, 2008)
4.1.2 Cell lines
Cell line Origin
HEK293T ATCC-Nr. CRL-1573
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4.1.3 Vectors and plasmids
The following vectors and plasmids were used, # indicates the number in the Schmid
laboratory plasmid database:
Vector Insert Origin #
pCR8/GW/TOPO - Invitrogen -
pCRII TOPO - Invitrogen -
pCS2+GW-A GW-Reading Frame A M. Teucke E04
pCS2+GW-A (vice versa) GW-Reading Frame A M. Teucke E03
IRBOp991G0282D grn1 cDNA imaGenes I24
IRBOp991A1165D grn2 cDNA imaGenes I25
pZFN1_grnb set1 ZFN1 grnb set1 Sigma-Aldrich H21
pZFN2_grnb set1 ZFN2 grnb set1 Sigma-Aldrich H22
pZFN3_grnb set2 ZFN3 grnb set2 Sigma-Aldrich H23
pZFN4_grnb set2 ZFN4 grnb set2 Sigma-Aldrich H18
pZFN5_grnb set3 ZFN5 grnb set3 Sigma-Aldrich H19
pZFN6_grnb set3 ZFN5 grnb set3 Sigma-Aldrich H20
pZFN1_grna set1 ZFN1 grna set1 Sigma-Aldrich H55
pZFN2_grna set1 ZFN2 grna set1 Sigma-Aldrich H56
pZFN3_grna set2 ZFN3 grna set2 Sigma-Aldrich H57
pZFN4_grna set2 ZFN4 grna set2 Sigma-Aldrich H58
pCS2+GW-A_grna grna B. Solchenberger L24
pCS2+GW-A_grna+MYC grna+MYC B. Solchenberger L25
pCS2+GW-A_grna_wt(AB) grnawt (AB) B. Solchenberger M51
pCS2+GW-A_grna_wt(TLF) grnawt (TLF) B. Solchenberger M52
pCS2+GW-A_grnb grnb B. Solchenberger H25
pCS2+GW-A_grnb+MYC grnb+MYC B. Solchenberger H63
pCS2+GW-A_grn1 grn1 B. Solchenberger I29
pCS2+GW-A_grn1+V5 grn1+V5 B. Solchenberger L03
pCS2+GW-A_grn2 grn2 B. Solchenberger I43
pCS2+GW-A_grn2+V5 grn2+V5 B. Solchenberger I41
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4.1.4 Oligonucleotides
Oligonucleotides were synthesized by Thermo Scientific or Sigma-Aldrich. Sequences
are given in 5’-3’ orientation. Abbreviation and number in the oligonucleotide name
refer to the Schmid laboratory oligonucleotide database.
Primer for cloning:
BS-E21 grnb+MYC R TTATTCATTCAAGTCCTCTTCAGAAATGA
GCTTTTGCTCCATGAGAGAATTATTCCAC
CACGT
BS-E27 grn2 F long ATGTTCCCAGTGTTGATGTTACTCATGGC
GGCTCTGGTGGCTGCA
BS-E28 grn1+Myc R TTATTCATTCAAGTCCTCTTCAGAAATGA
GCTTTTGCTCCATCCCCAACTCCAACCCG
CTG
BS-E29 grn2+V5 R TCACGTAGAATCGAGACCGAGGAGAGGGT
TAGGGATAGGCTTTCCACCCCCCAACTCC
AACTCGCTGCAGC
BS-E32 grna STOP XbaI R GCTCTAGAGCTTATAGAGTTAGGGCTCGT
TTC
BS-E33 grna+Myc XbaI R GCTCTAGAGCTTATTCATTCAAGTCCTCT
TCAGAAATGAGCTTTTGCTCCATCCCTAG
AGTTAGGGCTCGTTTC
BS-E35 grn2 R TTTGCTTACAACTCCAACTCG
BS-E36 grna F in TCCACCTGCTCAAAAAATGT
BS-E37 grna F out CCGCTGTTCACAAATCCA
BS-E38 grna R in GTGCTGCTGTGATGTTTATA
BS-E39 grna R out CTTGAGCATGTAAGTGTC
BS-F36 grn1+V5 R TCACGTAGAATCGAGACCGAGGAGAGGGT
TAGGGATAGGCTTTCCACCCCCCAACTCC
AACCCGCTG
oA01 M13 F TGTAAAACGACGGCCAGT
oA02 M13 R CAGGAAACAGCTATGACC
oC48 grnb F ATGGTGCGTGCAGCTTTCAT
oC49 grnb R TTAGAGAGAATTATTCCACCACGT
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oC54 grn1 F ATGTTCCCAGTGTTGATGTTAC
oC55 grn1 R TTACAACTCCAACCCGCTG
oC70 grna UTR F CTGCTCAAAAAATGTTGAGACTG
Primer for sequencing:
BS-A05 grna E9-10 F AGCCTGAAACTCAACGCACT
BS-A35 GRnARTPCRex6FORself2 GCTGTATGCTGTGATGACAA
BS-A11 grnb E9-10 F CAAAAGCACTGCTGTCCAGA
BS-A18 zfGRNBseqCxRev GCACACGGCATTTTTCATAGG
BS-A40 zfGRNBRTPCRex2For ACTGCTGTTATCAGGGAACTTTGT
BS-B01 zfGRNRTPCRBex6Bfor TACTAGAGACCGGTAGTTACGGATG
BS-B02 zfGRNBexon7Brev CTGACAAACACGTACTATGGATGAG
BS-B05 zfGRNBgATCpos1301For CGTGTCCAACCGGGACCACCTGCTG
BS-B07 zfGRNBgATCpos1901For GCTACATCTGTAAGCTGGAGTTAGG
BS-B10 grnb E6-7-gen E6 R TACACGATTTTGCCGTTGAA
BS-B11 grnb E6-7-gen E7 F CAGAATTCGCCACAGTGAAA
BS-B12 grnb E6-7-gen E7 R GCATCCGTAACTACCGGTCT
BS-B13 grnb E9-10-gen E9 R CAAAAGCACTGCTGTCCAGA
BS-B14 grnb E9-10-gen E10 F CCCCATTTTCCCCTGTTATT
BS-B15 grnb E9-10-gen E10 R GCACAAAGCATGACTGACCA
BS-B16 grna E9-10-gen E9+10 R GCTGCGTTCCAGACACAGTA
BS-B17 grna E13-14-gen E13+14 F CGGCACCATGAAACAGTAGA
BS-B18 grna E13-14-gen E13+14 R TTCACGCTTACCTTTGCTTG
BS-C07 ZfGRNaENS5’UTR6 GGAGATCATCTGCCTCCAAT
BS-C18 zfgrnBENSexon3Rev ATTTTTCATAGGACAGCAGCCCCAG
BS-C24 ZFGRNb5’UTR5BRev AAGTGAGATCTGTGAGGGGTGT
BS-D38 grna_ex3R GCGTGGATGTGTAAATGGTG
BS-D39 grna_ex4+5F CCTCTTGCCTCAACACACCT
BS-D40 grna_ex4+5R GGTGCCAGATACCAGCATTT
BS-E01 grna_ex6+7F CTGCTGGCCACATATCTTCA
BS-E02 grna_ex6+7R GGCATTACTGCGTGGAGTTT
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BS-E03 grna_ex8+9F ACCACCATAAAATGCCAAGG
BS-E04 grna_ex8+9R GCAAAACTTGCCTGACATGA
BS-E05 grna_ex11+12F CAGGAAAATTAGCGCAGAGC
BS-E06 grna_ex11+12R CTCAAGCTTTCCCAGAGCAC
BS-E07 grna_ex16/17F GGGCTAGTTGGGATGGGTAT
BS-E08 grna_ex16/17R CCAGAAAATCATCCAGAAAATCA
BS-E09 grnb_ex3F TTTCTCACCACTTAGCGAATGTA
BS-E10 grnb_ex4F TGTAAAGTGTTACCGTTTATTCCTT
BS-E11 grnb_ex5+6F CCGAAACACTGCACACACTC
BS-E12 grnb_ex8+9F TTGAAACTGACACCTCAGTATGTG
BS-E13 grnb_ex11F TTTCAAATCCGTTGTGTTGG
BS-E14 grnb_ex11R TGGCAGGGCAAGTAAAAATC
BS-E15 grnb_ex12F TTTGCGTGTACTAGTTTTTAGATCG
BS-E16 grnb_ex12R TTTCCCAAAGGGTTATCGAA
BS-E26 grna Seqcheck CATTCTCCAGCAATGTTCTTACAG
BS-F60 grna F for Seq. ROI1 ACACCTGTGCAATCAACTACTA
BS-F61 grna R for Seq. ROI2 CTCGACTGTTCATCGCATTTA
GATC grnb F V7 TTTGCACTGCCACACAC
GATC M13-FP TGTAAAACGACGGCCAGT
GATC M13-RP CAGGAAACAGCTATGACC
GATC SP6 ATTTAGGTGACACTATAGAA
GATC T7-981079 TAATACGACTCACTATAG
Primer for genotyping:
BS-E22 grnb ZFN F AATGACACAAGACGTCCTCATAAA
BS-E23 grnb ZFN R AAAAATAATAACCACAGCGCAACT
BS-E24 grna ZFN F TTCAGTCATTGTTTCAGAGGTCA
BS-E25 grna ZFN R TTCCTCTGATCCACTTTCTACCA
Primer for quantitative PCR:
BS-F72 FLNCa E4748 F CCTTCGTGGGTCAGAAGAAC
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BS-F73 FLNCa E4748 R GGAGTTCTAGGACCGTGGAC
BS-G06 grn1/grn2 ex34 Fa CCACCAGAACCTTCCAGAAA
BS-G07 grn1/grn2 ex34 Ra TGGCCAGTTCTAGTCTTGCAG
BS-G20 ctsd ex23 F GAAATACAACCTGGGCTTCC
BS-G21 ctsd ex23 R GAAGGTCTGGACAGGAGTGC
BS-G46 grnb ex68 F GTCGCAGGAAGCCATTAGAG
BS-G47 grnb ex68 R CAGCATGTTGTATCTTCTGGACA
BS-G62 ctsba ex78 F ACAGCCCCTCTTACAAGCAA
BS-G63 ctsba ex78 R TCCCTCTACTGGACCGTTCTT
BS-G68 ctsbb ex45 F GCCGAACTGTAAGACCCTCA
BS-G69 ctsbb ex45 R TGCTTCCCTTTACTGTGGATG
BS-G74 actb1 ex12a F GATCTTCACTCCCCTTGTTCA
BS-G75 actb1 ex12a R AAAACCGGCTTTGCACATAC
BS-H01 tbp ex23a F TCAGCATGGAGCAGAACAAC
BS-H02 tbp ex23a R CCCATACGGCATCATAGGAC
BS-H14 grna ex2324 F ACCACATGGGGATGTTGC
BS-H15 grna ex2324 R CCAAGTCTCCGGCTGAAATA
BS-H22 aldh1a2 ex1112 F GGCCGTCTTCACCAGAGATA
BS-H23 aldh1a2 ex1112 R TGAATCCTCCGAAAGGACAC
BS-H24 apoeb ex13 F GCTCCACACGGAGAAAAATC
BS-H25 apoeb ex13 R GCCTGGAACAGGCTACGAG
BS-H42 stat3 ex1112 F CCAGCTCAAAATCAAAGTGTG
BS-H43 stat3 ex1112 R TTGGATTCCTCCATGTTCATC
BS-H44 mmp9 ex23 F GGAGACCTGAAGTGGGATCA
BS-H45 mmp9 ex23 R AGCTCTGGCAAAAGCATCAT
BS-H50 flncb ex1213 F GGCCCTACAAAGTGGACATC
BS-H51 flncb ex1213 R CTTCAAACCAGGCCCATAAG
oA03 β-actin F TGTTTTCCCCTCCATTGTTGG
oA04 β-actin R TTCTCCTTGATGTCACGGAC
eif4a1b FW TTCAGAAACTCAGTACTAGCATACA
eif4a1b RV GTGACATCCAACACCTCTGC
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Eif5 FW CAAGTTTGTGCTGTGTCCCG
Eif5 RV AGCCTTGCAGGAGTTTCCAA
4.1.5 Bacteria
DH5α E. coli competent cells Hanahan (Hanahan, 1983)
One Shot TOP10 Chemically Com-
petent E. coli, C4040
Invitrogen
4.1.6 Antibodies
The following antibodies were used for whole mount immunofluoresecence stainings (IF)
and Western blotting (WB).
Primary antibodies:
Antibody (Species) Dilution Origin (Reference)
α-actinin, A7811 (mouse) IF: 1:500 Sigma-Aldrich (Schmid et al., 2013)
α-tubulin, T6199 (mouse) WB:
1:10000
Sigma-Aldrich
Calnexin, SPA-860 (rabbit) WB:
1:10000
Stressgen
Cathepsin D (rabbit) WB: 1:8000 C. Follo, Department of Medical Sci-
ences, University of Piemonte Orientale
“Amedeo Avogadro”, Novara, Italy (Follo
et al., 2011)
F59 (mouse) IF: 1:100 DSHB (Hammond et al., 2007)
FLAG M2-Peroxidase, A8592 WB: 1:2000 Sigma-Aldrich
MYC 9E11 (mouse) WB: 1:50 Institute of Molecular Immunology
(IMI), Helmholtz Center Munich
Pax7 (mouse) IF: 1:100 DSHB (Feng et al., 2006)
V5, AB3792 (rabbit) WB: 1:2000 Chemicon
ZE-BO 1F4 (rat IgG2a) IF: 1:50 E. Kremmer (Prengel, 2000)
zn1 (mouse) IF: 1:100 DSHB (Trevarrow et al., 1990)
znp1 (mouse) IF: 1:100 DSHB (Trevarrow et al., 1990)
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Primary peptide antibodies generated by the IMI, Helmholtz Center Munich:
Antibody (Species) Dilution Epitope
grna 12E7-111 (rat IgG2b) WB: 1:1 KQKKPETQRTTTRPTGTTS
grnb 11F4-11 (rat IgG2c) WB: 1:1 CTKSSSSTWWNNSL
Secondary antibodies:
Antibody Dilution Origin
anti-mouse IgG, HRP conj., W4021 1:5000 Promega
anti-rabbit IgG, HRP conj., W4011 1:10000 Promega
anti-mouse IgG1, HRP conj. 1:12000 IMI, Helmholtz Center Munich
anti-mouse IgG2a/b, HRP conj. 1:12000 IMI, Helmholtz Center Munich
anti-mouse IgG3, HRP conj. 1:12000 IMI, Helmholtz Center Munich
anti-rat IgG1, HRP conj. 1:8000 IMI, Helmholtz Center Munich
anti-rat IgG2a, HRP conj. 1:12000 IMI, Helmholtz Center Munich
anti-rat IgG2b, HRP conj. 1:2000 IMI, Helmholtz Center Munich
anti-rat IgG2c, HRP conj. 1:32000 IMI, Helmholtz Center Munich
Alexa Fluor 488 anti-mouse,
A-11029
1:500 Invitrogen
Alexa Fluor 555 anti-rat, A-21434 1:500 Invitrogen
4.1.7 Chemicals
4.1.7.1 Chemicals and reagents
Acetic acid, 100063.2511 Merck
Acridine orange (AO), 235474 Sigma-Aldrich
Acrylamide / bis solution, 10681.03 Serva
Agarose, 15510-027 Invitrogen
Ammonium persulfate (APS), 9592.2 Roth
Ampicillin, K029.2 Roth
Amplify fluorographic reagent, NAMP100 Amersham Biosciences
β-Mercaptoethanol, 4227.1 Roth
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Bacto agar, 214030 BD
Bacto trypton, 211699 BD
Boric acid, 100165.1000 Merck
Bovine serum albumin (BSA), A8022 Sigma-Aldrich
Bromophenol blue, 18030 Fluka
Calcium chloride (CaCl2), 102382.0500 Merck
Chloroform/isoamylalcohol, X984.1 Roth
Collagenase, C9891 Sigma-Aldrich
Copper(II) sulfate (CuSO4) 102790.0250 Merck
DanKlorix Colgate-Palmolive
DePex mounting medium e.g. Sigma-Aldrich
Deoxynucleoside triphosphates (dATP, dCTP, dGTP, dTTP) Thermo Scientific
Diethylpyrocarbonate (DEPC), D5758 Sigma-Aldrich
Dimethyl sulfoxide (DMSO), 317275 Merck
Disodium hydrogen phosphate (Na2HPO4), 106580.5000 Merck
Dithiothreitol (DTT) (100mM), Y00147 Invitrogen
6x DNA loading dye, R0611 Thermo Scientific
Deoxynucleoside triphosphate (dNTP), 11819362001 Roche
Dry ice -
dT16 Oligo gift from D. Edbauer
dT20 Oligo gift from D. Edbauer
Ethylenediaminetetraacetic acid (EDTA), 108418.1000 Merck
80% ethanol, UN1170 CLN
Ethanol p.a., 100989.1011 Merck
Ethidium bromide, 2218.2 Roth
FastRuler high range DNA ladder, 500-10000bp, SM1123 Thermo Scientific
FastRuler middle range DNA ladder, 100-5000bp, SM1113 Thermo Scientific
FastRuler low range DNA ladder, 50-1500bp, SM1103 Thermo Scientific
Fetal bovine serum (FBS), F7524 Sigma-Aldrich
Gelatin, 104080.0100 Merck
GeneRuler DNA ladder mix, SM0331 Thermo Scientific
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GeneRuler express DNA ladder, SM1553 Thermo Scientific
Glycerol p.a., 3783.2 Roth
Glycine p.a., 04943 Biomol
5x GoTaq buffer, M791A or M792A Promega
GoTaq DNA polymerase, M830B Promega
Guanidine hydrochloride, G4505 Sigma-Aldrich
Immersol W 2010 Zeiss
Isopropanol p.a., 109634.2511 Merck
Lipofectamine, 11668-019 Invitrogen
Liquid nitrogene (liq. N2) Linde
Loeﬄer’s methylene blue solution, 101287 Merck
LysoTracker Red DND-99, L7528 Molecular Probes
Magnesium chloride (MgCl2), 105833.1000 Merck
Magnesium sulfate (MgSO4), 105886.1000 Merck
Methanol p.a., 106059.2511 Merck
Methionine [S35]-label Hartmann Analytik
Methyl cellulose, M0387 Sigma-Aldrich
Meyer’s haematoxylin stain e.g. Sigma-Aldrich
Milk powder, T145.2 Roth
Monopotassium phosphate (KH2PO4), 104877.1000 Merck
Neutral red, 861251 Sigma-Aldrich
Newborn calf serum (NCS), N4762 Sigma-Aldrich
Nonidet P40 / NP40 / IGEPAL, 19628 USB
Orange G, O3756 Sigma-Aldrich
Paraformaldehyde (PFA), P6148 Sigma-Aldrich
Penicillin-Streptomycin, 15140-122 Gibco
Pentylenetetrazole (PTZ), P6500 Sigma-Aldrich
Periodic acid e.g. Sigma-Aldrich
Phenylthiourea (PTU), P7629 Sigma-Aldrich
Phenol/chloroform/isoamylalcohol, A156.1 Roth
Potassium chloride (KCl), 104936.1000 Merck
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Protease inhibitor (PI) mix, 05056489001 Roche
Pronase, 11459643001 Roche
Proteinase K (PK), 03115852001 Roche
Precision plus protein all blue standard, 161-0373 Bio-Rad
Pwo Polymerase, 01-5010 peqlab
Random hexamere primer, S0142 Thermo Scientific
Random primer mix, S1330S NEB
Restriction endonucleases NEB, Thermo Scientific
RiboLock RNase inhibitor (40U/µl), EO0382 Thermo Scientific
RNase H, 18021071 Invitrogen
RNAlater , AM7024 Ambion
Schiff Reagent Raymond A. Lamb
SeeBlue Plus2 pre-stained standard, LC5925 Invitrogen
Sodium acid (NaN3), 106688.0100 Merck
Sodium acetate (NaOAc), 6779.1 Roth
Sodium chloride (NaCl), 3975.2 Roth
Sodium dodecyl sulfate (SDS), 20765.03 Serva
SP6 polymerase, EP0131 Fermentas
Spectinomycin, 85555 Fluka
Sucrose, S1888 Sigma-Aldrich
T7 polymerase, EP0111 Fermentas
Tetramethylethylenediamine (TEMED), 2367.3 Roth
TissueTek O.C.T., 25608-9300 VWR
Tricain, A5040 Sigma-Aldrich
Tris, 08003 AppliChem
Triton X-100, 108603.1000 Merck
Tropix I-Block, T2015 Applied Biosystems
Tween 20, 822184.0500 Merck
Xylene, 108681.1000 Merck
Yeast extract, 212720 BD
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4.1.7.2 Solutions and buffer
For all solutions and buffers H2O was used that was purified and desalted by a Milli-Q
system (electric resistance 18.2MΩcm at 25◦C).
Acridine orange stock solution 3mg/ml in dH2O
1%-2% agarose 1%-2% agarose
1x TBE
Ampicillin stock 100mg/ml dissolved in dH2O and sterile filtered
10% APS (stock) 10% APS in dH2O
stored at -20◦C
Bleaching solution 1l tap water, 380µl DanKlorix
10x BSA stock 0.1g/ml
DEPC dH2O 200µl DEPC per 100ml dH2O
incubate o/n at 37◦C and autoclave
Destain solution 25% isopropanol
7% acetic acid
in H2O
GuHCl-stripping buffer 6M guanidine hydrochloride
20mM Tris
0.2% Triton X-100/NP40
adjust to pH7.5
I-Block 0.2% Tropix I-Block
0.1% Tween
in 1xPBS
4x Lämmli sample buffer 4ml 20% SDS
4ml glycerol
1ml β-mercaptoethanol
1.25ml 1M Tris, pH7.6
1 pinch bromophenol blue
Lysis buffer 10% PK stock in TE, pH8.0
6x Loading dye orange or blue 0.5% SDS
25% glycerol
25mM EDTA
in dH2O pinch of Orange G or Bromophenol blue
3% methyl cellulose 3% methyl cellulose in prewarmed H2O 70◦C
shake o/n at 4◦C and centrifuge until every bubble is gone
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NCST 10% NCS stock
0.1% Tween in 1xPBS
Neutral red stock solution 10mg/ml neutral red in E3
0.1M PB pH7.4 19ml 0.2M KH2PO4
81ml 0.2M Na2HPO4
ad 200ml dH2O
10x PBS 80g NaCl
17.8g Na2HPO4x2H2O
2.4g KH2PO4
2g KCl
ad 1l with dH2O
PBST 0.1% Tween in 1x PBS
PBST milk 3% milk powder
0.1% Tween in 1x PBS
10x PCR buffer 100mM Tris, pH8.3
500mM KCl
15mM MgCl2
0.1% (w/v) gelatin
in dH2O
PCR mix 60µl 100mM dATP
60µl 100mM dCTP
60µl 100mM dGTP
60µl 100mM dTTP
6ml 10x PCR buffer
36.3ml dH2O
0.5% periodic acid solution 0.5g periodic acid
in 100ml dH2O
4% PFA 4% PFA in 1x PBS
incubate approx. 5min at 80◦C until PFA is dissolved
cool to 4◦C prior to usage or store at -20◦C
PK stock 17mg/ml PK in dH2O
Pronase stock 30mg/ml pronase in dH2O
10x PTU 0.3mg/ml in E3
PTZ stock solution (150mM) 5.18mg PTZ
10% DMSO in 250ml E3
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Running gel buffer 1.5M Tris, pH8.8
10x running buffer 29g Tris
144g glycine
ad 1l with dH2O
and autoclave
SDS running buffer 0.1% SDS in 1x running buffer
Spectinomycin stock 30mg/ml dissolved in dH2O and sterile filtered
Stacking gel buffer 1M Tris, pH6.8
STEN lysis buffer 50mM Tris, pH7.6
150mM NaCl
2mM EDTA
1% NP-40
Stripping buffer 62.5mM Tris
2% SDS
adjust to pH6.7
10x TBE 1080g Tris
550g Boric acid
400ml 0.5M EDTA, pH8.0
ad 10l dH2O
10x TBS 1.25M NaCl
0.5M Tris
adjust to pH7.6 and autoclave
TBST 0.1% Tween in 1x TBS
TBST milk 3% milk powder
0.1% Tween in 1x TBS
TE pH8.0 10mM Tris
1mM EDTA
adjust to pH8.0 and autoclave
10x transfer buffer 30.3g Tris
144g glycine
ad 1l with dH2O
adjust to pH8.3 and autoclave
50x tricain 2g tricain
10.5ml 1M Tris pH9.0
ad 500ml with dH2O
adjust to pH7.0
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4.1.7.3 Media
Media used for the cultivation of bacteria were autoclaved to prevent the growth of
undesired organisms. After cooling sterile filtered antibiotics in the indicated concentra-
tions were added.
Cell culture medium DMEM
10% FBS
1% Penicillin-Streptomycin
Dulbecco’s Modified Eagel’s
Medium (DMEM), 61965-026
Gibco
E3 5mM NaCl
0.17mM KCl
0.33mM CaCl2
0.33mM MgSO4
E3 Methylene blue 5mM NaCl
0.17mM KCl
0.33mM CaCl2
0.33mM MgSO4
0.002% Loeﬄer’s methylene blue solution)
LB-Agar 1.5% Bacto Agar
1% Bacto Trypton
0.5% Yeast extract
17.25mM NaCl
in dH2O
Ampicillin 100µg/ml or Spectinomycin 100µg/ml
LB-Medium 1% Bacto Trypton
0.5% Yeast extract
17.25mM NaCl
in dH2O
Ampicillin 100µg/ml or Spectinomycin 100µg/ml
Opti-MEM, 51985-026 Gibco
SOC-Medium, 15544-034 Invitrogen
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4.1.8 Kits
A-Plus Poly(A) Polymerase Tailing Kit, PAP5104A Epicentre
BC Assay Protein Quantitation Kit, UP40840A Uptima
Gateway LR Clonase II Enzyme Mix, 11791-020 Invitrogen
GoTaq DNA Polymerase, M3175 Promega
iProof High-Fidelity DNA Polymerase, 172-5300 BioRad
iScript cDNA Synthesis Kit, 170-8891 BioRad
iQ SYBR Green supermix, 170-8880 BioRad
M-MLV Reverse Transcriptase, 28025-013 Invitrogen
MEGAClear Kit, AM1908 Ambion
mMESSAGE mMACHINE SP6 Kit, AM1340 Ambion
mMESSAGE mMACHINE T7 Kit, AM1344 Ambion
MessageMAX T7 mRNA transcription kit Epicentre
NucleoBond Xtra Midi, 740410 Macherey-Nagel
NucleoSpin Gel and PCR Clean-up, 740609 Macherey-Nagel
NucleoSpin Plasmid, 740588 Macherey-Nagel
pCR8/GW/TOPO TA Cloning Kit, K250020 Invitrogen
Pierce ECL Plus Western Blotting Substrate, 32132 Thermo Scientific
RNAqueous-Micro Kit, AM1931 Ambion
RNase-free DNase Set, 79254 Qiagen
RNeasy Mini Kit, 74104 Qiagen
SsoFast Eva Green Supermix, 172-5204 BioRad
TnT SP6 Coupled Reticulocyte Lysate System, L4601 Promega
4.1.9 Consumables
0.2ml Strip tubes, AB-0266 Thermo Scientific
96-Well PCR Plate, AB-0600 Thermo Scientific
Blotting Paper, MN 218 B Macherey-Nagel
Borosilicate glass capillaries, 1B120F-4 World Precision Instru-
ments
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Centrifuge tubes 15ml, 50ml Sarstedt
Combitips Plus 0.5ml, 5ml Eppendorf
Cover slip Thermo Scientific
Fluorodish Cell Culture Dish - 35mm, FD3510-100 World Precision Instru-
ments
Hard-Shell 384-Well PCR Plates, HSP-3805 BioRad
Microcentrifuge tubes 1.5ml, 2.0ml Sarstedt
Microscope slide Thermo Scientific
Microscope slide with wells Thermo Scientific
Microseal B Film, MSB1001 BioRad
Multi-well plates (6, 12, 24, 48, 96) Thermo Scientific
PCR Film , AB-0558 Thermo Scientific
Petri dishes 60mm, 100mm Sarstedt
Pipette tips 10µl, 10µl long, 200µl, 1000µl Sarstedt
Pipette tips with filter (10µl, 10µl long, 20µl, 100µl, 300µl,
1000µl)
Sarstedt
Phase Lock Tubes 1.5ml Eppendorf
PVDF Membrane, Immobilon-P, IPVH00010 Millipore
sterile serological pipetts 5ml, 10ml, 25ml Sarstedt
Superfrost Plus slides, J1800AMN3 Thermo Scientific
Transfer pipettes Sarstedt
X-ray films Kodak, BioMax MR Film, Cat8701302 Sigma Aldrich
X-ray films Super RX, 47410 19236 Fujifilm
4.1.10 Equipment
Accu jet pro Brand
Agarose gel documentation device Intas
Agarose gel systems Peqlab
Benchtop centrifuge 5415D Eppendorf
Benchtop cool centrifuge Biofuge fresco Heraeus
Bio-ice cooling unit, 170-3934 Bio-Rad
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C1000 Thermal Cycler Bio-Rad
Cassette for x-ray film exposure Radiographic Products
Casting stands Bio-Rad
Casting frames Bio-Rad
Centrifuge multifuge 3 S-R Heraeus
CO2 Incubator Binder
Cold-light source KL 1500 LCD Zeiss
Dumont Forceps # 5 Titanium Fine Science Tools
DMZ-Universal (needle) Puller Zeitz-Instrumente
Foam Pads Bio-Rad
Freezer -20◦C Liebherr
Freezer -80◦C Heraeus
Fridge Liebherr
Gel Releaser, 165-3320 Bio-Rad
Gel dryer, model583 Bio-Rad
iCycle-MyiQ BioRad
Incubator 28◦C, 37◦C, 55◦C Binder
Kontes Pellet Pestle, 1.5ml Fisher Scientific
Kontes Pellet Pestle Cordless Motor, K749540-0000 Fisher Scientific
Microwave Sharp
Microinjector (Femto Jet) Eppendorf
Microinjection molds e.g. Eppendorf
Micro scales BP2215 Sartorius
MilliQ academics Millipore
Mini gel holder cassette, 170-3931 Bio-Rad
Mini-PROTEAN Comb, 10-well and 15-well Bio-Rad
Mini-PROTEAN 3 cell Bio-Rad
Mini-PROTEAN Tetra cell Bio-Rad
Mini trans-blot central core, 170-3812 Bio-Rad
Multipipette plus Eppendorf
Nano Photometer IMPLEN
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Needles Kaut-Bullinger
OTF5000 Cryostat Bright
PCR Plate Sealer Eppendorf
PCR Thermocycler Eppendorf, BioRad
pH Meter WTW
Pipette 10µl, 100µl, 200µl and 1000µl Eppendorf
Plate reader PowerWaveXS BioTek
PowerPac Basic Power Supply, 164-5050 Bio-Rad
PowerPac HC Power Supply, 164-5052 Bio-Rad
Preserving boiler EKO 620 Petra
Scales BP3100S Sartorius
Schott bottles Schott
Sonifier (Cell Disruptor B15) Branson
Shaker Duomax 1030 Heidolph
Shaker cold room Bachofer
Short plates, 165-3308 Bio-Rad
Spacer plates 0.75mm, 165-3310 and 1.5mm, 165-3312 Bio-Rad
Spring Scissors, 3mm Blades, Straight Fine Science Tools
Spring Scissors, 5mm, Blades Angled to the Side Fine Science Tools
Stereo Microscope Stemi 2000 Zeiss
Tea nets -
Thermomixer comfort Eppendorf
Thermomixer compact Eppendorf
UV Detectionsystem Intas
Vortexgenie2 Scientific Industries
Waterbath GLF
X-ray detection system (Curix 60) Afga
53
4 Material and Methods
4.1.11 Microscopes
Axiovert 135 (inverted) DIC Zeiss
Cell Observer CSU-X1 Yokogawa Spinning Disk
AxioCam MRm and Evolve 512
Zeiss
Confocal laser scanning microscope LSM 710 Zeiss
Fluorescence-Stereomicroscope MZ 16F Leica
Fluorescence-Stereomicroscope MZ 16FA Leica
Mikroskop Zeiss Axioplan 2 imaging
AxioCam HRc
Zeiss
Stereomicroscope Zeiss Stemi 2000-C Zeiss
ZebraBox Revolution
High sensitivity digital camera (30 frames/s)
ViewPoint
4.1.12 Hardware and software
Adobe Illustrator CS5 Adobe Systems Software
Adobe Photoshop CS5 Adobe Systems Software
Axiovision 4.0 Zeiss
Bio-Rad CFX Manager 2.0 Bio-Rad
CLC Main Workbench 6 CLC bio
Gen5 BioTek
GraphPad Prism 6 GraphPad Software
ImageJ/Fiji NIH, USA
Leica Application Suite Leica
MacBookPro Apple
Microsoft Office for Mac 2011 Microsoft
Papers2 Mekentosj
Zebralab tracking software 3,22,3,9 ViewPoint
Zen Black 2011 Carl Zeiss Microimaging
Zen Blue 2011 Carl Zeiss Microimaging
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4.2 Methods
4.2.1 Zebrafish specific methods
4.2.1.1 Zebrafish husbandry and handling of embryos
Husbandry, breeding, and mating of wildtype, transgenic, and mutant zebrafish was
according to standard methods (Mullins et al., 1994). Embryos and larvae were kept at
28.5◦C in E3 medium until 5dpf. Developmental stages were determined as described
by Kimmel et al. (Kimmel et al., 1995). Zebrafish embryos and larvae used for in vivo
imaging or whole mount immunofluorescence (IF) stainings were treated with 1xPTU
to avoid pigmentation (Karlsson et al., 2001).
4.2.1.2 Bleaching of fertilized zebrafish eggs
Fertilized zebrafish eggs were bleached to prevent contamination of the zebrafish facility
by pathogens that can reside at the outer side of the chorion. This procedure is possible
after epiboly is finished, until approx. 1.5dpf. The fertilized zebrafish eggs were placed
in a tea net and were exposed to bleaching solution for 5min. Then the embryos were
washed for 5min in tap water. This procedure was repeated once. After that the fish
eggs were transferred into a new petri dish using E3 without methylene blue. 10µl of
Pronase stock solution were added to allow the embryos to hatch from the denatured
chorion.
4.2.1.3 Mating of adult zebrafish
For mating a female and male zebrafish were transferred to a mating box filled with
water from the zebrafish facility (afternoon/evening). If the eggs needed to be of the
same developmental stage the mating pairs were separated overnight (o/n) by a divider
in the mating box. In the morning the divider was removed to allow spawning. After
spawning, eggs were collected and put in a petri dish with E3 methylene blue.
4.2.1.4 Microinjection into zebrafish eggs
Microinjections into zebrafish eggs were performed at one- to two-cell-stage. Before
injections, injection needles and injection agar plates were prepared. Injection needles
were pulled with a needle puller using the programme P(A)60. Microinjection molds
were placed into a petri dish containing 1.5% agarose in E3 to generate injection agar
plates. Half of the freshly spawned eggs were sorted into the cavities, created by the
molds of the injection plates. The other half served as a control. 2-4pl of 0.4µg/µl/ZFN
mRNA solution of ZFN pairs or 0.1µg/µl to 0.4µg/µl mRNA solution (diluted with 0.4M
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KCl in DEPC or DEPC H2O) were injected into the yolk. Afterwards eggs/embryos
were transferred into a petri dish containing E3 methylene blue. All eggs/embryos were
kept at 28◦C and unfertilized eggs were sorted out after a few hours. The next days
embryos were examined for phenotypic alterations. Only injected embryos/larvae that
had a normal appearance were fixed for further analysis or were raised to adulthood in
the fish facility.
4.2.1.5 Fin biopsies from adult zebrafish
Determination of the genotype of a single zebrafish was performed on tail fin biopsies.
Adult zebrafish were anaesthetized in fish facility water containing 5-10% Tricain stock
solution, until the gills stop moving. A little piece of tissue from the periphery of the tail
fin was cut on a cutting board and fixed in 100% methanol. Afterwards the zebrafish
was transferred immediately to a single box containing fish facility water to recover.
4.2.1.6 Tissue harvesting from adult zebrafish
Tissues from adult zebrafish were isolated as described by Gupta and Mullins (Gupta
and Mullins, 2010) and Gerlach et al. (Gerlach et al., 2011).
4.2.1.7 Fixation and storage of zebrafish samples
Embryos, larvae, and tissues for protein analysis or mRNA isolation were transferred
to microcentrifuge tubes. The liquid was completely removed and samples were shock
frozen in liq. N2. Microcentrifuge tubes containing samples were stored at -80◦C until
usage.
Embryos for whole-mount IF stainings were transferred to microcentrifuge tubes. The
liquid was removed, replaced by 4% PFA and samples were fixed o/n at 4◦C. The
success of fixation was examined by stereo microscopy. PFA was removed and samples
were rinsed once with 1xPBST. Then they were washed three times for 5min with
PBST on a shaker at room temperature (RT). Finally, a set of methanol washes (30%
methanol in PBST, 60% methanol in PBST, 100% methanol) was performed with 5min
steps on a shaker at RT. Samples were stored in 100% methanol at -20◦C until usage.
Adult brain samples for cryosections were harvested as described above, washed in 0.1M
PB pH7.4 and fixed for 4h in cold 2% PFA in 0.1M PB pH7.4 at RT on a shaker. Then
the PFA was removed and brains were washed three times, 5min in 0.1M PB pH7.4.
Samples were kept in 0.1M PB pH7.4 at 4◦C until further processing.
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4.2.1.8 Whole mount immunofluorescence stainings
For whole mount IF stainings embryos previously fixed in 4% PFA and stored in
methanol were used. First the samples were rehydrated stepwise by a methanol series
(60% methanol in PBST, 30% methanol in PBST). After the 5min lasting rehydration
steps on a shaker at RT, the samples were washed three times for 5min in PBST at RT.
24hpf embryos for stainings with ZE-BO 1F4, Pax7, F59, or α-actinin were used for IF
stainings right after this step. 48hpf embryos for stainings with ZE-BO 1F4, Pax7, F59,
or α-actinin were treated on the bench at RT for 20min with 10µg/ml PK in PBST to
make them permeable for the antibodies. 28-29hpf embryos for stainings with Znp1
and Zn1 were treated for 6.5min with 1mg/ml collagenase in PBST instead. After
removal of PK or collagenase the remaining proteases were inactivated by re-fixating
the embryos for 20min in 4% PFA on a shaker at RT. After removing the PFA, samples
were washed for three times 5min in PBST.
Blocking was performed for 1h in NCST on a shaker at RT. Then the primary antibody
was added in NCST, 0.05% NaN3 and samples were incubated on a shaker at 4◦C
o/n. The next day the primary antibody was removed and kept for further use at 4◦C.
Afterwards, the samples were rinsed with PBST and washed three times for 15min in
PBST on a shaker at RT. Then they were blocked two times for 30min in NCST. The
secondary antibody was applied in NCST on a shaker at 4◦C o/n. After removal of
the secondary antibody samples were rinsed with PBST and washed three to five times
for 15min in PBST depending on the strength of the fluorescence signal. Samples were
recorded by microscopy as soon as possible. For longer storage samples were transferred
stepwise to 75% glycerol in PBST and stored at 4◦C.
4.2.1.9 Lämmli lysis of zebrafish samples
For the isolation of proteins Lämmli lysis was used. Microcentrifuge tubes containing
shock frozen embryos, larvae, or adult tissue were put on dry ice. Then the Lämmli
buffer was added at RT and the tissue was immediately and completely disrupted by
sonication or with the tissue homogenizer. Afterwards the samples, total lysates, were
boiled for 5min, 750rpm at 95◦C and centrifuged 15min at 13000rpm to remove debris.
The supernatant was used for SDS-PAGE. Remaining Lämmli lysed samples were stored
at -20◦C. For reuse samples were boiled once again for 5min, 750rpm at 95◦C and
centrifuged 1min at 11000rpm.
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4.2.1.10 Staging of zebrafish embryos
To address the issue of a developmental delay, zebrafish embryos were staged by somite
counting (Kimmel et al., 1995). Wildtype and homozygous mutant embryos were
produced by setting up incrosses of wildtype and homozygous mutants, respectively.
Spawning was only allowed for a short time period. Then the embryos were collected, put
to 28◦C, sorted for fertilization. 50 embryos were put into a new petri dish containing
fresh E3. O/n embryos were incubated at 21◦C to slow down the development of the
embryos. When wildtype embryos had reached the 14 somite stage, the somites were
counted at 21◦C in at least 30 embryos per genotype.
4.2.1.11 LysoTracker Red labeling
Acidic compartments, including lysosomes, were labelled using LysoTracker Red (He and
Klionsky, 2010). An end concentration of 10µM in E3 was used and living, anaesthetized
embryos were incubated for 30min in this solution, wrapped in aluminium foil to protect
the dye from degradation by light. Embryos were then rinsed twice with E3, embedded
in agarose for imaging and imaged immediately by spinning disk confocal microscopy
using a 561nm laser (Mahmood et al., 2013a).
4.2.1.12 Neutral red staining
Neutral red staining was performed to estimate the number of microglia (Herbomel
et al., 2001). An end concentration of 2.5µg/ml in E3 was used and living, anaesthetized
larvae were incubated for 1-2h in this solution, wrapped in aluminium foil to protect
neutral red from degradation by light. Larvae were then rinsed twice with E3 plus
1xTricain, embedded in agarose for imaging and imaged immediately by spinning disk
confocal microscopy using a 561nm laser.
4.2.1.13 Acridine orange staining
To estimate the number of cell undergoing cell death acridine orange staining was
performed (Paquet et al., 2009). Living, anaesthetized larvae were incubated for 30min
in 3µg/ml in E3 containing 1xTricain. The plates were wrapped in aluminium foil to
protect acridine orange from degradation by light. Then larvae were rinsed twice with
E3 1x Tricain, embedded in agarose for imaging and imaged immediately by spinning
disk confocal microscopy using a 488nm laser.
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4.2.1.14 In vivo imaging of zebrafish embryos and larvae
In vivo imaging of living zebrafish embryos or larvae was done using brightfield, laser
scanning confocal or spinning disk confocal microscopy. Animals were anaesthetized
in 1xTricain in E3 and mounted in 3% Methyl cellulose for short recordings or 1.5%
Agarose in E3 for long time in vivo imaging, both containing 1xTricain. Agarose
embedded embryos were covered with 1xTricain in E3 to protect the sample from drying
out.
4.2.1.15 Pentylenetetrazole treatment
Pentylenetetrazole (PTZ) is an agent known to induce seizures in zebrafish (Baraban
et al., 2005). Larvae were treated in 800µl E3 containing 15mM PTZ 1%DMSO and
their movement was tracked for 5min after an incubation period of 30min. Control
larvae were incubated in 800µl E3 1%DMSO.
4.2.1.16 Locomotion analysis
Locomotion analysis was performed at 5dpf. For each experiment 6 larvae per genotype
or treatment were analysed. Individual larvae were placed in a single well of a 24-well
plate in 800µl E3 or a solution containing the respective agent. After an adaption period
of 30min in the ZebraBox Revolution, movements were recorded at RT for 5min in this
device using a high sensitivity digital camera (30 frames/s) in combination with the
ZebraLab tracking software. Tracks were visualized by the ZebraLab tracking software
(max 115, small/large: 0.6cm/s, inact/small: 0.2cm/s). To test whether the swimming
response is changed upon a stimulus (darkness) in mutants compared to wildtype, larvae
were adapted to the device for 40min in 100% light. Then their movement was tracked
for 5min 100% light, 5min 0% light, 5min 100% light, 5min 0% light, and 5min 100%
light with the setup described above and tracks were analysed.
4.2.1.17 Cryosections of zebrafish larvae or brain
PTU-treated embryos or adult brains that were fixed previously were impregnated o/n
in 30% sucrose. Then the samples were mounted and frozen in TissueTek O.C.T. on
dry ice. 10-12mm sequential slices were cut on a cryostat and collected on Superfrost
PLUS slides (Mahmood et al., 2013a). Slides were stored at -80◦C.
4.2.1.18 Periodic acid-schiff stain
For Periodic acid-schiff (PAS) stain freshly prepared cryosections are needed. Before
staining the samples were rehydrated in dH2O. Then the slides with sections were
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immersed in 0.5% periodic acid solution at RT for 10min. Afterwards, the slides were
rinsed three times in dH2O, followed by 15min incubation in Schiff’s reagent at RT in
the dark. Then the sections were washed with tap water. Thereby, the sections turned
immediately dark pink. Sections were rinsed till the pink water-colour was gone. A
counterstain with Mayer’s Haematoxylin was performed for 30s. Sections were washed
in tap water for 5min. To dehydrate the sections the following series was done: 30s 70%
EtOH in dH2O, 30s 90% EtOH in dH2O, twice 2min 100% EtOH and 3min 100% EtOH.
Then slides with sections were incubated three times 5min in Xylene and mounted in
DePex Mounting Medium. After drying samples were ready for imaging.
4.2.1.19 Tail fin amputation in zebrafish embryo/larvae
Tail fins in zebrafish embryo/larvae were dissected at 2dpf or 3dpf with micro spring
scissors in 1xTricain in E3 (Yoshinari and Kawakami, 2011). For mRNA isolation from
the dissected tail fin, tail fins were amputated and embryos were fixed in RNAlater at
3hpa, 24hpa, 48hpa, and 72hpa. By cutting the fixed larvae after the yolk extension
tail fin tissue was enriched. This tissue was then used for mRNA extraction.
Tail fin dissected embryos used in the regeneration assay were kept in single wells and
imaged by brightfield microscopy at 0hpa, 24hpa, 48hpa, and 72hpa.
Transgenics with labelled myeloid cells with tail fins dissected were imaged immediately
by in vivo time-lapse spinning disk confocal microscopy.
4.2.1.20 Chemically induced inflammation assay
CuSO4 was used to induce an inflammation as described in d’Alençon et al. (d’Alençon
et al., 2010). Embryos were fixed for mRNA isolation after 1h of CuSO4 treatment and
after further 3h and 6h of recovery.
4.2.1.21 FACS of macrophages and neutrophils
Macrophages were FACS sorted from 150 to 200 Tg(mpeg1 :mCherry) larvae at 6dpf
and neutrophils from 150 to 200 Tg(mpx :GFP) larvae at 6dpf by Julien Rougeot at the
Institute of Biology, Leiden University (J. Rougeot, unpublished). For the macrophage
experiments 500000 cells were obtained for the negative background and around 60000
mCherry positive cells. For the neutrophils 500000 cells were obtained for the negative
background and around 5000 to 11000 GFP positive cells.
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4.2.1.22 Stab wound injury
Stab wound injuries in the adult zebrafish telencephalon were performed by Rossella di
Giaimo and Jovica Ninkovic at the Institute of Stem Cell Research, Helmholtz Center
Munich according to Baumgart et al. (Baumgart et al., 2012).
4.2.2 Cellbiological methods
Cellbiological experiments were performed in collaboration with Anja Capell and Katrin
Fellerer from our institute to obtain tagged-proteins for monoclonal antibody testing.
4.2.2.1 Cell cultivation
HEK293T were kept in cell culture medium. Cells were incubated in cell culture flasks
of different size at 37◦C and 5% CO2. For transfections cells were plated in 60mm or
100mm Petri dishes.
4.2.2.2 Transfection of cells
24h after plating (approx. 80% confluency) cells were transfected using the lipofec-
tamine transfection kit according to the manufacturer’s instructions. 8µg/60mm and
12µg/100mm expression plasmid/petri dish were used. To facilitate the analysis of
secreted proteins, the cell culture medium was removed 6h post transfection by Opti-
MEM. Cells and medium were harvested approx. 24h after transfection as described
below.
4.2.2.3 Harvesting of cells and whole cell lysis
Grna, Grnb, Grn1, and Grn2 are secreted proteins, therefore the cell medium was
collected, centrifuged for 15-20min at full speed and transferred to new microcentrifuge
tubes. The cell medium was kept on ice until further use or was frozen at -20◦C. In
parallel, the cells were washed twice with 1xPBS and detached from the dish with
1xPBS. Then they were centrifuged at 3500xg. PBS was removed and cells were either
kept on ice until further usage or were frozen at -20◦C. Cells were resuspended in ice-cold
STEN lysis buffer containing 1x PI mix and incubated 10-20min on ice. During this
incubation step, cells were mixed a few times intensely on a vortex device. Afterwards
the sample was centrifuged at 4◦C for 20min, 13000rpm. The supernatant was collected
in a new microcentrifuge tube and the pellet was washed once again in STEN lysis
buffer containing 1x PI mix. For further experiments the first supernatant (cell lysate)
and the pellet (cell pellet) were used. After determination of the protein concentration
4x Lämmli sample buffer was added to the cell lysate and cell medium, and samples
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were boiled at 95◦C, 750rpm for 5-10min. The cell pellet was boiled in 100µl 2x Lämmli
sample buffer. Then the samples were centrifuged for 1min at 13000rpm and were used
for Immunoblotting or stored at -20◦C.
4.2.3 Molecular biological methods
4.2.3.1 Isolation of genomic DNA
For the isolation of genomic DNA from tissue, which was fixed beforehand in 100%
methanol, the methanol was removed with a pipette. To remove the methanol completely,
the tissue was dried at 55◦C. Then 50µl of lysis buffer was added to the fin tissue (30µl to
embryos) and the samples were digested at 55◦C for at least 1h. The inactivation of PK
was done at 95◦C for 5-10min. Remaining debris was removed in a short centrifugation
step. The supernatant contains the genomic DNA and was used for further analysis.
4.2.3.2 Isolation of RNA
RNA from zebrafish embryos, zebrafish larvae, and adult zebrafish tissue was extracted
according to the protocol of the RNeasy Mini Kit including DNase treatment (RNase-
free DNase Set). Microcentrifuge tubes containing shock frozen embryos, larvae, or
tissues were put on dry ice. For all steps RNase free consumables and solutions were
used. The tissue was disrupted with the tissue homogenizer in 350µl+350µl RLT buffer
containing β-mercaptoethanol. RNA was eluted in 30-50µl RNase-free water. The
RNA quality was examined by agarose gel electrophoresis and the concentration was
determined using a NanoDrop device. RNA from FACS sorted cells was extracted with
the RNAqueous-Micro Kit. DNase treatment was performed with the DNase included
in the kit. RNA was eluted in 11µl RNase-free water. All RNA solutions were stored
at -80◦C.
4.2.3.3 cDNA synthesis
cDNA synthesis was performed as described in the M-MLV Reverse Transcriptase kit.
RiboLock RNase Inhibitor was utilized as RNase inhibitor. For cDNA that was used in
qRT-PCRs 0.8µg total RNA and Random Primer Mix was used. The Random Primer
Mix is an optimized mixture of hexamers and anchored-dT primer and does already
contain dNTPs. Therefore, the addition of dNTPs was not necessary. RNase H digest
was applied to remove RNA-DNA hybrids. For cDNA that was used in RT-PCRs
0.5µg total RNA were used. cDNA used for cloning of grna was amplified with a mix
of 0.5µl dT16 Primer (50µM) and 0.5µl dT20 Primer (50µM), 1µl dNTP mix 10mM
and 1-3µg total RNA. For the synthesis of all other cDNA 1µl Random Hexamere
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Primer (50ng/µl) and 1µl dNTP mix 10mM were used. cDNA synthesis from mRNA
derived from FACS sorted cells was performed using 10µl mRNA with the iScript cDNA
Synthesis Kit. A β-actin control PCR (see below) was used as a control for cDNA
synthesis was efficiency.
4.2.3.4 Polymerase chain reaction
Polymerase chain reactions (PCR) were used to amplify a chosen DNA fragment from
a DNA template. Oligonucleotides were designed as described below. If not stated
otherwise, the following mastermix / reaction was used:
mastermix / reaction 17.5µl PCR mix
0.5µl 10µM forward primer
0.5µl 10µM reverse primer
0.2µl GoTaq DNA Polymerase
An indicated volume of DNA or cDNA was mixed with 15µl Mastermix and the following
PCR programme was used as a standard scheme:
Cycle Step Temperature Time No. of cycles
Initial Denaturation 95◦C 2min 1
Denaturation
Annealing
Extension
95◦C
xx◦C
73◦C
30s
30s
xy min
xz
Final Extension 73◦C 5min 1
The annealing temperature (xx), extension time (xy), and number of cycles (xz) were
adjusted for each PCR reaction.
4.2.3.4.1 β-actin control PCR
A β-actin control PCR was performed on synthesized cDNA to proof that the synthesis
was successful. The general mastermix mentioned above was used and primers for the
amplification of β-actin were oA03 β-actin F and oA04 β-actin R. For one reaction
0.5µl cDNA and 15µl mastermix were used. The annealing temperature was 60◦C, the
extension time 1min and the number of cycles 35. PCR products were analysed by
agarose gel electrophoresis.
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4.2.3.4.2 PCRs for sequencing of grna and grnb
To analyse grna and grnb for SNPs or other sequence variations both genes were
partially sequenced. To amplify parts of grna and grnb, PCRs with the following primer
combinations were used:
Amplicon F Primer R Primer Annealing Temp.
grna exon3 BS-C07 BS-D38 61.8◦C
grna exon4+5 BS-D39 BS-D40 58.4◦C
grna exon6+7 BS-E01 BS-E02 66.8◦C
grna exon8+9 BS-E03 BS-B04 61.8◦C
grna exon10 BS-A05 BS-B16 60.0◦C
grna exon11+12 BS-E05 BS-E06 66.8◦C
grna exon13+14+15 BS-B17 BS-B18 64.6◦C
grna exon16+17 BS-E07 BS-E08 58.4◦C
grnb exon3 BS-E09 BS-C24 61.8◦C
grnb exon4 BS-E10 BS-C18 61.8◦C
grnb exon5+6 BS-E11 BS-B10 58.4◦C
grnb exon7 BS-B11 BS-B12 60.0◦C
grnb exon8 BS-E12 BS-B02 50.0◦C
grnb exon10 BS-B14 BS-B15 58.4◦C
grnb exon11 BS-E13 BS-E14 64.6◦C
grnb exon12 BS-E15 BS-E16 58.4◦C
The general mastermix was used with the primer pair combinations are listed in the table.
For each reaction 5µl genomic DNA and 15µl mastermix were used. The annealing
temperature was selected as shown in the table, the extension time was 1min and the
number of cycles was 40. PCR products were separated by agarose gel electrophoresis,
purified and sent for sequencing to GATC.
4.2.3.4.3 Screening/genotyping PCR for grna and grnb ZFN mutants
For screening/genotyping PCRs the general mastermix was used with the primer pairs
BS-E24 grna ZFN F and BS-E25 grna ZFN R for grna and BS-E22 grnb ZFN F
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and BS-E23 grnb ZFN R for grnb. For each reaction 2-2.5µl genomic DNA and 15µl
mastermix were used. The annealing temperature was 63◦C, the extension time 1min
and the number of cycles 35. 5µl of the PCR product were then used for restriction
endonuclease (RE) screening/genotyping, the residual PCR product was kept at 4◦C
and separated by agarose gel electrophoresis together with the sample that was digested
by RE (see below).
For sequencing of the mutant alleles the reaction volume was scaled up three times.
This PCR product was digested by restriction endonuclease digest, separated on an
agarose gel and the band of the mutant allele was purified by DNA gel electrophoresis
and sent for sequencing to GATC.
4.2.3.4.4 PCRs for cloning wildtype and mutant grna and grna+MYC
For the amplification of wildtype and mutant grna and grna+MYC cDNA templates
were used (see above) and the following protocols using iProof High-Fidelity DNA
Polymerase were applied:
grnaI grnaII grna+MYC Final conc.
5x iProof HF Buffer 4µl 4µl 4µl 1x
dNTP mix 10mM 0.4µl 0.4µl 0.4µl 200µM each
BS-E36 10µM 0.5µl - - 0.25µM
BS-E37 10µM 0.5µl - - 0.25µM
BS-E38 10µM 0.5µl - - 0.25µM
BS-E39 10µM 0.5µl - - 0.25µM
oC70 10µM - 1µl 1µl 0.5µM
BS-E32 10µM - 1µl - 0.5µM
BS-E33 10µM - - 1µl 0.5µM
cDNA 1µl 1µl 1µl -
DMSO 0.5µl 0.5µl 0.5µl 2.5%
iProof DNA Polymerase 0.2µl 0.2µl 0.2µl 0.02U/µl
sterile H2O ad 20µl ad 20µl ad 20µl
The PCR programme suggested in the iProof DNA Polymerase manual was used with
10s denaturation time, 65◦C annealing temperature, 20s annealing time, and 1min:30s
extension time. The number of cycles was 30 and final extension was done for 10min.
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1µl of the PCR products was analysed by agarose gel electrophoresis. If the analysis
was positive parts of the PCR product were used for TOPO cloning reactions.
4.2.3.4.5 PCR for cloning grnb+MYC
In order to add a MYC-tag to grnb, the primer pair oC48 grnb F and BS-E21 grnb
R+MYC was used. Instead of GoTaq DNA Polymerase 2µl pwo Polymerase were
used per reaction. For each reaction 1µl pCR8/TOPO/GW-grnb (10ng/µl) and 14.8µl
mastermix were used and 0.6µl GoTaq DNA Polymerase were added for the last 5 cycles
to obtain a PCR product with sticky adenosine overhang. The annealing temperature
was 60◦C, the extension time 2min and the number of cycles 36. 1µl of the PCR product
was analysed by agarose gel electrophoresis. If the analysis was positive parts of the
PCR product were used for TOPO cloning reactions.
4.2.3.4.6 PCR for cloning grn1, grn1+V5, grn2, and grn2+V5
To clone to grn1, grn1+V5, grn2, and grn2+V5, the primer pairs oC54 grn1 F and oC55
grn1 R, oC54 grn1 F and BS-F36 grn1+V5 R, BS-E27 grn2 F long and BS-E35 grn2
R, BS-E27 grn2 F long and BS-E29 grn2+V5 R were used, respectively. For all, the
general mastermix without polymerase was set up. 14.8µl mastermix and 1µl of a 1:10
dilution of the grn1 or grn2 EST were combined. To all reactions 2µl pwo polymerase
were added. The standard PCR programme was used with an annealing temperature
of 55◦C, an extension time of 1min:30s and 35 cycles. 1µl of the PCR products was
analysed by agarose gel electrophoresis. If the analysis was positive parts of the PCR
product were used for TOPO cloning reactions.
4.2.3.4.7 Gradient PCR
Gradient PCRs were performed to determine the optimal annealing temperature of
a primer pair. The general mastermix was used. A temperature gradient range from
50-70◦C was tested as possible annealing temperatures. The extension time was adjusted
to the expected size of the PCR product. PCR products were analysed by agarose gel
electrophoresis.
4.2.3.4.8 Colony PCR
For colony PCRs single clones were picked with pipette tips and 30µl LB medium with
the appropriate antibiotic were inoculated. Prior to the PCR the bacterial colonies were
incubated at RT on the bench for 30min and stored for short-terms at 4◦C. The general
mastermix was used. Primers were selected that allowed to determine, if the insert was
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integrated in the plasmid and in which orientation. For one reaction 3µl colony LB
culture and 15µl mastermix were used. Annealing temperature and extension time were
adjusted according to the primers used and the expected size of the PCR fragment.
PCR products were analysed by agarose gel electrophoresis.
4.2.3.4.9 Semiquantitative PCR for grna, grnb and grn1/grn2
Semiquantitative PCR for grna, grnb, and grn1/grn2 were done with the primer pairs
BS-H14 grna ex2324 F and BS-H15 grna ex2324 R, BS-G46 grnb ex68 F and BS-G47
grnb ex68 R, BS-G06 grn1/grn2 ex34 Fa and BS-G07 grn1/grn2 ex34 Ra, respectively.
The primer pair BS-H01 tbp ex23a F and BS-H02 tbp ex23a R was used to amplify
the control TATA binding protein (tbp). 1µl cDNA and 15µl mastermix were used.
The mastermix of one reaction contained 3.2µl 5x Green GoTaq Reaction Buffer, 0.3µl
dNTPs (10mM), 0.5µl 10µM forward primer, 0.5µl 10µM reverse primer, 11.4µl dH2O
and 0.1µl GoTaq DNA Polymerase. The annealing temperature was 69◦C, the extension
time 30s and the number of cycles 30. For all PCR products the same volume was
loaded on an agarose gel for agarose gel electrophoresis.
4.2.3.4.10 Quantitative PCR
All primer pairs for quantitative PCR (qPCR) spanned an exon-exon junction with
an intron larger than 1kb to exclude amplification of genomic DNA. Specificity of the
primers was tested by qPCR on wildtype cDNA and verified by a single peak in the
melting curve analysis and one single band of the predicted size in agarose gelelec-
trophoresis. Additionally, the qPCR product was sequenced. qPCR was performed in
384-well format on a C1000 Thermal Cycler. For one reaction 2µl 1:3 to 1:10 cDNA
dilution plus 3µl mastermix, composed of 2.5µl SsoFast Eva Green Supermix, 0.25µl
10µM forward primer and 0.25µl 10µM reverse primer were used. Each reaction was
performed in triplicates. The PCR programme was 30s at 95◦C, 50 cycles of 5s at 95◦C
and 10s at 60◦C and a melting curve from 60◦C to 95◦C with increases of 0.5◦C every
5s. qPCR on cDNA from FACS sorted macrophages or neutrophils was performed in
96-well format on a iCycle-MyiQ. For one reaction 5µl 1:10 cDNA dilution plus 15µl
mastermix, composed of iQ SYBR Green supermix, forward primer and reverse primer
were used. Each reaction was performed in duplicates. The PCR programme was
3min 95◦C, 40 cycles of 15s at 95◦C and 45s at 60◦C and a melting curve from 95◦C
to 65◦C with decreases of 0.5◦C every 10s. The relative expression of each gene was
calculated using the ∆∆CT-method and the normalized fold expression was calculated
by normalisation to the reference gene(s) mentioned in the figure legend.
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4.2.3.5 Agarose gel electrophoresis
Agarose gel electrophoresis was performed to analyse and separate PCR products, to
analyse RE digests or to control RNA quality. Dependent on the size of the expected
product 0.8-2% agarose gels containing ethidium bromide (approx. 1:50000) were used.
Samples containing loading dye and a suitable DNA ladder were transferred to the gel.
Electophoresis was performed in 1xTBE buffer until a clear separation of the bands of
interest could be documented with a UV detection and documentation device.
4.2.3.6 DNA gel extraction and PCR purification
For the purification of PCR amplicons two methods were used. Either the PCR products
were purified directly according to the NucleoSpin PCR Clean-up protocol or they were
separated on an agarose gel, cut out and purified as described in the NucleoSpin Gel
Clean-up protocol. Purified DNA was eluted in 30-50µl elution buffer NE and was
either analysed by sequencing or used for cloning.
4.2.3.7 TOPO cloning
For molecular cloning the pCR8/GW/TOPO TA Cloning Kit or the TOPO TA Cloning
Kit, Dual Promoter were used. Proof-reading polymerases do not generate sticky
adenosine ends, which are required for both kits. The sticky adenosine ends were added
as described in the following reaction: 20µl purified PCR product, 5µl 5x GoTaq Buffer,
0.5µl 10mM dATP and 0.3µl GoTaq DNA Polymerase were incubated for 15min at
72◦C. Then 1-4µl PCR product were used in a TOPO Cloning reaction following the
manual of the respective Cloning Kit. Instead of 1µl TOPO Vector 0.5µl were used.
The TOPO cloning reaction was incubated for up to 30min. Afterwards the TOPO
cloning reaction was used for transformation in chemically competent E. coli cells.
4.2.3.8 Gateway cloning
To transfer DNA fragments into expression clones the Gateway cloning system was
used. 100ng/µl pCR8/GW/TOPO vector containing the DNA fragment of interest
served as entry clone and 150ng/µl pCS2+ vector containing the Gateway cassette as
destination vector. The Gateway cloning reaction was conducted as described in the
user manual of the Gateway LR Clonase II Enzyme Mix. 1-5µl LR Clonase reaction
were subsequently used for transformation in chemically competent E. coli cells.
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4.2.3.9 Chemical transformation of bacteria
To transform plasmid DNA in bacteria, chemically competent DH5α or TOP10 E. coli
cells were used. Cells were thawed on ice and 2-4µl of TOPO cloning reactions, 2µl of
LR cloning reactions or 10pg- 100ng plasmid DNA were added and incubated on ice for
30min. Then a heat-shock at 42◦C for 30s was done and microcentrifuge tubes were
placed on ice again for 3min. To allow the bacteria to synthesise the antibiotics, 250µl
SOC medium were added and bacteria were incubated at 37◦C, 200rpm for 1h. Then
10-200µl of the transformation were spread on pre-warmed LB agar plates containing
the appropriate antibiotic. When using the TOPO TA Cloning Kit Dual Promoter
LB agar plates were coated beforehand with 40µl IPTG stock and 40µl X-Gal stock
to allow blue/white selection. LB agar plates were incubated o/n at 37◦C. If bacteria
colonies were present, some were selected and analysed for the integration of the correct
plasmid by colony PCR or miniprep culture and subsequent plasmid mapping using
RE digest.
4.2.3.10 Cultivation of bacteria and plasmid DNA isolation
Depending on the subsequent application, plasmids were isolated at a different scale
and purity.
For miniprep isolation of plasmids 3-5ml of LB medium containing the appropriate
antibiotics were inoculated with a single clone and incubated at 37◦C, 200rpm, o/n.
In parallel a LB agar masterplate with all single clones used was done. Plasmid DNA
was isolated as described in the NucleoSpin Plasmid protocol. The concentration was
determined with a NanoDrop device. Samples were stored at -20◦C. Plasmids were
mapped by RE digest and/or sequenced by GATC.
For midiprep isolation of plasmids 200ml of LB medium containing the appropriate
antibiotics were inoculated with a single clone and incubated at 37◦C, 200rpm, o/n.
Plasmid DNA was isolated as described in the NucleoBond Xtra Midi protocol and
dissolved in 200µl sterile dH2O. The concentration was determined with a NanoDrop
device and plasmid solutions were stored at -20◦C. Plasmids were control sequenced
by GATC and deposited to the Schmid laboratory plasmid database. Additionally, a
sample for the glycerol stock collection was set aside. 800µl of midiprep LB culture
were mixed with 200µl 80% glycerol in DEPC H2O and stored as a glycerol stock at
-80◦C.
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4.2.3.11 Restriction endonuclease digest
RE digest was used for plasmid mapping, plasmid linearisation, and screening/genotyping.
Plasmid mapping was performed on plasmid DNA from minipreps. 1µl plasmid DNA
was digested in 11µl RE solution. RE were used as recommended in the manufac-
turer’s manual in the most suitable buffer (https://www.neb.com/tools-and-resources/
interactive-tools/double-digest-finder) . The digested products were analysed by agarose
gel electrophoresis.
20µg ZFN plasmids were linearised in 100µl as described in the manufacturer’s instruc-
tion but with an excess of RE for at least 2h. For all other linearisations 5µg or 10µg
plasmid DNA were linearised in a 20µl or 50µl reaction. Agarose gel electrophoresis
was used to examine if the plasmid was successfully linearised.
For screening/genotyping 10µl mastermix were added to 5µl PCR product.
Mastermix / reaction 1.5µl buffer
0.3µl RE
8.2µl sterile dH2O
The samples were incubated for at least 2h at the temperature indicated in the manu-
facturer’s manual and examined by agarose gel electrophoresis.
4.2.3.12 DNA purification and precipitation
Linearised plasmids were purified prior to in vitro mRNA synthesis according to the
following different but similar protocols.
Protocol 1: To remove any residual RNase A activity, PK treatment was performed.
This was done at 55◦C for 30min in a solution containing 0.5µg/µl PK and 0.5%
SDS. Then the liquid was transferred to a phase lock gel tube. An equal volume of
phenol/chloroform/isoamylalcohol was added and microcentrifuge tubes were mixed
3min by vigorous inverting. Then the microcentrifuge tube was centrifuged for 5min
at full speed and an equal volume of chloroform/isoamylalcohol was added to the
supernatant. The microcentrifuge tube was vigorously inverted for 1min and centrifuged
for 5min at full speed. The supernatant ready for precipitation was transferred to a
new microcentrifuge tube (precipitation see below).
Protocol 2 (for ZFN): Steril dH2O was added ad 250µl and transferred to a phase lock
gel tube. 125µl phenol and 125µl chloroform were added and the liquid was mixed by
vigorous inverting. Then the samples were centrifuged for 5min at full speed and an
equal volume of chloroform was added to the supernatant. The microcentrifuge tube
was vigorously inverted and centrifuged for 5min at full speed. The supernatant was
transferred to a new microcentrifuge tube.
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For precipitation 1
10
vol% 3M NaOAc pH4.5 and 21
2
vol% 100% ethanol were added
and incubated for 15min at -20◦C. Then the samples were centrifuged for 20min at
4◦C at 13000rpm and the supernatant was discarded. 300µl 75% ethanol were added
and samples were centrifuged for 5-10min at 4◦C at 13000rpm. The supernatant was
removed. The pellet was dried at RT, dissolved in 20µl DEPC H2O and used for mRNA
synthesis.
4.2.3.13 In vitro mRNA synthesis and purification
mRNAs for microinjections require a 5’-cap and a polyA tail to enhance the stability
and efficient translation. mRNA was synthesized in vitro from linearised plasmids with
two different kits. grnb ZFN mRNAs were transcribed using the MessageMAX T7
mRNA transcription kit and grna ZFN mRNAs with the mMESSAGE mMACHINE
T7 kit. During the plasmid linearisation the BGH polyA site following the ZFN coding
sequence is cut of by the RE suggested in the manufacturer’s manual. Therefore it
was necessary to add a polyA tail by a polyA tailing reaction. The A-Plus Poly(A)
Polymerase Tailing Kit was used as described in the instructions. grna and grnb ZFN
mRNAs were purified using the MEGAClear Kit as described in the manufacturer’s
manual.
All other mRNAs for microinjections were synthesized with the mMESSAGE mMA-
CHINE T7 or SP6 kit according to the manufacturer’s protocol. For the purification
lithium chloride precipitation was performed as described in the manufacturer’s manual.
All in vitro synthesised mRNAs were controlled by agarose gel electrophoresis and the
concentration was determined using a NanoDrop device. mRNA was stored at -80◦C.
4.2.3.14 In vitro transcription and translation
The TNT Coupled Reticulocyte Lysate Systems (SP6) was used for in vitro transcription
and translation according to the technical bulletin. 0.5µg circular DNA templates were
used for each reaction. RiboLock was applied as ribonuclease inhibitor and radiolabelled
[35S]-labelled methionine (Met) was used. Once the translation reaction was completed
4x Lämmli buffer was added and samples were boiled at 95◦C for 5min to denature the
proteins. Denatured samples were separated and analysed by SDS-PAGE.
4.2.3.15 Determination of protein concentration
For the determination of protein concentrations in cell culture lysates a BC Assay was
applied as described in the protocol of the BC Assay Protein Quantitation Kit. BSA
was used for the standard curve. The reaction was measured with a plate reader at
562nm.
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4.2.3.16 SDS-polyacrylamide gel electrophoresis
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was done to separate proteins
according to their molecular weight (MW). The percentage of the running gel was
chosen depending on the expected MW of the protein of interest (http://www.thermos-
cientificbio.com/uploadedFiles/Resources/general-recommendations-for-sds-page.pdf) .
Running gel (25ml for three times 1.5mm or 6-times 0.75mm gels) and stacking gel
(6ml for 3 gels):
7% 8% 12% 15% St. gel
40% acrylamide 4.43ml 5.03ml 7.58ml 9.45ml 563µl
Running buffer 12.5ml 12.5ml 12.5ml 12.5ml -
Stacking buffer - - - - 750µl
10% SDS 250µl 250µl 250µl 250µl 60µl
dH2O 7.57ml 6.97ml 4.42ml 3.15ml 4.913ml
10% APS 250µl 250µl 250µl 250µl 60µl
TEMED 5µl 5µl 5µl 5µl 6µl
The PAGE equipment including denaturing gels was assembled and SDS running buffer
was added. Wells were rinsed with SDS running buffer prior to loading of samples as
well as protein standard to the wells. Electrophoresis was started with 80V, increased
to 120-150V after the protein standard began to separate and was stopped when the
region of interest showed a clear separation. Gels were subsequently used for Western
Blotting or those containing radioactively labelled proteins for autoradiography.
4.2.3.17 Autoradiography
Polyacrylamide gels containing radioactively labelled proteins were fixed in destain
solution for 30min on an orbital shaker. Then the solution was poured off and the gel
was washed with H2O until the acetic acid smell was gone. Subsequently, the gel was
soaked in Amplify-Solution (Amplify Fluorographic Reagent) for 30min on an orbital
shaker covered with aluminium foil to protect the light-sensitive solution. After that,
the gel was dried with a vacuum dryer at 75◦C for 1h:30min. X-ray films were put on
the dried polyacrylamide gel, were exposed for 2-14h and were developed.
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4.2.3.18 Protein transfer to PVDF-membrane (Western blotting)
Wet tank Western blotting was used to transfer and immobilize proteins on a membrane.
Prior to blotting on PVDF-membranes, pre-wetting (activation) of the PVDF-membrane
in methanol or isopropanol was performed. Afterwards, the membrane was washed in
dH2O and was put in 1x transfer buffer. Membrane and gel were assembled between
foam pads and Whatman paper in a holder cassette. Then the proteins were transferred
onto the PVDF-membrane in 1x transfer buffer at 400mA for 70min (90min for Grna).
Membranes were subsequently used for immunodetection.
4.2.3.19 Immunodetection of proteins
After Western blotting, membranes were incubated at RT for 1h on an orbital shaker in
i-Block, PBST milk, or TBST milk. Then the primary antibody was added in i-Block,
PBST milk, or TBST milk, 0.05% NaN3 and the membrane was incubated on a shaker
at 4◦C o/n. The next day the primary antibody was removed and kept for further use at
4◦C. Afterwards the membrane was rinsed with PBST or TBST, was washed two times
for 15min in PBST or TBST and then for two times for 15min in PBST milk or TBST
milk on a shaker at RT. The secondary antibody was applied in PBST milk or TBST
milk for 1h at RT. After removal of the secondary antibody the membrane was rinsed
with PBST or TBST, was washed four times for 15min and three times for 10min in
PBST or TBST. For immunodetection ECL Plus was used as indicated in the manual.
The HRP moiety of the secondary antibody or direct conjugated antibody induces the
emission of light from the substrate that can be detected upon exposure of X-ray films.
After immunodetection the membrane was washed three times for 5min in PBST or
TBST and either dried for storage or reused. Before a second immunodetection the
membrane was stripped using one of the following protocols.
Stripping protocol 1: The membrane was incubated in 50ml stripping buffer plus 350µl
β-mercaptoethanol at 50◦C in a horizontally shaking water bath for 1.5h. Then the
membrane was rinsed in PBST or TBST and washed six times for 5min in PBST or
TBST. Afterwards the membrane was ready for the second immunodetection which was
performed like the first immunodetection (see above).
Stripping protocol 2 (Yeung and Stanley, 2009): The membrane was incubated hori-
zontally shaking in 10ml GuHCl-stripping buffer plus 70µl β-mercaptoethanol (0.1M)
at RT for 5min. Then the membrane was washed two times for 5min in PBST or
TBST. A second round of 5min incubation in 10ml GuHCl-stripping buffer plus 70µl
β-mercaptoethanol followed. Afterwards, the membrane was rinsed in PBST or TBST
and washed five times for 5min in PBST or TBST. After that, the membrane was
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ready for the second immunodetection which was performed according to the first
immunodetection (see above).
4.2.4 Others
4.2.4.1 Custom zinc finger nucleases
Custom ZFNs targeting grna and grnb designed according to the CompoZrTM algo-
rithms were obtained from Sigma-Aldrich. grna and grnb were partially sequenced
to determine the exact sequences of grna and grnb in our AB wildtype-line. In the
pre-evaluation phase 16 pairs of possible ZFN DNA binding sites suggested by Sigma-
Aldrich were aligned to the determined wildtype sequences and these with a perfect
match were approved. After pre-evaluation the following ZFN sets summarised below
were obtained from Sigma-Aldrich (ZFN binding sites capital letters; spacer/cut site
small, italic letters). The in vivo evaluation of the ZFN sets and their usage for genome
editing are described in detail in the results section.
ZFN sets binding and cut site
grna PZFN1/PZFN2 TTTGCTCGCAGTGCCCCAataatGAAGTCTGTGAAGCAGGC
grna PZFN3/PZFN4 CTGACAGTCTGCCTCGCTgtggtgACCCTGGTTATTTGCT
grnb PZFN1/PZFN2 TACCACCTGCTGCCAGatgcctgATGGGGGCTGGGGCT
grnb PZFN3/PZFN4 TACCACCTGCTGCCAGatgcctgATGGGGGCTGGG
grnb PZFN5/PZFN6 ACCTGCTGCCAGATGcctgatGGGGGCTGGGGCTGCT
4.2.4.2 Generation of zebrafish specific monoclonal antibodies
Zebrafish specific monoclonal antibodies (mAb’s) detecting Grna, Grnb, Grn1, and Grn2
were generated by the service unit monoclonal antibodies at the IMI, Helmholtz Center
Munich. Peptides for immunization of mice and rats were synthesized and conjugated
N- or C-terminally with ovalbumin (OVA) by Peptide Specialty Laboratories GmbH.
The same peptides, also synthesized by Peptide Specialty Laboratories GmbH, were N-
or C-terminally conjugated with BSA or biotin for the enzyme-linked immunosorbent
assay (ELISA). The screening process for mAb’s is described in the results section.
4.2.4.3 Databases, alignments and primer design
Databases used in this study are Ensembl Genome Browser (http://www.ensembl.org/
index.html) and several resources provided by NCBI (http://www.ncbi.nlm.nih.gov/).
CLC Main Workbench was used for alignments, assemblies, sequence analysis of DNA,
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RNA and protein, calculation of the theoretical MW, RE mapping and construction of
plasmid maps. Oligonucleotides were designed with CLC Main Workbench or Primer3
(http://primer3.ut.ee/). Primer specificity was evaluated using Primer-BLAST (http://
www.ncbi.nlm.nih.gov/tools/primer-blast/). BLAST searches were performed on the
Ensembl (http://www.ensembl.org/Multi/blastview) and NCBI (http://blast.ncbi.nlm.
nih.gov/Blast.cgi) web pages.
4.2.4.4 Image processing and analysis
Images from microscopy were processed with ZEN blue, ZEN black, AxioVison, ImageJ,
or Adobe Photoshop. In Adobe Photoshop the image size and levels were adjusted.
Manual tracking of immune cells was done with the ImageJ plugin mTrackJ (Meijering
et al., 2012) and images were stitched using the ImageJ plugin Image Stitching (Preibisch
et al., 2009). Films from autoradiography or Western blotting were scanned with 600dpi
resolution, converted to greyscale and image size as well as levels were adjusted with
Adobe Photoshop. Bands on Western blot films were quantified by their density/intensity
using ImageJ.
4.2.4.5 Statistics
Means, standard deviation (SD), and standard error of the mean (S.E.M.) were calculated
using Graph Pad Prism. Graphs shown in this thesis were generated with the Graph
Pad Prism software. The statistical analysis and test used are indicated in the respective
figure legend.
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5.1 Characterization of zebrafish granulins
5.1.1 Four granulins in zebrafish
A database search in Ensembl (http://www.ensembl.org/index.html) identified four
zf-grns - grna, grnb, grn1 and grn2 - annotated in the Danio rerio genome. Of these
grna and grnb are listed to be orthologues of the mammalian GRN. grn1 and grn2
are paralogues of grna and grnb but lack a mammalian orthologue. The existence
of four zf-grns was previously described (Cadieux et al., 2005). grna is located on
chromosome 3 and due to its synthenic conservation potentially the true orthologue
of the 71
2
granulin domain containing human GRN (Fig. 5.1) (Cadieux et al., 2005). I
amplified grna from cDNA of 5dpf larvae and adult fin tissue. Its open reading frame
(ORF) is 3147bp and it is translated into a 1049 amino acid (aa) protein, containing
12 granulin domains (Fig. 5.1) with a theoretical molecular weight (MW) of 112kDa.
grnb, which is on chromosome 24, was amplified from cDNA of 4dpf larvae previously in
Figure 5.1 – Schematic illustration of human GRN and zf-Grns. Human GRN has 712
granulin domains, while 12 granulin domains were found in Grna, 9 in Grnb, and 112 in
Grn1 and Grn2. Grey and SP: signal peptide. Black numbers: aa. Darker color and white
letters/numbers: granulin domains.
the laboratory. Its ORF is 2187bp and translates into a 729aa protein with 9 granulin
domains (Fig. 5.1). The calculated MW is 78kDa. grn1 and grn2 are both located
side by side on chromosome 19 and are highly homologous (85% identity on aa level)
(Fig. 10.1 and 10.2). I amplified both 441bp protein coding ORFs from expressed
sequence tag (EST) clones. Both proteins are 147aa, with a theoretical MW of 16kDa
and contain 11
2
granulin domains (Fig. 5.1).
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5.1.2 Expression profile of zf-grns
The expression of the distinct zf-grn transcripts during development and in certain
adult tissues was determined by RT-PCR. grna was expressed at very low levels from
1dpf to 5dpf. It was also expressed in brain, fin, and kidney with the highest expression
in the kidney sample (Fig. 5.2 grna). In contrast, grnb was expressed from 1dpf to 5dpf
Figure 5.2 – Expression of zf-grns during development and in selected adult tissues. grna
was expressed from 1dpf to 5dpf at very low levels. It was expressed stronger in brain, fin,
and kidney. grnb was expressed throughout development and in all adult tissues analysed.
grn1/grn2 were expressed at very low levels from 1dpf to 3dpf. At 4dpf and 5dpf as well
as in brain, fin, and kidney grn1/grn2 were clearly expressed. tbp is used as reference.
Semiquantitative RT-PCR. NoT: no template. 30 cycles.
as well as in samples derived from brain, fin, and kidney at levels comparable to the
reference gene tbp (Fig. 5.2 grnb). Due to their high homology (Fig. 10.1) grn1 and
grn2 were analysed with a primer pair that amplifies both, grn1 and grn2, in one PCR
reaction. From 1dpf to 3dpf grn1/grn2 expression was almost absent, but at 4dpf and
5dpf they were clearly expressed, even higher than grna and grnb. In adult tissue the
grn1/grn2 expression resembled that of grna, being the highest in the kidney (Fig. 5.2
grn1/grn2 ).
grna and grn1/grn2 expression was very high in kidney tissue, which is the main
haematopoietic tissue in adult zebrafish, and grn1/grn2 expression was high from 4dpf
onward. At that stage of development the number of immune cells is increasing in
zebrafish larvae. Moreover, it was shown that fish granulins are enriched in haema-
tiopoietic tissue and cells of the myeloid lineage (Barreda et al., 2004; Belcourt et al.,
1993, 1995; Craig et al., 2008; Hanington et al., 2006; Sakai et al., 2005; Zakrzewska
et al., 2010). Therefore, I addressed if zf-grn transcripts are differentially expressed in
macrophages or neutrophils. In a collaboration with Julien Rougeot from the laboratory
of Annemarie Meijer at Leiden University, total mRNA was isolated from FACS sorted
mpeg1 :mCherry-positive cells, which are mainly macrophages, or mpx :GFP-positive
cells, which are mainly neutrophils, and qPCRs were performed. grna and grn1/grn2
mRNA transcripts were significantly enriched in the mpeg1 :mCherry-positive cells
from 6dpf old zebrafish larvae in comparison to mpeg1 :mCherry-negative cells. grna
expression was approx. 200-fold higher (p = 0.0005) and grn1/grn2 expression was ap-
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prox. 80-fold higher (p = 0.003) than in the corresponding mpeg1 :mCherry-negative cells
(Fig. 5.3A,C). In contrast, mpeg1 :mCherry-positive cells and mpeg1 :mCherry-negative
cells from 6dpf larvae showed similar expression levels of grnb (p = 0.2583) (Fig. 5.3B).
In mpx :GFP-positive cells grna and grn1/grn2 mRNA transcripts were approx. 4-5-fold
(p = 0.0609; p = 0.0144) higher than in mpx :GFP-negative cells (Fig. 5.3A,C). Whereas
Figure 5.3 – mRNA expression levels of zf-grns in macrophages and neutrophils. A: grna
mRNA was strongly enriched in mpeg1 :mCherry-positive and to some degree inmpx :GFP-
positive cells from 6dpf old larvae. ***p = 0.0005. B: grnb mRNA expression levels
were indistinguishable in mpeg1 :mCherry-positive and -negative cells and reduced in
mpx :GFP-positive cells from 6dpf old larvae. **p = 0.0039. C: grn1/grn2 mRNAs in
mpeg1 :mCherry- and mpx :GFP-positive cells from 6dpf larvae were enriched. **p = 0.0030.
*p = 0.0144. Normalized to tbp, eif4a1b and eif5. qPCR. n = 3. S.E.M. Unpaired t-
test (two-tailed). - : mpeg1 :mCherry- or mpx :GFP-negative. + : mpeg1 :mCherry- or
mpx :GFP-positive.
grnb mRNA was significantly depleted in mpx :GFP-positive cells (p = 0.0039) when
compared to the mpx :GFP-negative cells (Fig. 5.3B).
In summary, zf-grns are expressed during development at different levels and in various
tissues. Furthermore, grna and grn1/grn2 expression is increased in haematopoietic
tissue, particularly in macrophages, whereas grnb is not enriched in haematopoietic
tissue.
5.1.3 Screening for zf-Grn specific antibodies
To detect zf-Grn proteins for example by Western blotting, monoclonal antibodies
(mAbs) were generated. Epitopes in the zf-Grn proteins were selected that are located
in the linker region close to the border of the granulin domains, to reduce the likelihood
that the epitope is cleaved e.g. by elastase. The selected peptides and their conjugates are
listed in table 5.1. These conjugated peptides were used by the service unit monoclonal
antibodies (IMI, Helmholtz Center Munich) for the immunization of rats and mice.
For the generation of mAbs, antibody producing lymphocytes, from the immunized
animals, were fused with myeloma cells to hybridomas (Milstein, 1999). Supernatants
from hybridoma cell pools were assayed by an ELISA using BSA or biotin-conjugated
peptides at the service unit monoclonal antibodies (IMI, Helmholtz Center Munich).
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Table 5.1 – Peptides for mAb generation and summary of hybridoma pools tested.
Peptides for immunisation were conjugated N- or C-terminally to OVA via an endogenous
(C) or added cysteine (-C-). Internal cysteines were replaced by the isosteric aa α-
aminobutyric acid (AABA).
Peptide
name
peptide
sequence and
conjugates
No. of positive /
No. of all hybridoma
pools tested
grb1 KEPALRETQRVEDRHMC-OVA 5/25
grb2 OVA-CTKSSSSTWWNNSL 10/30
gra1 KDLT[AABA]TNATHTQPLAD-C-OVA 4/45
gra2 LRRRS[AABA]VKTTRLYV-C-OVA 0/2
GRN1 /
GRN2
VETVDTSASVIYC-OVA/
METEDVSASVIHC-OVA
3/145
grna_03 KQKRPETQRTTARPTGTTS-C-OVA 23/90
grna_04 GQRPSGKVK[AABA]NATHGC-OVA 2/13
Pools with a positive result were then tested in a first screen using immunoblotting
of MYC- or V5-tagged zf-Grn proteins. These tagged zf-Grn proteins were derived
from overexpression of zf-grn coding vectors in cell culture. While confirming the
expression of the tagged proteins by Western blotting using tag-specific antibodies,
I found Grna-MYC migrating on a SDS-PAGE between 150-250kDa at a MW of
approx. 200kDa (Fig. 5.4A), Grnb-MYC at approx. 110kDa (Fig. 5.4B), and Grn1-V5
and Grn2-V5 at about 22kDa (Fig. 5.4C,D). Table 5.1 summarizes the number of tested
Figure 5.4 – Overexpression of tagged zf-Grn proteins in HEK293T cell culture. A:
Grna+MYC did migrate on a SDS-PAGE at approx. 200kDa and was not detectable in the
untransfected control. B: Grnb+MYC was detected on a SDS-PAGE at approx. 110kDa
and was absent in the untransfected control. An unspecific band at 64kDa marked with
an asterisk (*) served as loading control. C-D: Grn1+V5 and Grn2+V5 did migrate at
about 22kDa on a SDS-PAGE and were not detected in the untransfected control. The
asterisk (*) marks an unspecific band slightly below 36kDa that served as loading control.
hybridoma supernatant pools and the number of these having the ability to detect
the overexpressed protein. The peptides selected to detect specifically Grn1 and Grn2
were very similar (Table 5.1), as Grn1 and Grn2 have a high homology (Fig. 10.2).
Therefore, all hybridoma supernatant pools from immunizations with peptides GRN1 or
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GRN2 were tested on Grn1+V5 and Grn2+V5 for Grn1 and/or Grn2 immuno-reactivity.
Single clones from up to four positive tested hybridoma supernatant pools were then
isolated by the service unit monoclonal antibodies (IMI, Helmholtz Center Munich).
Media from these isolated single clones were tested in a second screen by immunoblotting
using cell culture samples to isolate positive monoclonal Abs. By testing media from
isolated single clones, no mAb for Grn1 and Grn2 could be established. For Grna
clone grna_03 12E7-111 and for Grnb clone grb2 11F4-11 were positive. To confirm
that these two mAbs do also recognize native zebrafish Grna or Grnb, grna and grnb
mRNA were injected with and without a tag at one cell stage in fertilized zebrafish eggs.
Overexpression of grnb in zebrafish embryos led to an increased intensity of the band
above 98kDa at approx. 110kDa using mAb Grnb 11F4-11 for detection (Fig. 5.15).
The detection of overexpressed Grna in embryos by Western blotting was not feasible.
To confirm the specificity of mAb Grna 12E7-111, Grna was in vitro transcribed
and translated from a vector coding for the ORF of grna using the TNT Coupled
Reticulocyte Lysate System. [35S]-labelled Grna protein from in vitro transcription and
Figure 5.5 – The mAb Grna 12E7-111 detected in vitro transcribed and translated Grna.
A: Autoradiography of in vitro transcribed and translated grna cDNA from wildtype (wt)
AB and wt TLF zebrafish labelled with [35S]-Met. Luciferase (Luc) control DNA labelled
with [35S]-Met. No vector control. B: In vitro transcribed and translated grna cDNA
from wt AB and wt TLF zebrafish detected with mAb Grna 12E7-111. Luc control DNA
and no vector control show no signal.
translation was detected on an autoradiography (Fig. 5.5A) and by mAb Grna 12E7-111
(Fig. 5.5B) at the same MW. In this assay Grna migrated at a lower MW than in vivo
since post-translational modifications are not added to the protein in the in vitro assay.
Therefore, this assay confirmed indirectly the specificity of mAb Grna 12E7-111.
Taken together, zebrafish specific mAbs detecting Grna and Grnb were successfully
generated.
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5.1.4 Grna and Grnb expression throughout development
Immunoblotting was performed with the Grna and Grnb specific mAbs to determine the
protein expression of Grna and Grnb during development. No Grna specific band could
Figure 5.6 – Protein expression of Grna and Grnb during development. A: Grna protein
levels were below the detection limit from 1dpf to 5dpf. All lanes contained protein
(partially masked by yolk proteins) as confirmed by the Calnexin Ab. Two embryos per
lane. B: Grnb was expressed from 1dpf to 5dpf as visualized by a band above 98kDa
marked by a black arrow. The α-tubulin blot served as control. One embryo per lane. *
unspecific band.
be detected between 150-250kDa (Fig. 5.6A), the range where Grna was expected since
Grna+MYC derived from cell culture overexpression was migrating at approx. 200kDa
(see also Fig. 5.15). This might be due to very low expression levels of grna at these
stages of development (see Fig. 5.2). The Calnexin blot showed that the blotting was
successful, even though the Calnexin band was masked at 1dpf to 3dpf by yolk proteins
(Fig. 5.6A). When immunodetection with the Grnb specific mAb was performed a distinct
Grnb signal above 98kDa was clearly detectable at all stages analysed (Fig. 5.6B). Also
α-tubulin expression was detected throughout development. From 1dpf to 5dpf the
amount of α-tubulin was increasing as the embryos/larvae were growing (Fig. 5.6B).
In contrast to α-tubulin, Grnb expression was not increasing from 1dpf to 5dpf, which
could be a hint that the Grnb expression is decreasing throughout development.
It can be concluded that Grna expression is below the detection limit from 1dpf to 5dpf
and that Grnb protein is expressed from 1dpf through 5dpf.
5.2 Generation of Grna and Grnb loss of function mutants
Since it is published that patient mutations in GRN in FTLD-TDP/GRN and
NCL/GRN lead to a partial or complete loss of functional protein (Cruts et al.,
2012; Smith et al., 2012), I decided to generate Grna and Grnb loss of function zebrafish.
I selected these two genes because of their orthology to human GRN. Like GRN, they
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are composed of several granulin domains and would most likely allow to study the
full length function of GRN. Loss of protein function studies can either be performed
by KD or KO of a gene of interest. I chose a KO approach for this study, since it is
more stable, inheritable, and additionally allows analyses in adult zebrafish. Moreover,
unspecific phenotypes due to toxicity of the KD reagents are no longer an issue in KO
zebrafish. One possibility to perform genome editing in a gene of interest in zebrafish is
the application of ZFNs (Doyon et al., 2008; Meng et al., 2008).
5.2.1 ZFNs targeting grna and grnb
CompoZr Custom ZFNs from Sigma Aldrich targeting grna and grnb were obtained to
generate mutations, which can lead to a stable and inheritable loss of protein function.
The ZFNs were designed to target the first coding exons. Mutations in the very 5’
Figure 5.7 – Localisation of ZFN target sequences in grna and grnb. A: Schematic
illustration of the genomic structure of grna. grna ZFN set1 and set2 target the first
coding exon. grna ZFN set1 induced mutations can be detected with RE TspDTI and
these of set2 using RE Eco91I. B: Schematic illustration of the genomic structure of grnb.
All grnb ZFN sets are located in the third coding exon and ZFN induced mutations can be
detected with RE XcmI. Grey boxes: untranslated region (UTR). Coloured boxes: coding
region. Light red and light blue boxes: ZFN target sites. Green lines: binding and cut
sites of RE.
region of the ORF, leading to a preTT codon, increase the likelihood for loss of function
mutations, as such mRNAs are recognized by the NMD machinery (Vicente-Crespo and
Palacios, 2010). Moreover, possible truncated proteins are very short and lose functional
domains. I obtained two sets of ZFNs for grna, both targeting the first coding exon
(Fig. 5.7A), and three sets for grnb, all targeting the third coding exon (Fig. 5.7B). For
all targeting regions a BLAST search (http://blast.ncbi.nlm.nih.gov/Blast.cgi) with the
target sites of the ZFN DNA binding domains was performed to evaluate the specificity
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of the ZFN sets. grna and grnb were always the top hits and the only ones with a query
cover of 100%. This indicates that the target sites of all ZFN sets are unique in the
zebrafish genome and most likely highly specific for the respective gene of interest. Next,
Figure 5.8 – Schematic illustration of mRNA injections of grna and grnb ZFNs and the
resulting P0 generation.
the ZFN sets were injected as mRNAs by microinjection into fertilized zebrafish eggs at
one cell stage (Fig. 5.8). Since all ZFNs contain a FLAG-tag in their coding sequence
the translation of the ZFN mRNAs into proteins could be controlled by immunoblotting
using an antibody detecting the FLAG-tag. In all samples injected with ZFNs bands
at approx. 50kDa were present, that were absent in the uninjected siblings (Fig. 5.9).
For most ZFN sets the two bands, which are derived from the ZFN that binds on the
forward strand and the ZFN that binds on the reverse strand appeared as one band.
The MW of the single ZFN is very similar. Nevertheless, the aa composition of the
DNA binding site is unique for each ZFN and can result in a minor shift to a higher or
lower MW (e.g. Fig. 5.9 ZFN grna set2). With these immunoblots I confirmed, that all
Figure 5.9 – All ZFN mRNAs were translated into FLAG-tagged proteins. A: Anti-
FLAG immunoblot on control and grna ZFN mRNA injected samples. B: Anti-FLAG
immunoblot on control and grnb ZFN mRNA injected samples. The asterisk (*) marks an
unspecific band that served as loading control.
ZFN mRNAs were successfully translated into proteins.
The expression of proteins did not provide any information about the functionality
of the ZFNs. To be functional the ZFNs need to form a nuclease heterodimer, that
is able to cut double-strand DNA. Therefore, screening assays for all ZFN sets were
established, which allow the detection of mutations induced by the cell’s error-prone
repair mechanism NHEJ, while repairing DSBs caused by active ZFNs. Thus, the
screening assays are a read-out for ZFNs functionality and can additionally be used for
genotyping of the established mutants afterwards. I amplified genomic DNA containing
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Table 5.2 – Summary of screening assays for ZFN induced mutations in grna and grnb.
ZFN set PCR product
[bp]
RE (No. of
cut sites)
band pattern in
digested wt [bp]
band pattern in
digested mut [bp]
grna set1 392 TspDTI (4) 46, 56, 79, 98, 113 46, 56, 79, 211
grna set2 392 Eco91I (1) 159, 233 392
grnb set1-3 582 XcmI (1) 325, 257 582
the target sites of the ZFNs by PCR and digested the PCR product with the respective
RE (Table 5.2). PCR product and RE digest were separated side by side by agarose
gelelectrophoresis (Fig. 5.10). In a wildtype situtation, the PCR product is completely
digested, which is represented by a complete shift to digested, smaller MW bands in the
samples treated with RE. If the RE cuts once in the PCR product, two smaller bands
are present in the sample digested with the RE (Fig. 5.10B,C uninjected), whereas if a
RE cuts multiple times, several smaller bands are the result (Fig. 5.10A uninjected).
Mutations altering the RE recognition site may prevent the digest and therefore, the
Figure 5.10 – Screening assays for ZFN-induced mutations in grna and grnb. Uninjected
and injected P0 embryos were tested. PCR product and RE-digested PCR product were
separated on agarose gels. A: Injection with ZFN grna set1 mRNAs. RE: TspDTI. The
red plus mark the 211bp band that should be absent in RE-digested uninjected samples.
B: Injection with ZFN grna set2 mRNAs. RE: Eco91I. C: Injection with ZFN grnb set1-3
mRNAs. RE: XcmI. A-C: The black asterisks (*) mark the band size in the RE-digested
samples that remained in ZFNs injected samples only.
PCR product is digested only partially. The REs used for the screening assay and
the expected band patterns are summarized in table 5.2. Since the RE, TspDTI, used
for ZFN grna set1 cut four times in the grna PCR product, this screening assay was
more complex compared to the other screening assays. Moreover, TspDTI led only to a
partial digest in uninjected wildtype samples as the 211bp band, which corresponds to
the band of ZFN induced mutations, was also visible in samples that were not injected
with ZFNs (Fig. 5.10A). Therefore, it was difficult to discriminate with this screening
assay between an incomplete digest and a partial digest due to ZFN induced mutations.
Because of the lack of a suitable, robust screening assay ZFN grna set1 was no longer
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pursued. In embryos injected with ZFN grna set2 mRNA (Fig. 5.10B) or ZFN grnb
set1-3 mRNAs (Fig. 5.10C) (P0) the PCR bands at 392bp or 582bp were only partially
digested and it can be concluded, that some cells of the P0 embryos carry mutations in
grna or grnb, respectively. These P0 embryos are mosaic mutation carriers. They carry
mutations in some somatic cells and most likely also in some germ cells. Several P0
siblings from positively tested ZFN mRNA microinjections were raised to adulthood for
further screenings (Fig. 5.8).
In summary, I obtained two sets of ZFNs for grna and three sets of ZFNs for grnb.
All ZFNs are successfully translated into proteins and it was shown that set2 of ZFNs
targeting grna and all sets of ZFNs targeting grnb do cut double strand DNA in the
ZFN targeting regions leading to induction of mutations in grna and grnb by the cellular
repair mechanism NHEJ.
5.2.2 Screen for grna and grnb mutants
Injected P0 founder fish are still mosaic, meaning that they carry distinct mutations in
randomly distributed cells throughout their bodies. To identify F1 zebrafish that carry
a single mutation in every cell, the following screen (Fig. 5.11) was performed: Adult
Figure 5.11 – Schematic illustration of the screening performed to establish Grna and
Grnb loss of function mutants by ZFN-mediated genome editing.
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ZFNs injected P0 zebrafish were mated to wildtype zebrafish (Fig. 5.11), to obtain a F1
generation that carries one single mutation in every somatic cell and 50% of the germ
cells. At least 12 F1 offspring were sacrificed as embryos and were analysed using the
screening assay (see Fig. 5.10). If mutations were detected, the siblings (F1) were raised
to adulthood (Fig. 5.11). Fin biopsy were taken from these adult F1 zebrafish and the
samples were analysed for mutations using the screening assay (Fig. 5.11). Sequencing
was performed with samples from mutation carrier to determine the sequence of the
mutation. Amongst the mutations - deletion, insertion, or indels - these were selected
that result in a preTT codon in the same coding exon (Fig. 5.11). F1 mutation carrier
with a preTT mutation were bred to homozygosity (Fig. 5.11).
For all sets of ZFNs, except grnb set3, more than 50% of the F1 clutches analysed
carried mutations (Fig. 5.12). Consequently, more than 50% of the injected P0 fish had
mutations in the germline, which were transmittable to the next generation. As all grnb
Figure 5.12 – ZFN induced mutations were transmitted through the germline with a high
frequency. The percentages of germline transmission were 75%, 62%, 58%, and 33% for
grna set2, grnb set1, set2, and set3, respectively. White numbers (N) are for the number
of P0 founders analysed.
ZFN sets target almost the same genomic site, I decided to proceed only with zebrafish
that carry ZFN grnb set1-induced mutations.
For grna offsprings from 13 P0 founder fish were analysed and up to five distinct
mutations were detected that originate from one founder. This means that distinct
mutations were present in the germ cell population of the P0 founder that were inherited
to the F1 generation. These mutations trace back to various ZFN cutting events and
subsequent DSB repair by the cells error-prone repair mechanism NHEJ. This explains
why the mutations are slightly different from each other. All mutations induced by
the grna ZFN set2 are summarized in Fig. 10.5A. In total 13 different mutations were
detected and 6 of these result in a frameshift in the ORF. For grnb offsprings from 8 P0
founder fish were analysed and as much as three different mutations were detected in
adult fish that descend from one founder. All mutations that emerged from this set of
ZFN are summarized in Fig. 10.5B. All together 15 different mutations were detected
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among which 11 result in a frameshift in the ORF. Four distinct grna and three distinct
grnb mutations were selected that code for a preTT codon when translated into protein
(Fig. 5.13). These four and three alleles were used in further experiments and carriers
were bred to homozygosity.
In summary, ZFNs induced mutations in the germline, that were transmitted to the
next generation. Mutations that result in a preTT codon were identified, likely leading
to loss of protein function.
Figure 5.13 – Sequences of selected alleles that carry a preTT codon and lead to a preTT
when translated into protein. A: grna wildtype and the four selected grna mutation
alleles as well as their translation into proteins are shown. B: grnb wildtype and the three
selected grnb mutation alleles as well as their translation into proteins are shown. wt:
wildtype. ∆: deletion. +: insertion. *: Stop.
5.2.3 grna and grnb mutants are protein null mutants
In a KO animal model it is essential to confirm that the mRNA levels are reduced and
even more important that the protein is no longer produced. Therefore, I performed
qPCR experiments at 5dpf. grna mRNA levels in homozygous grna mutants carrying
presumptive loss of function alleles were significantly reduced to approx. 50% of the
mRNA expression levels detected in wildtype larvae (Fig. 5.14A). In grnb mutants
homozygous for the presumptive loss of function alleles the reduction in mRNA levels
was even more pronounced. Here the mRNA levels were reduced to approx. 10% of the
expression levels detected in wildtype larvae (Fig. 5.14B).
The mutated mRNAs containing a preTT codon are most likely degraded via NMD.
This endogenous RNA quality control mechanisms of cells hampers the synthesis of
truncated, non-functional proteins by enhancing the degradation rate of mRNAs with
preTT codons intensely (Garneau et al., 2007). Consequently, these mRNAs are not
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Figure 5.14 – The mRNA levels were reduced in all selected grna-/- and grnb-/- mutants.
A: mRNA levels of grna were significantly reduced in grna mutants. B: grnb mRNA levels
were significantly reduced in grnb mutants. 5dpf. Normalized to actb1 and tbp. qPCR.
S.E.M. Mann-Whitney test (one-tailed). ∗ p = 0.05. n = 3. No statistical analysis for
grnamde54c−/− and grnbmde357a−/− since n = 1.
translated anymore leading to a loss of the associated protein. To show that Grna and
Grnb protein is absent in grna-/- and grnb-/- mutants, respectively, immunoblots of
either adult kidney samples or 1.5dpf embryos, using Grna and Grnb specific mAbs
were performed. Grna protein was absent in all homozygous mutants analysed. The
Grna specific band present in wildtype samples at approx. 200kDa was no longer
detectable (Fig. 5.15A) in all adult kidney samples from grna-/- mutants. I used adult
Figure 5.15 – Grna and Grnb protein was absent in all grna-/- and grnb-/- mutant alleles
analysed. A: The Grna specific band was absent in all adult kidney samples derived
from grna-/- mutants, whereas a Grna specific signal was detectable in wildtype samples.
Calnexin served as a loading control. B: The Grnb specific band observed in wildtype
samples was absent in all 1.5dpf samples from different grnb-/- mutants. Injection of grnb
mRNA led to an increase in signal intensity of the Grnb specific band. The loading control
α-tubulin was present in all samples.
kidney samples for this experiment as this is the tissue with the highest grna expression
(Fig. 5.2). Grna was not detectable by immunoblotting using any other larval (Fig. 5.6A)
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or adult tissue. In samples from grnb-/- mutants the Grnb protein was absent. The
Grnb specific signal, observed in wildtype samples, was not detectable in all grnb-/-
mutants analysed (Fig. 5.15B). It can be stated that all mutant alleles of grna and grnb
are no longer translated into proteins.
In summary, all selected grna and grnb alleles are loss of function alleles and result in a
KO of the respective protein.
5.3 Basic characterization of Grna and Grnb KO zebrafish
One of the aims of this study was to establish stable mutant lines to study the in
vivo function of zf-grns. With the Grna and Grnb KO zebrafish I now addressed the
following questions: What are the consequences if Grna, Grnb, or both proteins are
lost? What is the phenotype of grna and grnb single and double mutants?
5.3.1 Single and double mutants are viable and fertile
I started to bred single and double mutants to hetero- and homozygosity and examined
them for viability until adulthood and possible reproductive phenotypes. In rats GRN
is expressed in rat oocytes (Suzuki et al., 2000) and it is published to be an important
factor for processes like blastocyst hatching, adhesion, and outgrowth (Qin et al.,
2005). Additionally, GRN was detected in the acrosome of the sperm in guinea pig and
mice (Baba et al., 1993) and a decreased ejaculation incidence in GRN-deficient mice
was reported (Kayasuga et al., 2007). Based on these publications, it was possible that a
KO of Grna, Grnb, or both could have an effect on fertility in grna and/or grnb mutant
zebrafish. In all in- and outbreedings performed, fertilized eggs were obtained. Among
these all possible genotypes were present in a ratio expected according to Mendelian
laws (Table 5.3). Larvae could be raised to adulthood and the lifespan of mutants was
undistinguishable from wildtype zebrafish.
Taken together, grna and grnb single and double mutants have a normal viability and
fertility.
5.3.2 Single and double mutants have no obvious morphological phenotype
I next examined the single and double mutants for obvious morphological alterations.
Body shape, yolk, eye, brain, notochord, and somites were morphologically examined
and at all embryonic, larval, and adult stages analysed, grna and grnb single and double
mutants could not be phenotypically distinguished from wildtype. Representative
images of 1.5dpf old wildtype and mutant embryos are shown in Fig. 5.16. When the
wildtype and mutant embryos/larvae grew older the heart started to beat, systemic
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Table 5.3 – Mendelian laws apply for incrosses of grna-/-, grnb-/-, and
grna-/-;grnb-/-mutants. The number of clutches analysed is indicated. Examined ra-
tions are mean values and the SD is given.
Incross of grna+/-, (n = 6)
Genotype grna+/+ grna+/- grna-/-
Examined ra-
tio
25.2± 7.1% 51.1± 6.3% 23.8± 4.7%
Theoretical
ratio
25% 50% 25%
Incross of grnb+/-, (n = 8)
Genotype grnb+/+ grnb+/- grnb-/-
Examined ra-
tio
21.6± 8.3% 53.6± 9.8% 24.8± 7.9%
Theoretical
ratio
25% 50% 25%
Incross of grna-/-;grnb-/-, (n = 10)
Genotype a+/+;
b+/+
a+/-;
b+/+
a+/+;
b+/-
a+/-;
b+/-
a-/-;
b+/+
a+/+;
b-/-
a-/-;
b+/-
a+/-;
b-/-
a-/-;
b-/-
Examined ra-
tio
8.3 ±
6.2%
15.0 ±
8.5%
7.6 ±
4.6%
24.0 ±
8.6%
5.7 ±
4.2%
8.7 ±
6.5%
8.0 ±
4.4%
14.0 ±
8.0%
8.8 ±
6.5%
Theoretical
ratio
6.25% 12.5% 12.5% 25% 6.25% 6.25% 12.5% 12.5% 6.25%
Figure 5.16 – Single and double mutants had no obvious morphological phenotype.
Images of 1.5dpf old wildtype, grna-/-, grnb-/- and grna-/-;grnb-/- mutants. Lateral view.
Anterior to the left. Single images were taken on a spinning disk microscope using
transmitted light and were stitched using the Image Stiching plugin of ImageJ.
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blood flow was initiated, pigmentation became visible and independent hatching was
observed. Also juvenile and adult wildtype and mutants could not be discriminated
according to their size, shape, or behaviour.
5.3.3 Single and double mutants lack compensation by paralogues
One possible explanation for the lack of a phenotype are compensatory mechanisms.
Grnb could for example compensate the loss of Grna or Grn1 and Grn2 could compensate
for the loss of Grna and Grnb. qPCR experiments were performed on total mRNA from
5dpf larvae to investigate possible compensatory mechanisms on the transcriptional
level. First, grnb mRNA levels were examined in grna-/- mutants and these were
alike in wiltype and grna-/- mutants (Fig. 5.17A). In the reverse experiment, the grna
mRNA levels were equally expressed in wiltype and grnb-/- mutants (Fig. 5.17B).
Therefore, it can be excluded that increased expression of the transcripts, grna and
Figure 5.17 – Single and double mutants lacked compensatory upregulation of other
zf-grns. A: mRNA levels of grnb were alike in wildtype and grna-/- mutants. n = 3,
n = 1 grnamde54c−/−. B: grna mRNA levels were the same in wildtype and grnb-/-
mutants. n = 3, n = 1 grnbmde357a−/−. C: grn1/grn2 mRNA levels were unchanged in
grna-/-;grnb-/- mutants when compared to wildtype. n = 4. A-C: Normalized to actb1
and tbp. 5dpf. qPCR. S.E.M. Mann-Whitney test (two-tailed). D: Grnb levels were
indistinguishable in wildtype and grna-/- mutants samples from 3dpf old larvae. α-tubulin
served as a loading control. E: Grna levels were about the same in adult kidney samples
from wildtype and grnb-/- mutants. α-tubulin served as a loading control.
grnb, compensates for the loss of the paralogue. qPCR experiments detecting grn1/grn2
in grna-/-;grnb-/- mutants revealed that the loss of Grna and Grnb together did not
lead to increased mRNA levels of grn1/grn2 in comparison to wildtype (Fig. 5.17C).
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Since it is possible that the KO of Grna or Grnb is compensated by an increased
translation of the protein encoded by the paralogue, the Grnb protein expression levels
were analysed by immunoblotting of 3dpf grna-/- mutants and the Grna levels were
determined by immunoblotting of adult kidney samples from grnb-/- mutants. In none
of the mutants analysed the protein levels of Grnb or Grna were increased. Therefore, it
can be excluded that a KO of Grna or Grnb is compensated by enhanced translation of
the protein encoded by the paralogue. Due to a lack of a Grn1/Grn2 specific antibody,
a compensation of Grn1/Grn2 could not be addressed in grna-/-;grnb-/- mutants.
In summary, compensatory upregulation of the paralogues in grna and grnb single and
double mutants does not occur on the transcriptional level. Moreover, it can be excluded
that Grna and Grnb compensated for the loss of each other on the translational level.
5.3.4 Single and double mutants are not developmentally delayed
GRN is published to be a growth factor (Bateman and Bennett, 2009), therefore, I asked
if a KO of Grna, Grnb, or both could have an influence on the rate of development.
Counting of the somites is a common staging parameter during development (Kimmel
et al., 1995). Therefore, somites were counted in wildtype and single as well as double
mutant embryos at 13-14 somite stage. The number of somites at that stage of
Figure 5.18 – grna-/-, grnb-/-, and grna-/-;grnb-/- mutants were not developmentally
delayed. A: The number of somites in grna-/- mutants and wildtype was indistinguishable.
B: grnb-/- mutants and wildtype had about the same number of somites. C: The number
of somites in grna-/-;grnb-/- mutants and wildtype was alike at the stage analysed. SD.
Mann-Whitney test (two-tailed). All n.s.. n ≥ 30.
development was alike in grna-/- (p = 0.3858), grnb-/- (p = 0.0627), and grna-/-;grnb-/-
(p = 0.2968) mutants when compared to wildtype control embryos (Fig. 5.18). Thus, the
pace of development is normal in single and double mutants also making comparisons
of clutches from different matings possible.
93
5 Results
5.4 Analysis of Grna;Grnb KO embryos for neuronal pheno-
types
In the past, the analysis of SpMN axon outgrowth in the zebrafish trunk gained
attention as a model for neurodegenerative diseases especially for MND. Loss of function
embryos or transgenic zebrafish overexpressing neurodegenerative disease-associated
genes were analysed for altered branching during axonal outgrowth or for SpMN axon
truncation by quantifying the SpMN axon length (Chitramuthu et al., 2010; Ciura
et al., 2013; Kabashi et al., 2010, 2011; Laird et al., 2010; Lemmens et al., 2007;
McWhorter et al., 2003; Paquet et al., 2009; Schmid et al., 2013; Song and Pimplikar,
2012). Mutations in GRN are clearly linked to FTLD-TDP and GRN might be a minor
risk factor for ALS (Del Bo et al., 2011; Sleegers et al., 2008). It is also published
that grna (Chitramuthu et al., 2010; De Muynck et al., 2013; Laird et al., 2010) and
grnb (Laird et al., 2010) morphants have defects in SpMN axon outgrowth and extended
SpMN axon branching was demonstrated (Chitramuthu et al., 2010). To confirm that
Figure 5.19 – grna-/-, grnb-/-, and grna-/-;grnb-/- mutants did not have SpMN axon that
show extended branching. A: Schematic illustration of a 28hpf embryo and a detail (red
box) of the region analysed. SpMNs and their axons are depicted in white. The red line
illustrates for SpMN axon 1 the measured SpMN axon length. Grey: spinal cord. B:
Examples of whole-mount IF stainings of wildtype, grna-/-, grnb-/-, and grna-/-;grnb-/-
mutants at 28hpf stained with znp1 antibody. The five SpMN axons above the end of
the yolk extension are displayed. Images taken by spinning disk confocal microscopy.
Maximum projection. Lateral view. Anterior to the left. Scale bar: 100µm.
data, the SpMN axon outgrowth regarding length and branching was examined in grna
and grnb single and double mutants by whole-mount IF stainings. Having made the
experience that inter-clutch variations can result in slight but significant differences
in the SpMN axon length (Fig. 5.20A), I did only compare embryos from one clutch.
Briefly, I fixed the embryos at 28hpf, performed whole-mount IF stainings with the znp1
antibody, genotyped the anterior part of each stained embryo and imaged and analysed
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Figure 5.20 – The SpMN axon length of the five SpMN axons above the end of the
yolk extension was normal. A: A comparison of the SpMN axon length of wildtype,
grna-/-, grnb-/-, and grna-/-;grnb-/- incrossings at 28hpf revealed a significant increase
in the SpMN axon length in grna-/- mutants (****p(1-5) < 0.0001, n = 66), a partially
significant increase in grnb-/- mutants (p(1) = 0.1715, p(2) = 0.3425, *p(3) = 0.0378,
*p(4) = 0.0350, *p(5) = 0.0447, 65≤n≤67), and a significantly reduced SpMN axon
length in grna-/-;grnb-/- mutants (**p(1) = 0.0021, ****p(2) < 0.0001, **p(3) = 0.0029,
**p(4) = 0.0032, ***p(5) = 0.0004, n = 64) when compared to wiltype (n = 63). S.E.M.
Mann-Whitney test (two-tailed). B-D: Wildtype, heterozygous, and homozygous embryos
from spawnings of heterozygous mutants. B: grna mutants. n = 30. C: grnb mutants.
n = 30. D: grna;grnb mutants. n = 25. E-G: Wildtype and homozygous embryos
from spawnings of homozygous mutant females and heterozygous mutant males. E: grna.
n = 30. F: grnb mutants. n = 30. G: grna;grnb mutants. n = 30. B-G: S.E.M. Two-way
ANOVA. Bonferroni post-test. All n.s..
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the five SpMN axons above the end of the yolk extension. From each clutch up to
ten embryos from every genotype were imaged. To prevent that inter-clutch variations
influence the results, I made sure that an equal number of wildtype, heterozygous, and
homozygous embryos from each of the three independent experiments was included
in the study. In none of the images taken, extended branching of the SpMN axons
was observed (Fig. 5.19). Embryos for the first experiment derived from spawnings of
heterozygous single and double mutant zebrafish. Consequently, wildtype, heterozygous,
and homozygous embryos were compared. Measurements of the SpMN axon length,
which is defined as the length of the SpMN axon from the ventral side of the spinal
cord to its growth cone, revealed that the length was not altered in single and double
heterozygous and homozygous embryos when compared to wildtype (Fig. 5.20B-D). This
indicates that the SpMN axon outgrowth is normal in grna, grnb, and grna;grnb mutants.
Still I had to exclude that maternal mRNA precludes SpMN axon outgrowth defects.
Maternal mRNA, which is also targeted by translation inhibition KD technologies, is
provided to the eggs by the mother and allows the embryos to synthesise proteins before
the own transcription machinery is functional (Pelegri, 2003). To deplete maternal
grna and/or grnb mRNA, a second experiment was set up with embryos originating
in spawnings of homozygous mutant females and heteroyzgous mutant males. Herein,
the SpMN axons also showed no extended branching and a comparison of the SpMN
axon length in heterozygous and homozygous mutant embryos did not point to any
differences in SpMN axon outgrowth (Fig. 5.20E-G).
In summary, the SpMN axons and their outgrowth are indistinguishable in Grna and
Grnb single and double KO embryos compared to wildtype embryos and I could not
confirm the data published from Laird and colleagues (Laird et al., 2010), Chitramuthu
and colleagues (Chitramuthu et al., 2010) and De Muynck and colleagues (De Muynck
et al., 2013) obtained in Grna and Grnb KD experiments.
5.5 Analysis of Grna;Grnb KO embryos for muscle phenotypes
It was also demonstrated that Grna has an influence on zebrafish muscle growth and
regeneration (Li et al., 2013). Most of the study was done with grna morphants but also
grnb morphants were used. Both morphants, but especially the grna morphants, showed
a reduced number of Pax7-positive cells at 24hpf. At that stage of development Pax7
labels the nuclei of MPCs, which are located at the surface of the trunk musculature (Feng
et al., 2006; Patterson et al., 2008) and therefore it was concluded that grna and grnb
morphants have less MPCs (Li et al., 2013). With the observation from our laboratory
that tardbp-/-;tardbpl-/- double mutant zebrafish show muscle degeneration (Schmid et al.,
2013), I asked if the grna-/-;grnb-/- double mutants do also have a muscle phenotype. I
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performed whole-mount IF stainings with the Pax7 antibody at 24hpf and quantified the
number of Pax7-positive MPCs in the four somites above the end of the yolk extension
(Fig. 5.21A). Pax7-positive MPCs can be distinguished from xanthophores, which are
also Pax7-positive at that stage of development, by their localization at the lateral
muscle surface, their roundish shape and their less intense labelling (Seger et al., 2011).
In addition, I performed whole-mount IF stainings using α-actinin, F59-c, and ZE-BO
Figure 5.21 – The muscle in double mutants was normal. A-C: The number of Pax7-
positive cells was not decreased in double mutant embryos. A: Schematic illustration of a
24hpf embryo and a detail (red box) of the region analysed. MPCs are represented as white
dots. The crosshatched area marks the four somites, in which the Pax7-positive MPCs were
quantified. B: IF stainings with Pax7 at 24hpf wildtype and grna-/-;grnb-/- mutants. The
somites are marked with white dashed lines. Pax7 did also label xanthophores at 24hpf,
which can be distinguished from Pax7-positive MPCs by their elongated shape and intense
staining. Examples are marked with a red ’x’. C: Quantification of Pax7-positive MPCs
in the four somites above the end of the yolk extension. n = 15. S.E.M. Mann-Whitney
test (two-tailed). D-F: The IF stainings of different muscle markers were alike in wildtype
and double mutants at 48hpf.D: α-actinin. E: F59-c. F: ZE-BO 1F4. B,D-F: Lateral
view. Anterior to the right. Maximum projection. Recorded by spinning disk confocal
microscopy. Scale bar: 50µm.
1F4, to see, if the muscle is intact at 48hpf. α-actinin is a marker for Z-discs (Zhang
et al., 2009), F59 binds to the myosin heavy chain of lateral adaxial slow-twitch muscle
fibres (Zeller et al., 2002) and ZE-BO 1F4 detects smooth muscles as well as striated
skeletal and heart muscles (fast-twitch muscle fibres) (Prengel, 2000). The Pax7-IF
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did not show a different staining in wildtype and grna-/-;grnb-/- mutants (Fig. 5.21B).
Quantification of the number of Pax7-positive MPCs in the four somites above the end of
the yolk extension revealed that the number of Pax7-positive MPCs was not significantly
decreased in all somites analysed (p(S1) = 0.0854. p(S2) = 0.7977. p(S3) = 0.3489.
p(S4) = 0.2337.) (Fig. 5.21C). No obvious differences in the muscle stainings using
the α-actinin (Fig. 5.21D), F59-c (Fig. 5.21E), and ZE-BO 1F4 (Fig. 5.21F) antibodies
at 48hpf were detectable in Grna;Grnb KO embryos when compared to age-matched
wildtype. This indicates that the Z-discs and the slow- and fast-twitching muscle-fibres
in the muscle are morphologically normal and intact at 48hpf in grna-/-;grnb-/- mutants.
Taken together there is no reduction in Pax7-positive MPCs in the grna-/-;grnb-/-
mutants as previously published in morphants (Li et al., 2013) and the truck muscles
are morphologically intact at 48hpf.
5.6 Analysis of Grna;Grnb KO embryos for vascular pheno-
types
It is published that administration of GRN increases the size and number of blood
vessels in murine transcutaneous wounds and it was concluded that GRN has angiogenic
properties (He et al., 2003). In a mouse model that expresses Grn in endothelial
cells it was shown in vivo that Grn has an influence on growth and development of
blood vessels (Toh et al., 2013). Moreover, tardbp-/-;tardbpl-/- mutant zebrafish show a
mispatterning of (intersegmental) blood vessels (Fig. 5.22C) (Schmid et al., 2013). I
therefore analysed, if grna-/-;grnb-/- mutants develop a vascular phenotype. I crossed
grna;grnb mutants and wildtypes with the transgenic line Tg(fli1a:EGFP). In this line
blood vessels can be visualized due to their expression of GFP under the blood vessel
specific promoter fli1a (Lawson and Weinstein, 2002). Subsequently, I imaged the blood
vessels above the end of the yolk extension in wildtype and Grna;Grnb double KO
embryos at 48hpf by confocal microscopy (Fig. 5.22A). The images taken showed that
the dorsal aorta (DA), which is located dorsal to the yolk, is present in wildtype and
grna-/-;grnb-/- double mutant embryos. The pattern of the intersegmental blood vessels
(ISV) in grna-/-;grnb-/- double mutant embryos and wildtype was indistinguishable and
the dorsal longitudinal anastomotic vessels (DLAV) had connected the ISV in wildtype
and mutants of 48hpf (Fig. 5.22B). Moreover, the circulation was established and the
blood flow was indistinguishable in wildtype and grna-/-;grnb-/- double mutant embryos.
Therefore, I conclude that there is no vascular phenotype at 48hpf in grna;grnb mutants
and that a KO of Grna and Grnb does not influence vasculogenesis.
98
5.7 Analysis of Grna;Grnb KO zebrafish for disease-related pathology
Figure 5.22 – The blood vessels in grna-/-;grnb-/- double mutants above the end of the
yolk extension were patterned normal. A: Schematic illustration of a 48hpf embryo and a
detail (red box) of the region analysed. Blood vessel are represented in white. DLAV: dorsal
longitudinal anastomotic vessel. DA: dorsal aorta. ISV: intersegmental blood vessels. B:
Representative images of a Tg(fli1a:EGFP) wildtype and a Tg(fli1a:EGFP) grna-/-;grnb-/-
mutant at 48hpf. Lateral view. Anterior to the right. Maximum projection. Images
recorded by confocal laser scanning microscopy. n = 3. Scale bar: 100µm. C: Representa-
tive images of a Tg(kdrl :mCherry) wildtype and a Tg(kdrl :mCherry) tardbp-/-;tardbpl-/-
mutant at 48hpf. Lateral view. Anterior to the right. Maximum projection. Images
recorded by confocal laser scanning microscopy. Scale bar: 100µm. Recorded and kindly
provided by Katrin Strecker.
5.7 Analysis of Grna;Grnb KO zebrafish for disease-related
pathology
A partial and a complete loss of GRN lead to FTLD-TDP and NCL, respectively (Klein-
berger et al., 2013; Smith et al., 2012) and Grn-deficient mice were shown to model some
of the behavioural phenotypes, neuropathological as well as biochemical alterations (Fil-
iano et al., 2013; Götzl et al., 2014; Kleinberger et al., 2013). As I aimed to establish
a zebrafish model that could help to unravel the so far elusive pathomechanisms of
FTLD-TDP/GRN and NCL/GRN, I investigated whether the Grna;Grnb KO zebrafish
develop disease-related pathology. Thereby, I concentrated on neuropathological and
biochemical alterations as well as behavioural phenotypes that have been reported in
patients and/or mouse models before. Since Claire Russell and her colleagues have
previously developed several assays to address NCL pathology in zebrafish (e.g. Mah-
mood et al., 2013a), I collaborated for a few of the following experiments with her and
performed some of them in her laboratory at The Royal Veterinary College, University
of London.
Amongst the most consistent neuropathological findings in Grn-deficient mammals are
micro- and astrogliosis and increased lipofuscinosis (Kleinberger et al., 2013), of which
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the latter is associated with lysosomal dysfunction. I asked if these neuropathological
alterations or even neurodegeneration do occur in the Grna;Grnb KO zebrafish.
5.7.1 Analysis of Grna;Grnb KO larvae for neurodegeneration
In contrast to human FTLD-TDP/GRN and NCL/GRN patients (Rohrer et al., 2010;
Smith et al., 2012), only one strain of Grn KO mice did develop neurodegeneration
upon ageing (Ahmed et al., 2010) while all other Grn KO stains were devoid of
neurodegeneration (Ghoshal et al., 2012; Wils et al., 2012). The vital dye acridine
Figure 5.23 – There was no increased neurodegeneration in grna-/-;grnb-/- mutants. A:
Schematic illustration of a 5dpf larvae (lateral view) and a detail (red line) of the region
analysed (dorsal view). The Z-Stack is indicated by the red rectangular prism. Dying
cells are represented as green dots. B: Quantification of the number of acridine orange
positive particle in the larval brain of wildtype and grna-/-;grnb-/- mutants. n = 15.
S.E.M. Mann-Whitney test (two-tailed).
orange was used previously as a marker to estimate the number of dying cells in
zebrafish (Paquet et al., 2009). I applied this dye at 5dpf to analyse and quantify the
number of acridine orange positive cells in the brain region indicated in the illustration
(Fig. 5.23A) in grna-/-;grnb-/- double mutants and wildtype controls. This quantification
revealed that the number of acridine orange positive cells was not increased in the
grna-/-;grnb-/- double mutants, when compared to wildtype larvae (p = 0.69) (Fig. 5.23B).
I concluded that there is no increased cell death in the brain of grna-/-;grnb-/- larvae at
5dpf and most likely no neurodegeneration associated to loss of Grna and Grnb.
5.7.2 Analysis of Grna;Grnb KO larvae for microgliosis
In the murine brain Grn is expressed by neurons and microglia (Petkau et al., 2010).
Moreover, it was shown that zebrafish grna is expressed by microglia and was even
used as a microglial marker (Craig et al., 2008; Huang et al., 2012). As mentioned
above, FTLD-TDP/GRN patients (Chen-Plotkin et al., 2010; Josephs et al., 2007;
Mackenzie et al., 2006) and homozygous Grn KO mice (Ahmed et al., 2010; Ghoshal
et al., 2012; Petkau et al., 2012; Wils et al., 2012; Yin et al., 2010a,b) develop micro-
and astrogliosis. In contrast to mammals, zebrafish lack glia cells that resemble the
mammalian astrocytes, while microglia are present already during larval stages. To
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investigate, if grna-/-;grnb-/- double mutant larvae develop microgliosis, I performed
neutral red staining and approximated the number of microglia in the larval brain at
3dpf. Neutral red is a vital stain, that is incorporated in its red fluorescent form by
macrophages and microglia and was used previously to label microglia in zebrafish (Her-
bomel et al., 2001). A quantification of the number of neutral red positive particles in
the larval zebrafish brain (Fig. 5.24A) did not reveal a significant difference in wildtype
and grna-/-;grnb-/- double mutant larvae at 3dpf (p = 0.2884) (Fig. 5.24B). Therefore, it
Figure 5.24 – There was no microgliosis in grna-/-;grnb-/- mutant larvae. A: Schematic
illustration of a 3dpf larvae (lateral view). The red square in the dorsal view below marks
the region analysed in B and the red dashed line marks the region analysed in C-E. A
Z-Stack is indicated by the red rectangular prism. Microglia are represented as dark red
dots. B: Quantification of the number of neutral red positive particles in the larval brain
of wildtype and grna-/-;grnb-/- mutants. C-E: Microglia in wildtype and grna-/-;grnb-/-
mutants were similar. C: Still images from time-lapse recordings in the optic tectum
of Tg(apoeb:lynEGFP) wildtype and Tg(apoeb:lynEGFP) grna-/-;grnb-/- mutants. Two
representative cells are marked with a yellow and white arrow. 3dpf. Recorded by spinning
disk confocal microscopy. Orthogonal projection. Dorsal view. Anterior to the left.
n = 3. Scale bar: 50µm. Recording time: 60min. 1frame/min. D: The distance microglia
move within one hour was similar in wildtype and grna-/-;grnb-/- mutants. E: Microglial
processes persisted for about the same time in wildtype and grna-/-;grnb-/- mutants. D-E:
Quantification of the time-lapse recordings shown in C. 3dpf. B, D-E: n = 15. S.E.M.
Mann-Whitney test (two-tailed).
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can be concluded that the number of microglia is not increased in grna-/-;grnb-/- double
mutant larvae when compared to age-matched wildtype controls. Besides an increase in
the number of microglia, activated microglia are indicative of microgliosis (Streit et al.,
1999). During larval stages zebrafish microglia are still highly motile and phagocytic
(amoeboid). Within the first weeks they mature to ramified microglia with a small cell
body (Svahn et al., 2013). These ramified microglia can transform into morphologically
different active microglia upon an injury (Baumgart et al., 2012) but the amoeboid
microglia largely maintain their morphology even after an inflammatory stimulus (Sieger
et al., 2012). Consequently, it is not informative to categorize microglia during larval
development in active and inactive. Instead I compared wildtype and grna-/-;grnb-/-
mutant microglia according to their distance moved within one hour and the persistence
of their processes, two parameters that were used before for the characterization of larval
microglia (Svahn et al., 2013). For the visualisation of microglia, I crossed wildtype
and grna;grnb double mutants in the transgenic line Tg(apoeb:lynEGFP) that labels
some microglia (Peri and Nüsslein-Volhard, 2008). By in vivo time-lapse microscopy I
recorded the microglia in the optic tectum of wildtype and grna-/-;grnb-/- mutants at
3dpf and quantified the path or persistence of randomly selected microglia or processes,
respectively. Still images of the in vivo time-lapse analysis demonstrate that microglia
from wildtype and grna-/-;grnb-/- mutants can not be discriminated due to their mor-
phology (Fig. 5.24C). Moreover, the distance moved within one hour (p = 0.0671)
(Fig. 5.24D) and the persistence of microglial processes (p = 0.8296) (Fig. 5.24E)
was not statistically different in wildtype and grna-/-;grnb-/- mutants indicating that
amoeboid microglia in wildtype and grna-/-;grnb-/- mutants are phenotypically similar.
As the number of microglia was also not increased, I concluded that grna-/-;grnb-/-
double mutant larvae lack microgliosis. Additionally, my collaboration partner Rossella
di Giaimo (Helmholtz Center Munich) performed a first staining on sections of adult
zebrafish telencephali derived from wildtype and grna-/-;grnb-/- double mutants with
antibodies specific for microglia. These stainings did not reveal any obvious differences
between microglial stainings in wildtype and Grna;Grnb KO brains. A quantification
of active and ramified microglia in the adult zebrafish brains in an increased number of
animals would be required to exclude effects on microglia at adult stages.
Taken together, brains from grna-/-;grnb-/- zebrafish seem to be devoid of microgliosis
in early development.
5.7.3 Analysis of Grna;Grnb KO zebrafish for lipofuscin aggregates
Another hallmark of FTLD-TDP and NCL but also other neurodegenerative diseases
are aggregated proteins. In FTLD-TDP/GRN the main deposited protein is TDP-
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43 (Eriksen and Mackenzie, 2008). In NCL/GRN the storage material in the brain is
still unknown but an eccrine pale cell showed the typical NCL-lipofuscin fingerprint pro-
file (Smith et al., 2012). As Grn-deficient mice are devoid of TDP-43 aggregates (Ahmed
et al., 2010; Petkau et al., 2012; Wils et al., 2012), I did not perform stainings to detect
TDP-43-positive inclusions in grna-/-;grnb-/- mutants. The main storage material in
aggregates of NCL is SCMAS or Saposin A and D (Jalanko and Braulke, 2009; Shacka,
2012) but by the time of analysis it was not clear if any of these two candidates is
aggregating in NCL/GRN. Therefore, PAS stain was performed, a method that en-
ables to stain aggregates of glycoproteins, including lipofuscin, and can be part of the
examinations done to diagnose NCL in patients (Hall et al., 1989) and mice (Koike
et al., 2005). It was shown previously, that PAS stain can stain lipofuscin in sections of
aged zebrafish liver (Kishi et al., 2008). However, the existence of neurolipofuscin in
zebrafish is controversially discussed (Kishi et al., 2003, 2008; Rosa et al., 2010). PAS
stain was performed on 5dpf eye, forebrain, and optic tectum as well as 11mpf adult
brain cryosections derived from wildtype and grna-/-;grnb-/- mutants. Some dense pink
Figure 5.25 – PAS stain in wildtype and grna-/-;grnb-/- mutants. Cryosections of 5dpf
eye, forebrain, and optic tectum as well as 11mpf old adult brain, stained with PAS stain.
The PAS stained sections of wildtype and grna-/-;grnb-/- mutants are similar. Images by
brightfield microscopy. Scale bar: 50µm.
structures were detected in the sections from larval and adult brain, but they were
observed both in wildtype and grna-/-;grnb-/- mutant samples (Fig. 5.25) and seemed
to be too small for lipofuscin aggregates. Since the literature provides no images of
neurolipofuscin in zebrafish (Rosa et al., 2010) and I and others could not come up with
a zebrafish neurolipofuscin (positive) control, it is difficult to draw conclusions from
this experiment. Consequently, it is not possible to provide a final answer to the issue
whether increased neurolipofuscinosis is occurring in grna-/-;grnb-/- mutant zebrafish.
Moreover, the staining raises the question if lipofuscin deposits develop in the zebrafish
brain at all.
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5.7.4 Analysis of Grna;Grnb KO larvae for lysosomal dysfunction
NCL/GRN is per definition a lysosomal storage disorder with impaired lysosomal
function (Kollmann et al., 2013; Smith et al., 2012) and there is now increasing evi-
dence that lysosomal dysfunction plays a role in FTLD-TDP/GRN (Götzl et al., 2014).
Moreover, studies in Grn-deficient mice point towards a lysosomal dysfunction as the
protein expression levels of some lysosomal proteins were shown to be increased (Götzl
et al., 2014; Tanaka et al., 2013; Wils et al., 2012). I first performed LysoTracker
staining in wildtype and Grna;Grnb KO larvae. LysoTracker, an in vivo dye that was
used in zebrafish before, labels acidic cell compartments e.g. lysosomes and phagolyso-
somes (Mahmood et al., 2013a; Peri and Nüsslein-Volhard, 2008). Consequently, this
Figure 5.26 – Acidic cell compartments were present in wildtype and grna-/-;grnb-/-
microglia. LysoTracker staining at 3dpf in Tg(spi1b:Gal4;UAS:EGFP) wildtype and
Tg(spi1b:Gal4;UAS:EGFP) grna-/-;grnb-/- mutants. A: LysoTracker positive vesicles in
microglia were detectable in wildtype and grna-/-;grnb-/- mutant larval brains. B: Repre-
sentative close-ups of two wildtype and two grna-/-;grnb-/- mutant microglia. Maximum
projections. Dorsal view. Images by spinning disk confocal microscopy. Scale bar: 20µm.
Images are gamma corrected for better visualisation. n = 6.
staining would show if the acidic compartments in grna-/-;grnb-/- mutants are still able
to maintain an acidic pH, which is required for a proper function of lysosomal proteins.
Moreover, a dramatic increase in the size of acidic compartments could be uncovered
using this staining (Mahmood et al., 2013a). I applied LysoTracker at 3dpf and acidic
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cell compartments in the optic tectum (see Fig. 5.24A) of Tg(spi1b:Gal4/UAS:GFP)
wildtype and Tg(spi1b:Gal4/UAS:GFP) grna-/-;grnb-/- mutants were visualized by confo-
cal microscopy. In the transgenic line Tg(spi1b:Gal4/UAS:GFP) numerous microglia are
labelled by GFP-expression (Peri and Nüsslein-Volhard, 2008) and it was demonstrated
previously by LysoTracker staining that zebrafish microglia contain several acidic cell
compartments of different size (Peri and Nüsslein-Volhard, 2008). In both wildtype and
grna-/-;grnb-/- mutants acidic vesicles could be visualized in microglia by LysoTracker
staining indicating that acidic cell compartments were present in microglia of wildtype
and grna-/-;grnb-/- mutants (Fig. 5.26A,B). Moreover, the analysis revealed no obvious
increase in the size of acidic vesicles in grna-/-;grnb-/- mutants when compared to
age-matched wildtype controls (Fig. 5.26A,B). Nevertheless, it was not possible to draw
final conclusions regarding the number, size, or functionality of the lysosomes using
LysoTracker staining.
To address whether lysosomal function in Grna;Grnb KOs is disturbed, I examined the
expression levels of the lysosomal protease Ctsd (Benes et al., 2008) in grna-/-;grnb-/-
double mutants. CTSD is itself linked to NCL since homozygous loss of function muta-
tions in CTSD are causative for congenital NCL (Siintola et al., 2006; Tyynelä et al.,
2000). It was reported, that Grn-deficient mice exhibit elevated Ctsd mRNA expression
and Ctsd protein levels (Götzl et al., 2014; Tanaka et al., 2013; Wils et al., 2012), sug-
gesting an accumulation of lysosomal proteins due to lysosomal dysfunction in the Grn
KO mice. Recent data indicate that also frontal cortex samples from FTLD-TDP/GRN
patients show elevated CTSD levels (Götzl et al., 2014). Therefore I asked, if this
increase in ctsd mRNA or Cstd protein does also occur in the grna-/-;grnb-/- double
mutants and performed qPCR experiments and immunoblotting of 5dpf whole zebrafish
larvae and 7mpf and 22mpf adult brain samples, respectively. In contrast to the data
in Grn-deficient mice, I could not detect differences in ctsd mRNA expression neither
in larval stages nor in adult brain of Grna;Grnb KO zebrafish samples when compared
to wildtype samples (p(5dpf) = 1.0, p(7mpf) = 0.4, p(22mpf) = 0.7) (Fig. 5.27A). The
well characterized Ctsd antibody (a gift from Prof. Isidoro) (Follo et al., 2011) used
for immunoblotting detected endogenous Ctsd at 5dpf and in 7mpf as well as 22mpf
brain samples as a single band at 41kDa at about equal intensities in wildtype and
grna-/-;grnb-/- double mutant samples (Fig. 5.27B). In contrast to mammalian CTSD
proprotein, which is cleaved into heavy- and light-chain, zebrafish Ctsd matures into
a single-chain protein (Follo et al., 2013). Therefore, immunoblots from mammalian
CTSD show two bands derived from proprotein and heavy-chain, whereas zebrafish Ctsd
is represented by a single band (Follo et al., 2013; Götzl et al., 2014). A quantification
of the Ctsd signals normalized to the loading control α-tubulin revealed no significant
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Figure 5.27 – ctsd mRNA and Ctsd protein levels were unchanged in grna-/-;grnb-/-
double mutants. A: ctsd mRNA expression in grna-/-;grnb-/- mutants was not changed at
5dpf and in 7mpf as well as 22mpf brain samples when compared to wildtype samples.
Normalized to actb1 and tbp. qPCR. 5dpf: n = 4. 7mpf and 22mpf: n = 3. S.E.M.
Mann-Whitney test (two-tailed). B: Immunoblots showing Ctsd and α-tubulin in 5dpf
whole lysis samples as well as whole lysates from 7mpf and 22mpf brains. C: There was no
increase in Ctsd levels in grna-/-;grnb-/- double mutants. Quantification of Immunoblots
displayed in B normalized to α-tubulin. 5dpf: n = 4. 7mpf and 22mpf: n = 3. S.E.M.
Mann-Whitney test (two-tailed).
changes in the amount of Ctsd in grna-/-;grnb-/- double mutant samples when compared
to wildtype (p(5dpf) = 0.8857, p(7mpf) = 1.0, p(22mpf) = 0.7) (Fig. 5.27C). This data
indicate that Ctsd is not accumulating in grna-/-;grnb-/- double mutants.
In summary, grna-/-;grnb-/- double mutants are capable to acidify acidic vesicles and do
not accumulate the lysosomal protease Ctsd indicating a normal lysosomal function in
grna-/-;grnb-/- double mutants.
5.7.5 Analysis of Grna;Grnb KO samples for biochemical alterations
Apart from indications that GRN might have a lysosomal function (Götzl et al., 2014;
Smith et al., 2012; Tanaka et al., 2013; Wils et al., 2012), the biological function of
GRN and GRN-associated signaling mechanisms are still largely elusive. To provide
information that could help to unravel the biological function of GRN I addressed
the expression levels of genes that were differentially expressed in Grn KO mice and
FTLD-TDP/GRN patients in the grna-/-;grnb-/- double mutants. Amongst those genes,
I selected STAT3 and FLNC. In zebrafish there is one orthologue of STAT3, also named
stat3, but two orthologues of FLNC, flnca and flncb. stat3 was of interest since it
is upregulated in the transcriptom and proteom analysis of tardbp-/-;tardbpl-/- double
mutant zebrafish (Schmid, unpublished; Schmid et al., 2013), seems to be upregulated
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in Grn KO mice and was elevated in samples of FTLD-TDP/GRN patients (Janssens
and Banzhaf-Strathmann, unpublished). flnca was upregulated in the transcriptom and
proteom analysis of tardbp-/-;tardbpl-/- double mutant zebrafish (Schmid, unpublished;
Schmid et al., 2013). Therefore, flnca and flncb were chosen for analysis. Moreover,
FLNC was elevated in brain samples of FTLD-TDP/GRN patients and Grn KO
mice (Janssens, unpublished; Schmid et al., 2013). To determine the mRNA expression
levels of stat3, flnca, and flncb, qPCR experiments were performed at 5dpf and in
7mpf as well as 22mpf brain samples from wildtype and Grna;Grnb KO zebrafish. The
Figure 5.28 – stat3, flnca, and flncb mRNA levels were not significantly increased in
grna-/-;grnb-/- mutants. A: stat3 mRNA levels were slightly decreased in grna-/-;grnb-/-
double mutants. B: The flnca mRNA levels were unchanged in grna-/-;grnb-/- mutants.
C: flncb mRNA was a little decreased in 5dpf grna-/-;grnb-/- double mutants. Not altered
at 7mpf and slightly increased in brain samples from grna-/-;grnb-/- double mutants at
22mpf. Normalized to actb1 and tbp. qPCR. 5dpf: n = 4. 7mpf and 22mpf: n = 3. S.E.M.
Mann-Whitney test (two-tailed). All n.s.
qPCR experiments for stat3 revealed, that the mRNA expression was slightly, but
not significantly, decreased in whole larvea at 5dpf and brain from 7mpf or 22mpf old
grna-/-;grnb-/- double mutant zebrafish when compared to wildtype samples (p(5dpf) =
0.1, p(7mpf) = 0.4, p(22mpf) = 0.4) (Fig. 5.28A). flnca mRNA levels were unchanged,
comparing wildtype and Grna;Grnb double KO samples of 5dpf larvae and 7mpf as
well as 22mpf brains (p(5dpf) = 0.4, p(7mpf) = 0.7, p(22mpf) = 0.7) (Fig. 5.28B).
flncb mRNA levels appeared to be decreased at 5dpf, unchanged at 7mpf and slightly
increased at 22mpf in grna-/-;grnb-/- double mutants in comparison to wildtype samples.
However, these changes were not statistically significant (p(5dpf) = 0.1, p(7mpf) = 0.4,
p(22mpf) = 0.4) (Fig. 5.28C).
Taken together, biochemical alterations namely increased expression levels of STAT3
or FLNC observed in FTLD-TDP/GRN patients and Grn-deficient mice were not
observed in grna-/-;grnb-/- double mutant zebrafish.
5.7.6 Analysis of Grna;Grnb KO zebrafish for behavioural phenotypes
Clinical symptoms of FTLD are behavioural abnormalities and language dysfunc-
tion (Rademakers et al., 2012), of which especially the latter is not feasible to ex-
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amine in zebrafish. Due to massive neurodegeneration, NCL patients suffer from
seizures (Jalanko and Braulke, 2009; Shacka, 2012). Seizures were also described to
occur in NCL/GRN patients (Smith et al., 2012). Seizure-like behaviour or abnor-
mal bouts are documented in zebrafish larvae as quick, roundish spinning (Mahmood
et al., 2013a,b) and can be induced by chemicals like pentylenetetrazole (PTZ) (Bara-
ban et al., 2005). Despite a lack of neurodegeneration in the grna-/-;grnb-/- double
mutant larvae (see above), I did track the swim behaviour in grna-/-;grnb-/- double
mutants to exclude seizure-like behaviour. After an adaptation time of 30min, the
swim path was recorded for 5min in 5dpf wildtype, grna-/-;grnb-/- mutants as well
as DMSO-, and PTZ-treated wildtype larvae. The PTZ-treated samples served as a
positive control. I additionally extracted from the 5min-trackings the total distance
moved, the mean velocity, and the percentage of time larvae spent on movements
with a velocity above 2mm/s. In contrast to wildtype, grna-/-;grnb-/- mutants, and
DMSO-treated larvae, the PTZ-treated larvae were much more active (Fig. 5.29A).
This is also reflected in the total distance moved, which was significantly increased
in the PTZ-treated larvae (p(wt-grna-/-;grnb-/-) = 0.2386, p(wt-DMSO) = 0.0534,
***p(wt-PTZ) = 0.0002) (Fig. 5.29B). The mean velocity and the percental time larvae
spent for movements faster than 2mm/s was comparable in wildtype, grna-/-;grnb-/- mu-
tants, and DMSO-treated larvae but significantly elevated in PTZ-treated wildtype larvae
(Mean velocity: p(wt-grna-/-;grnb-/-) = 0.5657, p(wt-DMSO) = 0.8081, *p(wt-PTZ) =
0.0137. Movements > 2mm/s: p(wt-grna-/-;grnb-/-) = 0.2585, p(wt-DMSO) = 0.0668,
**p(wt-PTZ) = 0.0016.) (Fig. 5.29C-D). This data suggests that swimming in 5dpf
wildtype and grna-/-;grnb-/- mutant larvae is very similar and devoid of seizure-like
behaviour as observed upon PTZ-treatment.
The age at onset is very diverse in FTLD-TDP/GRN (Seelaar et al., 2008; van Swieten
and Heutink, 2008) and it is believed that a second hit is required to trigger the dis-
ease (Dormann and Haass, 2011; Seelaar et al., 2008). To test if grna-/-;grnb-/- mutants
respond differently to a stressful stimulus, wildtype and grna-/-;grnb-/- mutants were ex-
posed to abrupt changes in illumination, which induces a photomotor response (Burgess
and Granato, 2007; Vignet et al., 2013). Especially when facing abrupt darkness, a stim-
ulus that is avoided by zebrafish larvae (Chen and Engert, 2014), zebrafish larvae tend
to be more active (de Esch et al., 2012; MacPhail et al., 2009; Vignet et al., 2013). After
an adaptation of 40min, 100% light in the recording device the 5dpf larvae were first
exposed to 100% light for 5min and then two cycles of 5min darkness, 5min 100% light
followed (Fig. 5.30). Within the time frames of 5min, the movies were analysed with
respect to the total distance moved, the mean velocity, and the percental time spent for
movement with a velocity above 2mm/s. Both wildtype and grna-/-;grnb-/- mutants re-
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Figure 5.29 – The swim tracks of wildtype and grna-/-;grnb-/- mutants revealed no
abnormal swim behaviour. A: In contrast to PTZ-treated wildtype larvae the swim path
of wildtype, grna-/-;grnb-/- mutants, and DMSO-treated controls lacked abnormal bouts
and bursts. 5dpf. Movements < 2mm/s: black lines. Movements 2mm/s− 6mm/s: green
lines. Movements > 6mm/s: red lines. Adaptation time: 30min. Recording time: 5min.
Recorded by a digital camera (30 frames/s). B: The total distance moved within 5min was
equal in wildtype, grna-/-;grnb-/- mutants, and DMSO-treated larvae but significantly in-
creased in PTZ-treated larvae. ***p(wt-PTZ) = 0.0002. **p(DMSO-PTZ) = 0.004.
C: The mean velocity was equal in wildtype, grna-/-;grnb-/- mutants, and DMSO-
treated larvae but significantly increased in PTZ-treated larvae. *p(wt-PTZ) = 0.0137.
**p(DMSO-PTZ) = 0.0014. D: The time spent for movements with a velocity above 2mm/s
was significantly more in PTZ-treated larvae when compared to wildtype, grna-/-;grnb-/-
mutant, and DMSO-treated larvae. **p(wt-PTZ) = 0.0016. **p(DMSO-PTZ) = 0.0037.
B-D: Quantification from the movies recorded in A. n = 18. S.E.M. Mann-Whitney test
(two-tailed).
sponded to the stimulus darkness with a significant increase in the total distance moved,
the mean velocity, and the percentage of movements faster than 2mm/s (Fig. 5.30A-C).
Upon abrupt reillumination all parameters analysed declined significantly in wildtype
and grna-/-;grnb-/- mutants to a similar extent (Fig. 5.30A-C). In the second round of
stimulation the response was still occurring but it was less pronounced (Fig. 5.30A-C).
In the mutants the photomotor response seemed to be less pronounced than in wild-
type but this did not reach statistical significance when wildtype and grna-/-;grnb-/-
mutants are compared within the same time frame (Fig. 5.30A-C) (Distance moved:
p(1) = 0.4463, p(2) = 0.2626, p(3) = 0.3347, p(4) = 0.2366, p(5) = 0.2173. Mean
velocity: p(1) = 0.5612, p(2) = 0.3852, p(3) = 0.1404, p(4) = 0.2493, p(5) = 0.3517.
Movements > 2mm/s: p(1) = 0.3496, p(2) = 0.2366, p(3) = 0.4204, p(4) = 0.4761,
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Figure 5.30 – Wildtype and grna-/-;grnb-/- mutants showed a similar photomotor re-
sponse. A-C: Quantification of movies recording the photomotor response in wildtype
and grna-/-;grnb-/- mutants. The following protocol has been applied: 40min adaptation
time, 5min light (+) (1), 5min darkness (-) (2), 5min light (+) (3), 5min darkness (-)
(4), 5min light (+) (5). A: The distance moved was significantly increased during the
periods of darkness in wildtype and grna-/-;grnb-/- mutants. B: The mean velocity of
wildtype and grna-/-;grnb-/- mutants was significantly elevated in darkness. C: Wildtype
and grna-/-;grnb-/- mutant larvae spent significantly more time with movements faster
than 2mm/s when they were exposed to darkness. A-C: Periods of darkness are indicated
in grey. 5dpf. n = 18. S.E.M. Mann-Whitney test (two-tailed). *p < 0.05. **p < 0.01.
***p < 0.001. ****p < 0.0001.
p(5) = 0.6000.). Therefore I concluded that the photomotor response is alike in wildtype
and Grna;Grnb KO larvae at 5dpf and that Grna:Grnb KO larvae seem to show a
normal reaction to stressful stimuli.
In summary, neuropathological alterations like neurodegeneration and microgliosis or
biochemical alterations observed in Grn-deficient men or mice are absent in Grna;Grnb
KO zebrafish. Moreover, their swim bahaviour as well as their photomotor response
is normal indicating that Grna;Grnb KO zebrafish lack disease-related pathological
phenotypes.
5.8 Wound healing and regeneration in Grna;Grnb KOs
Due to the lack of a phenotypes in healthy Grna;Grnb KO zebrafish, I next hypothesise
that the grna-/-;grnb-/- double mutants need to be challenged to exhibit phenotypes.
Several publications demonstrated that GRN is involved in wound healing and inflam-
mation (He et al., 2003; Qu et al., 2013; Tanaka et al., 2012; Zhu et al., 2002) and there
are some reports suggesting a contribution of zf-Grns in injury and inflammation (Lien
et al., 2006; Mathew et al., 2009; van der Sar et al., 2009). Moreover, I could show
within this study that grna and grn1/grn2 expression is enriched in haematopoietic
tissue and macrophages. Therefore, I selected injuries and the induction of inflammation
as a challenge for Grna;Grnb KOs.
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5.8.1 Analysis of wound healing and regeneration in Grna;Grnb KO larvae
One advantage of the zebrafish as a model organism is that numerous larvae are obtained
from one single spawning. Additionally, it is possible to keep zebrafish larvae optically
transparent allowing in vivo imaging during development. To take these advantages
into consideration I first analysed wound healing and regeneration in Grna;Grnb KO
larvae.
5.8.1.1 Identifying a larval injury model with zf-Grn involvement
To increase the likelihood of a phenotype in challenged Grna;Grnb mutants, I evaluated
larval injuries models and inducers of inflammation for increased zf-grn expression levels
after the challenge. Previously, it has been reported that grna is upregulated after
tail fin amputation in zebrafish larvae (Mathew et al., 2009), a well established assay
in the field (Yoshinari and Kawakami, 2011). To confirm these findings, I performed
qPCR for grna, grnb, grn1/grn2, and apoeb in wildtype zebrafish samples that were
prepared according to the following procedure: The tail fin was amputated at 48hpf
and embryos were fixed in RNAlater at the indicated time points - 3hpa, 24hpa,
48hpa, and 72hpa. By cutting the fixed larvae after the yolk extension, tail fin tissue
was enriched. This tissue was then used for qPCR analysis. apoeb was used as a
positive control, as it was shown before to increase after an injury in zebrafish (Lien
et al., 2006; Mathew et al., 2009; Monnot et al., 1999). At 3hpa the grna levels were
unchanged (p(3hpa) = 1.000), but grna was significantly increased to 1.5-fold in the
tail fin tissue of injured embryos at 24hpa when compared to uninjured tail fin tissue
(*p(24hpa) = 0.0313). At 48hpa the levels were still slightly elevated (p(48hpa) =
0.3125) and at 72hpa there was no difference in the mRNA expression levels between
injured and uninjured control tail fin samples (p(72hpa) = 0.8438) (Fig. 5.31A). grnb
levels remained unchanged at all time points analysed. There was no increase after
injury in comparison to uninjured fin tissue (p(3hpa) = 1.000, p(24hpa) = 0.4375,
p(48hpa) = 0.5625, p(72hpa) = 1.000) (Fig. 5.31B). grn1/grn2 levels showed a large
variance at all time points examined in injured and uninjured samples. There might be
a tendency to an increase in injured tissue, when compared to uninjured control samples,
but this did not reach statistical significance (p(3hpa) = 0.1563, p(24hpa) = 0.0938,
p(48hpa) = 0.5625, p(72hpa) = 1.000) (Fig. 5.31C). The positive control apoeb showed
the first significant increase in injured tail fin tissue compared to uninjured tissue at
24hpa (p(3hpa) = 0.4375, *p(24hpa) = 0.0313). At 48hpa apoeb was still elevated but
to a lower extent (p(48hpa) = 0.0625) and at 72hpa there was a further decline in apoeb
levels (p(72hpa) = 0.1563) (Fig. 5.31D). In summary, grna expression is elevated after
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Figure 5.31 – grna was increased after tail fin amputation in zebrafish embryos/larvae.
A: grna expression was significantly elevated in the injured tail fin tissue at 24hpa and
mildly at 48hpa. *p(3hpa) = 0.0313. B: grnb mRNA levels were the same in injured and
uninjured control tail fin tissue at all time points analysed. C: grn1/grn2 expression had a
tendency to be increased in all tail fin tissue samples after amputation but the expression
was highly variable. D: apoeb was increased significantly at 24hpa and slightly higher
at 48hpa and 72hpa in injured tail fin tissue. *p = 0.0313. A-D: n = 6. Normalized to
actb1 and tbp. qPCR. The difference (∆) between cut and uncut fin tissue samples are
diagrammed. S.E.M. Wilcoxon signed-rank test (two-tailed).
tail fin amputation in zebrafish embryos/larvae, similar to the positive control apoeb.
grn1/grn2 might be augmented after larval fin injury whereas grnb expression is not
changed at all.
As a second independent assay I performed chemically induced wounding using CuSO4.
This inflammation assay is also suitable for in high-throughput (d’Alençon et al., 2010)
and does not require time-consuming manual amputation of tiny larval fins. Groups of
wildtype larvae were exposed at 3dpf for 1h to CuSO4. Whole zebrafish larvae were fixed
directly after 1h of CuSO4 treatment and after additional 3h as well as 6h of recovery.
In contrast to the tail fin amputation in zebrafish larvae, there was no increase of grna
at any of the time points analysed, when compared to untreated samples (p(1h) = 1.0,
p(1+3h) = 0.5, p(1+6h) = 0.5) (Fig. 5.32A). grnb and grn1/grn2 expression were
unchanged, as well (grnb: p(1h) = 0.25, p(1+3h) = 1.0, p(1+6h) = 0.75. grn1/grn2):
p(1h) = 0.5, p(1+3h) = 0.5, p(1+6h) = 0.75) (Fig. 5.32B,C). Also apoeb, which was used
as a positive control in the tail fin amputation assay, remained unchanged in all CuSO4-
treated samples analysed (p(1h) = 0.75, p(1+3h) = 0.75, p(1+6h) = 0.5) (Fig. 5.32D).
mmp9 expression, which served as a positive control in this assay (d’Alençon et al., 2010),
was strongly increased after 1h of CuSO4 treatment (p(1h) = 0.25), remained slightly
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upregulated after 3h of recovery when compared to untreated samples (p(1+3h) = 0.25)
and decreased further after 6h of recovery (Fig. 5.32F), confirming that the CuSO4-
induced wounding itself did work. As a consequence of these experiments it can be
summarized that chemical wounding with CuSO4 has no effect on zf-grn expression
levels in wildtype larvae and that is not a promising inflammation assay for the purpose
pursued in the following.
Figure 5.32 – CuSO4 induced wounding at 3dpf did not lead to increased zf-grn expression
levels at any of the time points analysed. A: grna mRNA levels remained unchanged
in all samples analysed. B: grnb mRNA levels remained unchanged in all samples.
C: grn1/grn2 were not increased in any samples analysed. D: apoeb was unchanged
after CuSO4 treatment. E: mmp9 raised 5-fold after 1h CuSO4 treatment compared to
untreated samples. After 3h of recovery the mRNA levels were still elevated by 2-fold.
A-E: Normalized to actb1 and tbp. The difference (∆) between cut and uncut fin tissue
samples are diagrammed. qPCR. n = 3. S.E.M. Wilcoxon signed-rank test (two-tailed).
Rec: recovery.
5.8.1.2 Regeneration of the tail fin in Grna;Grnb KO larvae
After demonstrating that grna is significantly increased after a tail fin amputation I
asked if the KO of Grna and Grnb has an influence on the regeneration of the larval tail
fin. For the analysis of the regenerative capacity in grna-/-;grnb-/- mutants, the tail fins
of wildtype and grna-/-;grnb-/- double mutant embryos were dissected with microscissors
at 48hpf and images were taken by brightfield microscopy at 0hpa, 24hpa, 48hpa, and
72hpa. A comparison of the regenerating tail fins at the selected time points after injury
in wildtype and grna-/-;grnb-/- double mutant embryos/larvae showed that there was
no obvious difference between the two genotypes, as illustrated in representative images
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(Fig. 5.33A). In both, wildtype and grna-/-;grnb-/- double mutant embryos/larvae the
wound was first sealed and then the amputated fin was restored in size and shape
within three days (Fig. 5.33A). To approximate if the larval fin was restored in the
same size in wildtype and grna-/-;grnb-/- double mutants, I quantified the length growth
in the regenerating larval fin tissue. The length is defined as the minimal distance from
Figure 5.33 – grna-/-;grnb-/- mutants regenerated the tail fin after amputation like
wildtype. A: Representative images of wildtype and grna-/-;grnb-/- mutant embryos/larvae
after amputation are shown. n = 12. Scale bar: 100µm. The white dashed line highlights
the border of the fin. Lateral view. Anterior to the left. Images by brightfield microscopy.
B: Quantification of the length growth after tail fin amputation. The length growth was
alike in wildtype and grna-/-;grnb-/- double mutants. n = 12. S.E.M. Mann-Whitney test
(two-tailed).
the caudal border of pigmentation to the most distal part of the fin and represents
the length growth in caudal direction. This analysis revealed that the length growth
in caudal direction was comparable in wildtype and grna-/-;grnb-/- double mutants
within all intervals analysed (p(0-24) = 0.7430, p(0-48) = 0.7430, p(0-72) = 0.2876)
(Fig. 5.33B) indicating that the regeneration of the tail fin after amputation is not
affected by a KO of Grna and Grnb.
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5.8.1.3 Myeloid cell response in Grna;Grnb KO larvae after tail fin ampu-
tations
I showed that grna and grn1/grn2 expression is enriched in macrophages and in the
kidney, which is the main haematopoietic tissue in zebrafish. Therefore, I asked if
myeloid cells, including macrophages, in grna-/-;grnb-/- double mutants are still able
to react normally to an injury by migrating to the wound margin. Moreover, it was
suggested that macrophages from Grn-deficient mice are more active (Kao et al.,
2011; Yin et al., 2010a). To visualize myeloid cells, I raised wildtype and grna;grnb
double mutants with fluorescently labelled myeloid cells by using the transgenic line
Tg(spi1b:Gal4;/UAS:EGFP) (Peri and Nüsslein-Volhard, 2008). At 3dpf the number
of myeloid cells is higher than at 48hpf, therefore, I dissected the tail fin for this
experiment at 3dpf and imaged the migration of myeloid cells to the wound in vivo for
the subsequent 16h by time-lapse recordings using confocal microscopy. Representative
still images from the in vivo time-lapse recordings in Tg(spi1b:Gal4/UAS:GFP) wildtype
and Tg(spi1b:Gal4/UAS:GFP) grna-/-;grnb-/- double mutants illustrate that the cells of
the myeloid lineage, of which a subset was GFP-positive, migrated towards the wound
margin after tail fin amputation (Fig. 5.34A). These cells seemed to react similarly in
wildtype and grna-/-;grnb-/- double mutant larvae (Fig. 5.34A).
To obtain a better insight in the myeloid cell migration after tail fin amputation in
wildtype and Grna;Grnb KO larvae, the first five GFP-positive cells that arrived at the
wound edge in the recordings described above (Fig 5.34A) were manually tracked and
quantified using the ImageJ plugin mTrackJ (Meijering et al., 2012). The parameters
were chosen according to a previous publication that quantified the macrophage- and
neutrophil-response after tail fin amputation (Ellett et al., 2011). I extracted the
migration path, the mean velocity, the meandering index (direct path length/actual
path length), the time to the wound, and the percentage of time the cells spent
in the wound. All cell migration paths obtained from the four wildtype and four
grna-/-;grnb-/- mutants looked similar (Fig 5.34B) and could not be assigned to a
respective genotype. There was no difference in the mean velocity of the tracked
myeloid cells in wildtype and Grna;Grnb KO larvae (p = 0.2734) (Fig. 5.34C) and the
meandering index showed a slight but not significant reduction in the grna-/-;grnb-/-
double mutants compared to wildtype (p = 0.1124) (Fig. 5.34D). In both wildtype and
Grna;Grnb double KOs the time to the wound margin was about the same (p = 0.5638)
(Fig. 5.34E) and the percentage of time the myeloid cells spent in the wound was a bit
but not significantly reduced in grna-/-;grnb-/- double mutant larvae in comparison to
wildtype larvae (p = 0.1146) (Fig. 5.34F). This suggests that myeloid cells do respond
similarly to a tail fin amputation in wildtype and Grna;Grnb double KO larvae.
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Figure 5.34 – The myeloid cell reponse in grna-/-;grnb-/- larvae after tail fin amputation
at 72hpf was like that in wildtype. A: Representative images from in vivo time-lapse
recordings of cells of the myeloid linage that did respond to a tail fin amputation in
wildtype and grna-/-;grnb-/- double mutant Tg(spi1b:Gal4/UAS:EGFP). Recording time:
16h. 1frame/min. Scale bar: 100µm. n = 4. Overlays of DIC and green fluorescence
channels. The white dashed line highlights the margin of the larval fin. Single plane.
Lateral view. Anterior to the left. Recorded by spinning disk confocal microscopy. B: Cell
migration paths for the first five GFP-postive cells that arrived at the wound, followed for
16 hours after tail fin amputation. Extracted from the movies illustrated in A. Manual
tracking. C-F: Quantitative analysis of the migration path after tail fin amputation from
the manual trackings in B. C: The mean velocity of myeloid cells over the whole time
of recording was about the same in wildtype and grna-/-;grnb-/- double mutant larvae.
D: Myeloid cells in wildtype and Grna;Grnb KO larvae had a similar meandering index
(direct path length/actual path length). E: The time myeloid cells needed to migrate to
the wound was alike. F: In wildtype and grna-/-;grnb-/- mutants myeloid cells spent about
the same time at the wound edge. n = 4x5. S.E.M. Mann-Whitney test (two-tailed).
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Taken together, I confirmed increased grna expression levels after tail fin amputation,
but a lack of Grna and Grnb does not affect the regeneration of the larval tail fin and
does not disturb the recruitment of myeloid cells to the wound.
5.8.2 First steps towards an analysis of wound healing and regeneration in
adult Grna;Grnb KO brains
Developmental processes are characterized by a massive proliferation and selective cell
death. Signaling pathways involved during development are sometimes unlike those in
adulthood. Despite the fact that zebrafish grow throughout their life (Kishi et al., 2003)
and have a tremendous regenerative capacity (Gemberling et al., 2013), it is possible
that such differences between larval and adult tissue could prevent the manifestation
of phenotypes in Grna;Grnb KO embryos and larvae even after a challenge like an
injury. Moreover, phenotypes caused by Grn-deficiency seem to require ageing, as it
was demonstrated in Grn-deficient mice that Grn-related phenotypes become more
prominent upon ageing (Götzl et al., 2014; Wils et al., 2012). This is also supported
by the fact that NCL/GRN patients, which are homozygous for a loss of function
mutation in GRN, have an age at onset in young adulthood (Smith et al., 2012).
Both NCL/GRN and FTLD-TDP/GRN are diseases of the brain and additionally
Grn is upregulated in mice after a traumatic brain injury (Tanaka et al., 2012). To
examine if the zf-grn levels are also upregulated after an injury in adult zebrafish
brains and with the aim to analyse the Grna;Grnb KO mutant brains after an injury
in the future, I initiated a collaboration with Rossella di Giaimo and Jovica Ninkovic
at the Helmholtz Center Munich. Their group has established stab wound injuries in
the adult zebrafish telencephalon (Baumgart et al., 2012). Interestingly, a microarray
approach, performed on samples from stab wound injured zebrafish telencephali in this
laboratory, indicates an upregulation of zf-grns after such kind of injury (di Giaimo,
unpublished). To confirm their findings and determine which zf-grns are upregulated
after a stab wound injury in the adult telencephalon I performed qPCRs for grna, grnb,
and grn1/grn2 in wildtype telencephali two days after a telencephalic stab wound injury
(dpi) and compared them to uninjured wildtype telencephalon samples. I found grna
to be approx. 40-fold upregulated after 2dpi in injured telencephalon samples, when
compared to uninjured controls (*p = 0.05) (Fig. 5.35A) whereas grnb mRNA remained
unchanged (p = 0.35) (Fig. 5.35B). grn1/grn2 expression levels were increased 35-times
in comparison to uninjured samples in response to a stab wound injury (*p = 0.05)
(Fig. 5.35C). Interestingly, both, grna and grn1/grn2, did respond stronger to the
injury than the positive controls apoeb (*p = 0.05) and mmp9 (*p = 0.05), which were
significantly elevated to approx. 30-fold in telencephali from injured samples, when
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Figure 5.35 – grna and grn1/grn2 were increased after stab wound injury in wildtype
adult telencephalon. A: grna was increased 2dpi in injured telencephalon samples. B:
grnb levels were comparable in injured and uninjured telencephali. C: grn1/grn2 was
strongly elevated at 2dpi in injured telencephali. D: 2dpi apoeb was enhanced in samples
from injured telencephali. E: mmp9 rose at 2dpi in response to an injury in the adult
telencephalon. A-E: Normalized to tbp. mRNA isolated from adult zebrafish telencephali.
n = 3. qPCR. S.E.M. Mann-Whitney test (one-tailed). *p = 0.05.
compared to uninjured controls (Fig. 5.35D,E). In summary, grna and grn1/grn2 were
upregulated strongly after stab wound injury in the adult telencephalon, whereas grnb
did not respond to the injury.
Because of these promising results a first test experiment was performed comparing
wildtype and Grna;Grnb KO brains after a stab wound injury. These imply that the
number of proliferating cells in the subventricular zone might be increased in Grna;Grnb
KO telencephali when compared to wildtype. For a further detailed analysis and for
quantifications a larger sample size is required. These animals are currently growing
and ageing in the fish facility.
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6.1 GRN function split onto four zebrafish genes
In contrast to the single GRN gene in mammals, there are four zf-grns encoded in the
zebrafish genome (Cadieux et al., 2005). The existence of grna and grnb, the GRN
orthologues with several granulin domains can be explained by the hypothesis that the
zebrafish underwent an additional round of whole-genome duplication during evolution,
the so-called teleost-specific genome duplication (TSD) (Cadieux et al., 2005; Howe
et al., 2013; Meyer and Schartl, 1999; Taylor et al., 2003). Due to the TSD, one human
gene is frequently represented by two orthologues in the zebrafish genome. Interestingly,
the carp and goldfish genome seem to contain only shorter Granulins, as long Granulins
were not described so far in those species (Belcourt et al., 1993, 1995). Therefore, it
is possible, that the shorter zf-grns, grn1 and grn2, are encoding Granulins that are
specific to non-mammalian vertebrates. This is supported by the fact that there are no
orthologues of grn1 and grn2 in mammals. It is likely that the shorter zf-Grns were
lost in mammals during evolution due to functional redundancy (Meyer and Schartl,
1999). The existence of the two shorter zf-grns in zebrafish is likely to derive from a
single gene duplication in zebrafish, since grn1 and grn2 are located in tandem on the
same chromosome (Meyer and Schartl, 1999). Moreover, other related fish species, like
medaka, harbour only one shorter granulin in their genome. The function of all zf-Grns
and reasons why the zebrafish has in contrast to carp and goldfish also long zf-Grns
is elusive. The zf-Grns with several granulin domains resemble more the mammalian
full-length protein, GRN, and the shorter zf-Grns could function similar to the cleaved
mammalian granulin peptides. In mammals both GRN and the granulin peptides are
bioactive and it was shown that they can have opposing functions. GRN antagonizes
for example inflammation and the granulin peptides boost inflammation (Zhu et al.,
2002). Whether Grna and Grnb are also proteolytically processed in zebrafish is unclear.
I hypothesise that Grn1 and Grn2 perform the function of the mammalian granulin
peptides superseding the proteolytical processing of Grna and Grnb. Taken together,
the coexpression of long and short zf-Grns suggest a functional diversification of the
Granulins in zebrafish.
6.1.1 Different splice variants of grna?
For the generation of zf-Grn-specific tools the full length cDNAs of grna and grnb tran-
scripts were cloned and grn1 and grn2 were amplified from ESTs. For grnb the transcript
deposited at the Ensembl database and published previously was confirmed (Cadieux
et al., 2005). For grna a splice variant was amplified that is deposited at the Ensembl
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database and encodes a 1049aa protein with 12 granulin domains. This grna transcript
is longer and encodes two more granulin domains than the grna transcript, which was
published previously and is also deposited in the Ensembl database (Cadieux et al.,
2005). It is possible that the two splice variants are transcribed in distinct tissues,
but within this study I did only obtain the longer splice variant from zebrafish of
different age and from different tissues. In mouse Grn, skipping of one exon results in a
transcript, that encodes a Grn protein lacking one granulin domain (He and Bateman,
2003). Moreover, the previous published grna was amplified from an EST (Cadieux
et al., 2005), that was no longer commercially available. For human GRN 21 splice
variants are listed in the Ensembl database and a transcript coding for a 593aa protein
seems to be the most abundant. Since I could only isolate the grna transcript coding
for Grna with 12 granulin domains, I conclude, that this is, even if other transcripts
might be present, the main grna transcript. Consistent with the human cells, one major
splice variant was isolated for grna and grnb, respectively.
6.1.2 zf-Grns seem to be posttranslationally modified
All tagged zf-Grns, derived from cell culture overexpression, migrate in SDS-PAGE at a
higher MW than the calculated MW. GRNs are complex glycosylated glycoproteins.
Among other factors glycosylation can prevent efficient binding of SDS to the protein,
leading to a slower migration in SDS-PAGE (Lottspeich and Engels, 2012; Songsrirote
et al., 2010). Human GRN has a calculated MW of 68.5kDa, but is migrating in
SDS-PAGE due to heavy glycosylation at approximately 75-90kDa (Capell et al., 2011;
Songsrirote et al., 2010). Similar to human GRN, zf-Grns contain predicted glycosylation
sites and are likely to also migrate at a higher MW in SDS-PAGE than calculated. Two
laboratories described migration of Grna and Grnb at lower MW than the calculated
MW using self-made polyclonal Grna as well as Grnb peptide antibodies (Baranowski,
2008; Chitramuthu et al., 2010; Li et al., 2010, 2013). Unfortunately, both laboratories
did not provide a detailed characterization of their antibodies, raising concerns about
the specificity of these antibodies. It is possible, that Grna and Grnb are proteolytically
processed and that specific cleaving products do migrate at a lower MW. However,
in my hands zf-Grns did migrate at a higher MW similar to the running behaviour
observed for human GRN and I did not observe Grna or Grnb specific bands at the
MW suggested in the published literature (Baranowski, 2008; Chitramuthu et al., 2010;
Li et al., 2010, 2013).
Since there were no antibodies commercially available that detect zf-Grns, zebrafish-
specific mAbs detecting Grna and Grnb as well as Grn1/Grn2 were generated. In
mammals it was shown that the full-length GRN can be proteolytically cleaved in
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the linker region (Kleinberger et al., 2013). This was taken into consideration for the
selection of the peptide for the generation of the mAb. Moreover, it is very difficult to
generate antibodies detecting the granulin peptides themselves (personal communication
A. Capell; Nguyen et al., 2013). Therefore, peptides chosen for the mAb generation are
located partially in the linker region and partially in the granulin domain. Additionally
it was evaluated if the selected peptides are suitable antigenes. Zebrafish-specific mAb
were successfully generated for Grna and Grnb but not for Grn1 and Grn2. The latter
two proteins are highly homologous and only one peptide sequence almost identical in
Grn1 and Grn2 did fulfil the requirements for antigene selection. It is possible that
exactly this region in Grn1 and Grn2 is posttranslationally modified masking the epitope
and preventing recognition by mAbs. Furthermore, generation of antibodies detecting
granulin peptides proved to be very difficult in the past (personal communication A.
Capell; Nguyen et al., 2013). As Grn1 and Grn2 resemble the granulin peptides it is
possible that a generation of Grn1 and Grn2 specific mAbs is facing the same limitations
as the generation of antibodies raised against the granulin peptides. In contrast to
previous publications (Baranowski, 2008; Chitramuthu et al., 2010; Li et al., 2010, 2013)
the specificity of the Grna and Grnb mAb used in this study was demonstrated with
different independent approaches e.g. overexpression in cell culture and dose dependent
detection in samples from homo- and heterozygous mutants strengthening the validity
of the mAbs generated within this study. Proper determination of antibody specificity
using different independent experiments like performed herein prevents pitfalls like the
confirmation of a KD and an antibody specificity in the same experiment. Since our
Grna and Grnb mAb are clearly specific for either protein, they provide a great, novel
tool for the analysis of zebrafish Grna and Grnb.
6.1.3 grna and grn1/grn2 expression is enriched in macrophages
During development all four zf-grns are expressed (Cadieux et al., 2005). However,
the expression levels at different developmental stages are distinct. grna and grnb
are expressed throughout development (Cadieux et al., 2005) and grnb is expressed at
much higher levels than grna. This was not described in a previous characterization of
zf-grns (Cadieux et al., 2005). On the protein level, Grnb levels are higher as well. Grnb
is detectable throughout development, while Grna is only expressed below the detection
limit. However, it can not be excluded, that the Grnb mAb is more sensitive than the
Grna mAb precluding Grna detection. Since grn1 and grn2 are highly homologous
(ORF: 92% identity), they were analysed together. In the first days of zebrafish
development grn1/grn2 is almost absent, in line with previous findings (Cadieux et al.,
2005).
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In contrast all zf-grns are expressed in adult brain, fin, and kidney. Interestingly,
the expression of grna and grn1/grn2 was very strong in the kidney, which was not
described previously (Cadieux et al., 2005). Moreover, the adult zebrafish kidney was
the only tissue were Grna was detectable on protein level. The kidney is the main
haematopoietic tissue in zebrafish (Jing and Zon, 2011) and previous data from other fish
species indicated a role of Granulins in haematopoiesis and macrophage differentiation
as well as maturation (Barreda et al., 2004; Belcourt et al., 1993, 1995; Hanington et al.,
2006). Interestingly, the increase of grn1/grn2 expression seems to coincide with the
developmental timeframe in which the number of leukocytes is rising, indicating that
grn1/grn2 might be enriched in leukocytes (Jing and Zon, 2011).
In a collaboration with Julien Rougeot from the laboratory of Annemarie Meijer
at Leiden University, the expression levels of zf-grns in FACS sorted leukocyte cell
populations were analysed and revealed a strong enrichment of grna and grn1/grn2
in macrophages. Also in the mpx :GFP-positive cells, which are mainly neutrophils
and a subpopulation of inflammatory macrophages (Mathias et al., 2009), there was a
minor enrichment of grna and grn1/grn2. This can be assigned to the macrophages
in the mpx :GFP-positive cell population. This data is supported by publications that
found an enrichment of GRN in cells of the human and mouse myeloid lineage, e.g. in
macrophages and (activated) microglia (Chantry et al., 1998; Hashimoto et al., 1999,
2003; Martens et al., 2012; Ong et al., 2006; Petkau et al., 2010; Tanaka et al., 2012).
Since zebrafish microglia derive from primitive macrophages, it can be speculated that
grna and grn1/grn2 expression levels are also elevated in this cell type in zebrafish.
Moreover, in situ data during zebrafish development revealed that the zf-grns are
expressed in haematopoietic tissues (Cadieux et al., 2005) and grna was used as a
marker for microglia (Craig et al., 2008; Huang et al., 2012). This data indicate
that zf-grns, but especially grna and grn1/grn2, are involved in haematopoiesis and
possibly in macrophages and microglia function (Craig et al., 2008; Huang et al.,
2012). Macrophages and microglia are phagocytic cells and especially in activated
macrophages and microglia phagosomes fuse with lysosomes, to degrade the ingested
material (Murphy et al., 2008). There is now increasing evidence for a possible role of
GRN in lysosomal function (Belcastro et al., 2011; Hu et al., 2010; Kollmann et al., 2005;
Nykjaer and Willnow, 2012; Qian et al., 2008; Tanaka et al., 2013; Zheng et al., 2011)
and recently a lysosomal dysfunction in Grn-deficient men and mice was proposed (Götzl
et al., 2014; Tanaka et al., 2013). Additionally, it is known that treatment of cells
with compounds that alkalize the pH of the lysosome or inhibit the vacuolar ATPase,
like Bafilomycin-A1, increase GRN levels (Capell et al., 2011). Therefore, I speculate
that GRN’s lysosomal function could be to sense and balance the amount of functional
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lysosomes. It is also possible that GRN is involved in the regulation of macrophage
and microglia activation, as it was demonstrated that macrophages and microglia from
Grn KO mice are more phagocytic (Kao et al., 2011; Yin et al., 2010a). Moreover it is
likely that Grna and Grn1 as well as Grn2 have an important function in balancing
the inflammatory response, as it was published that GRN exhibits anti-inflammatory,
whereas the granulin peptides exhibits pro-inflammatory properties (Zhu et al., 2002).
According to my data Grnb seems to have a different expression pattern and it is
possible, that Grnb is bioactive in distinct processes within different tissues. It was
recently published that GRN is important for a functional blood brain barrier since
it is needed for a normal endothelial tight junction structure (Jackman et al., 2013).
At least in the larval brain, grnb expression (Cadieux et al., 2005) resembles that of
claudin 5a and claudin 5b, which are components of the tight junction in zebrafish (Xie
et al., 2010). It would therefore be interesting to examine if grnb plays a role in tight
junction integrity in zebrafish.
6.2 zf-Grns and a role in the inflammatory response
Due to the enrichment of grna and grn1/grn2 expression in macrophages and
haematopoietic tissues as well as previous observations that grna is, for example,
increased after a tail fin amputation in zebrafish larvae (Mathew et al., 2009) or after
ventricular resection of the adult zebrafish heart (Lien et al., 2006), the expression
levels of zf-grns were analysed after three different stimuli that trigger an inflammatory
response. First, tail fin amputation, second, chemically induced wounding with CuSO4,
and third, a stab wound injury in the adult zebrafish telencephalon.
After a tail fin amputation in zebrafish larvae grna but not grn1/grn2 is significantly
increased, confirming previously published data (Mathew et al., 2009). Even though the
effect was less pronounced and did not last as long as described before (Mathew et al.,
2009), it was statistically significant. Since grn1 and grn2 are expressed at very low
level during the larval stages analysed, it is possible that a minor differential grn1/grn2
expression after tail fin amputation is not detectable due to the poor signal to noise
ratio that can interfere with the analysis of low abundant transcripts. This is also a
possible explanation of the striking divergences in the analysis of grn1/grn2 after larval
tail fin amputation.
Despite successful wounding, CuSO4 treatment in zebrafish larvae did not have an
influence on the expression of any of the zf-grns It is described that CuSO4 treatment
leads to the recruitment of neutrophils to the injured neuromasts (d’Alençon et al., 2010;
Wittmann et al., 2012). Whether macrophages are also involved in the inflammatory
response to CuSO4 is not analysed so far. Therefore, it is possible that only neutrophils
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are responsive to CuSO4 treatment and macrophages, including an activation of grna
and/or grn1/grn2, are not.
After an injury in the adult zebrafish telencephalon, grna and grn1/grn2 are strongly
increased at 2dpi. Since it was demonstrated before that the number of microglia is
increased at 2dpi and that the microglia are in an activated state (Baumgart et al.,
2012) it is possible that the increase of grna and grn1/grn2 is a direct consequence of
an increase in microglia.
It is still unclear why grna and grn1/grn2 expression levels are increased after injury.
They are expressed in macrophages and most likely in microglia, as well. The number
of macrophages and microglia is increased around the wound site at the fin fold or
in the telencephalon, respectively (Baumgart et al., 2012; Ellett et al., 2011), and
after both injuries, tail fin amputation and stab wound injury, I did selectively analyse
the injured tissue and not the whole larvae or whole zebrafish, as it was done after
the CuSO4 treatment. It is unclear if the number of cells expressing grna as well
as grn1/grn2, most likely macrophages or microglia, increases or if the expression of
grna and grn1/grn2 per cell is increased upon injury. It is also possible that both
scenarios are occurring simultaneously. Furthermore, it is of interest, if a wound is
needed or if also degenerative processes as seen in neurodegenerative diseases in the
absence of a wound, can trigger increased grna and grn1/grn2 expression. GRN was
demonstrated to be involved in wound healing (He et al., 2003) and in mice it was
shown that Grn is upregulated for example after a traumatic brain injury (Tanaka
et al., 2012) or after spinal contusion (Naphade et al., 2010). Moreover, GRN was
shown to be upregulated in several neurodegenerative diseases, like in the spinal cord
of ALS patients and around amyloid plaques in AD patients (Ahmed et al., 2007).
Consequently, it would be interesting to examine the zf-grns levels in zebrafish models
of neurodegenerative diseases.
Taken together, the observations made within this study in zebrafish strengthen pre-
vious data describing an involvement of GRN in the inflammatory response to an
injury and confirm previous data in zebrafish. It is likely that the increase in GRN
expression in these processes is conserved in vertebrates, including zebrafish, making
the zebrafish an excellent model organism to study the role of GRN upon injury. It still
remains unclear why GRNs accross different species are increased after an inflamma-
tory stimulus and during chronic inflammation. Therefore, it still needs to be further
established, how GRN is involved in inflammation and why a lack of GRN is connected
to neurodegenerative diseases.
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6.3 Consequences of Grna and Grnb KO in zebrafish
FTLD-TDP/GRN patients suffer from GRN haploinsufficiency (Hardy and Rogaeva,
2013) and NCL/GRN patients have no GRN (Smith et al., 2012). Therefore, I decided
to generate zebrafish loss of function mutants, to model aspects of the here mentioned
neurodegenerative diseases in zebrafish. Moreover, Grna and Grnb KO zebrafish
provide an excellent model to elucidate the physiological function of these two proteins.
Zebrafish mutants, in contrast to morphants, allow the analysis of phenotypic alterations
also in adult zebrafish. This is of special interest since NCL/GRN patients become
symptomatic in their twenties and FTLD-TDP/GRN patients usually above 50 (Fujioka
and Wszolek, 2011; Smith et al., 2012). Additionally, mutations are stable and can
be inherited. Among the four zf-grns, grna and grnb, the two GRN orthologues were
chosen for the generation of loss of function mutants. grna is believed to be the true
orthologue of GRN, due to it synthenic conversation (Cadieux et al., 2005) and grnb is of
interest because of its expression in the brain during development (Cadieux et al., 2005;
Shankaran et al., 2008). Moreover, a deficiency of both grn orthologues in zebrafish
would exclude a possible compensation for the loss of the paralogue, which was observed
before for example in the single tardbp-/- mutants, where alternative splicing of tardbpl
compensates for the loss of tardbp (Schmid et al., 2013).
6.3.1 Generation of KO alleles in Grna and Grnb using ZFNs
For targeted mutagenesis in grna and grnb ZFNs were used, which were at the beginning
of my thesis the state-of-the-art technology for genome editing in zebrafish (Doyon et al.,
2008; Meng et al., 2008; Schmid et al., 2013; van Bebber et al., 2013). The CompoZr
Custom ZFN from Sigma Aldrich for grna and grnb were targeting the first and third
coding exon, respectively, and mRNAs carrying mutations leading to a preTT codon
that could escape the NMD, would result in very short, most likely not functional,
truncated proteins. All analysed ZFN sets were demonstrated to be functional and did
induce mutations at the preselected target sites in grna and grnb. These mutations
were heritable, as it was shown before for other ZFN-induced mutations (Doyon et al.,
2008; Meng et al., 2008; Schmid et al., 2013; van Bebber et al., 2013). Among all
frameshift mutations generated, a subset (four for grna and three for grnb) was selected
that caused a preTT codon. mRNAs with a preTT codon are normally eliminated
by NMD (Vicente-Crespo and Palacios, 2010), leading to a loss of functional protein.
To determine if Grna and Grnb are absent in the respective mutants, grna and grnb
mRNA expression and Grna and Grnb protein levels were determined. I could show
that grna and grnb mRNAs are significantly reduced. Despite the fact that the NMD
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machinery enhances the degradation rate of mRNAs containing a preTT codon resulting
in a decreased amount of preTT codon containing transcripts, such transcripts are
still detectable. In the Grna and Grnb mutants the residual mRNA expression of grna
reached a plateau at 50% of the wildtype mRNA expression levels and grnb plateaued
at 10%. I speculate that the grna mRNA is stabilized by an antisense RNA (Cadieux
et al., 2005) slowing down the degradation rate of mutated grna mRNA by NMD. The
Grna and Grnb proteins are not detectable in all Grna and Grnb KO samples analysed.
Therefore, it can be concluded that all grna and grnb mutant alleles selected in this
study are resulting in a loss of functional proteins and that all homozygous Grna and
Grnb mutants are Grna or Grnb KO zebrafish.
6.3.2 zf-Grns do not compensate for each other’s loss
Due to an additional round of genome duplication in the teleost lineage, there are two
orthologues of GRN in zebrafish, Grna and Grnb (Howe et al., 2013; Meyer and Schartl,
1999; Taylor et al., 2003). Furthermore, zebrafish have retained smaller Granulins, Grn1
and Grn2, which seem to be absent in mammals. It is likely that the loss of function of
one of the zf-Grns is compensated by the upregulation of the other(s), as observed for
example in the tardbp mutant zebrafish (Schmid et al., 2013). Interestingly, neither in
grna nor grnb single mutants the other zf-grn is differentially expressed. On the protein
level Grna or Grnb also do not compensate for the loss of the paralogue. grn1/grn2
mRNAs do not compensate for the loss of Grna and Grnb. If they compensate for
the loss of Grna and Grnb by increased translation remains to be determined upon
availability of specific antibodies. Despite their structural similarities grna and grnb have
quite different expression patterns (Cadieux et al., 2005) and the lack of compensation
suggests also that they might have distinct functions and are regulated differentially,
pointing to a functional diversification or a gain of new functions during evolution (Meyer
and Schartl, 1999). According to the expression pattern (Cadieux et al., 2005) and
the data obtained within this study, Grn1 and Grn2 are more likely to compensate
a lack of Grna than Grnb. Grn1 and Grn2 are structurally different from Grna and
do resemble more the processed granulin peptides. Since Grn was demonstrated to be
anti-inflammatory and the granulin peptides to be pro-inflammatory (Zhu et al., 2002),
it is difficult to imagine that Grn1 and Grn2, which do only have 11
2
granulin domains
take over the function of the presumably anti-inflammatory Grna, which has 12 granulin
domains in zebrafish. But this remains to be answered. Moreover, it is possible that
zf-Grns are not essential in the healthy developing zebrafish larvae making compensation
not necessary. Maybe functional zf-Grns are only needed in special conditions such as
injury, inflammation or other insults. Additionally, other less related proteins could
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compensate for the loss of Grna and Grnb. Taken together, a loss of Grna and Grnb
seems to cause no compensatory upregulation of the paralogue, indicating different
functions.
6.3.3 No need of Grna and Grnb for reproduction and development
Grn was identified in rodents in the reproductive system (Bateman and Bennett, 2009).
Therefore, it was of interest if Grna and Grnb KO zebrafish are fertile. Matings
did provide information that even the grna-/-;grnb-/- double mutants are fertile and
capable to produce viable offsprings according to Mendelian ratios. Single and double
homozygous mutant offsprings did not show any obvious morphological changes either.
This is consistent with observations in rodents where Grn KO mice are viable and fertile
and do not have obvious morphological phenotypes (Ahmed et al., 2010; Ghoshal et al.,
2012; Petkau et al., 2012; Wils et al., 2012; Yin et al., 2010a,b).
Since GRN is a growth factor (Bateman and Bennett, 2009), it was of interest if the
lack of Grna or Grnb or both has an effect on the rate of development of zebrafish
embryos. I showed that a KO of Grna and Grnb does not lead to a delay in development.
It is possible that other growth factors are more important for a proper zebrafish
development (Eivers et al., 2004) or that Grna and Grnb do not have a function as a
growth factor during development. Growth factors can have specific functions and can
act therefore tissue specific (Rentzsch et al., 2004). Even though zf-Grns are secreted
proteins it is possible that they can only influence the growth of distinct cell types
at distinct developmental stage. Whether Grna or Grnb display growth factor like
properties in certain tissues or in adult zebrafish remains to be answered. In summary,
reproductive phenotypes and a reduced developmental rate due to a lack of Grna and/or
Grnb can be excluded.
6.4 Different phenotypes in Grna and Grnb KO and KD
KD is a powerful tool to study genes in zebrafish, especially during development (Eisen
and Smith, 2008) and also for the zf-Grns a few KD studies are published (Chitramuthu
et al., 2010; De Muynck et al., 2013; Laird et al., 2010; Li et al., 2010, 2013). With
the grna and grnb single and double mutants in hands, I aimed to confirm some of the
previously published findings. In the following the strikingly different results obtained
in Grna and Grnb KO and KD zebrafish are discussed.
127
6 Discussion
6.4.1 SpMN axon outgrowth in Grna and Grnb KO embryos
Even though GRN is only a minor risk factor for ALS (Del Bo et al., 2011; Sleegers
et al., 2008), two laboratories did analyse the SpMN axon outgrowth in zebrafish
morphants and could show that grna and grnb morphants have SpMN axons outgrowth
defects (Chitramuthu et al., 2010; De Muynck et al., 2013; Laird et al., 2010). Here I
would like to point to a discrepancy reported by one laboratory (Cadieux et al., 2005;
Chitramuthu et al., 2010). grna and grnb, which code for presumably secreted proteins,
do not seem to be expressed in SpMNs or the tissue surrounding the SpMN axons
in a study published in 2005 (Cadieux et al., 2005). But in a follow-up study grna
expression was stated to be observed at the somite boundaries, in the spinal cord, and
in SpMN axons. Interestingly, whole-mount IF using an antibody apparently specific
for Grna showed immunoreactivity at the somite boundaries, in the spinal cord, and in
the SpMN as well (Chitramuthu et al., 2010). According to the literature available, I
aimed to confirm the published data and analysed the SpMN axon outgrowth in grna
and grnb single and double mutants. In these, the SpMN axons showed no signs of
truncation or extended branching, when compared to wildtype controls. The analyses
performed in this study were very carefully controlled, meaning that always the five
SpMN axons above the end of the yolk extension were analysed and are shown as single
bars in the graph. This clear definition of the region analysed was partially done in the
KD studies published (Chitramuthu et al., 2010; De Muynck et al., 2013; Laird et al.,
2010). When the length of still growing SpMN axons is determined a clear regional
definition is essential as the more ventral SpMN axons are longer than more caudal ones
at that stage of development. After I experienced SpMN axon length variations due to
minor inter-clutch variations, I compared only siblings and included from each clutch
the same quantity of embryos in the dataset. If inter- or intra-clutch comparisons were
made in the KD studies is not stated (Chitramuthu et al., 2010; De Muynck et al., 2013;
Laird et al., 2010). In the KD publications I observed that some of the KD embryos
appeared morphologically abnormal (Chitramuthu et al., 2010). Including such kind of
embryos in the analysis of the SpMN length could easily reveal a significantly reduced
SpMN length because of reduced growth or developmental delay in general. To exclude
an influence of maternal mRNA, which is also reduced when translation inhibition MO
are used, the SpMN axon outgrowth analysis was repeated with matings of homozygous
females and heterozygous males. The heterozygous embryos served as controls in this
experimental setup, since it was shown before that the SpMN axons in heterozygous
grna and grnb single and double mutants do not have any SpMN axon outgrowth
defects. Also in this experimental setup, in the absence of maternal and zygotic mRNA,
the embryos are devoid of any SpMN axon outgrowth defects. Contradictory results
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obtained from morphants and mutants regarding SpMN axon outgrowth phenotypes,
have been described previously in zebrafish (den Broeder et al., 2009; Kabashi et al.,
2010; Schmid et al., 2013; Tucker et al., 2006) and raise the question if a MO-induced
off-target effect or neurotoxicity is responsible for the SpMN axon outgrowth phenotypes
observed in morphants. Both Grna and Grnb KD studies are done carefully, however
important controls are missing or are unclear (Chitramuthu et al., 2010; Laird et al.,
2010). Western blot analysis with a specific antibody are necessary to control the
effectivity of a translation inhibition MO (Eisen and Smith, 2008). Chitramuthu and
colleagues used an anti-Grna antibody to confirm the KD, but they detected Grna and
its KD-mediated reduction at a MW of 55kDa, which is smaller than the theoretically
calculated MW of Grna (112kDa) and far below the MW of Grna (approx. 200kDa)
determined within this study, raising some doubts about the antibody specificity and
the provided KD control. They also rescued the Grna KD by human GRN and grna
mRNA overexpression. This was only possible for the MO-induced truncation of SpMN
axons but not the extended branching, indicating that the extended branching could be
a toxic off-target effect of the MO- or mRNA-injections. For their Grnb KD they did
not provide any KD control (Chitramuthu et al., 2010). Laird and colleagues showed a
dose-dependent effect of two independent grna and grnb MOs on the SpMN axon length,
of which they could rescue one grna MO-induced SpMN truncation by the expression
of human GRN mRNA. For the other grna MO and the grnb MOs rescue experiments
are not provided (Laird et al., 2010). Unfortunately, they did not show images of the
MO-mediated KD and it is possible that the truncation of SpMN could be caused by
MO-induced toxicity or developmental delay. Taken together, these observations raised
serious questions about the specificity of the MOs used and the significance of those
studies. In contrast, the grna and grnb mutants generated and used in this study were
carefully characterized and every embryo used for the SpMN axon outgrowth analysis
was genotyped. Therefore, I conclude that neither Grna nor Grnb is needed for a proper
outgrowth of SpMN axons in zebrafish and that even a lack of both proteins does not
result in SpMN axon outgrowth defects.
6.4.2 MPCs in Grna;Grnb double KO embryos
It was demonstrated that a KD of Grna leads to an impaired muscle growth and the
authors showed that grna and grnb morphants have a reduced number of Pax7-positive
MPCs (Li et al., 2013). In contrast, the number of Pax7-positive MPCs in grna-/-;grnb-/-
double mutant embryos was not decreased and there was no effect on the differentiated
slow and fast trunk muscles. There is one transverse section included in the study from
Li and colleagues that shows the expression of Grna in the larval trunk myotome, but
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negative or positive controls confirming the antibody specificity are missing (Li et al.,
2013). Moreover, the expression pattern of grna and grnb described by others are not
consistent with a muscle phenotype, since neither the muscle itself nor the surrounding
tissue is expressing grna or grnb (Cadieux et al., 2005). Li and colleagues used a
translation inhibition MO that was carefully validated in their laboratory before (Li
et al., 2010). In the previous study they showed that the MO is able to silence a
grna-GFP reporter construct, confirmed the KD on protein level (98kDa) and rescued
the observed liver phenotype by overexpression of grna (Li et al., 2010). Also the number
of Pax7-positive MPCs was rescued by overexpression of grna but in between the two
studies of the same laboratory the MW of Grna dropped to 55kDa and therefore, the
Grna KD was confirmed by the reduction of a signal at 55kDa (Li et al., 2013), raising
serious doubts about the KD efficiency especially in the later study. Moreover, the Grna
KD embryos shown in the publication have a massive increase in cell death, pointing
towards toxicity and the Grnb KD embryos displayed seem to be developmentally
younger than 24hpf. With the additional finding in the Grna;Grnb KOs I conclude that
neither Grna nor Grnb has an influence on the muscle growth.
Taken together, the data obtained herein highlights that KD studies have to be analysed
with great caution, since the phenotypes often cannot be confirmed by a genetic
KO (Schmid and Haass, 2013).
6.5 Grna and Grnb are not required for proper vasculogenesis
GRN is published to be an angiogenic factor (He et al., 2003; Ho et al., 2008; Toh
et al., 2013) and tardbp-/-;tardbpl-/- double mutant zebrafish have mispatterned blood
vessels (Schmid et al., 2013). I therefore analysed the blood vessels in grna-/-;grnb-/-
double mutants for proper vessel patterning. During embryonic stages the blood vessels
in grna-/-;grnb-/- double mutants had a wildtype pattern, suggesting that Grna and
Grnb are not required for proper vasculogenesis during zebrafish development. Grn1
and Grn2 could be important for vascular patterning, but at the developmental stages
analysed grn1 and grn2 expression is very low. In mice, Grn is expressed in the
developing microvasculature (Daniel et al., 2003). In contrast to that, there is no clear
evidence for an expression of zf-grns in the developing vasculature (Cadieux et al.,
2005). Therefore, it is possible that blood vessels in zebrafish do not need zf-Grns for
proper vasculogenesis. Whether zf-Grns have angiogenic capacities at all, similar to
mammalian GRN (He et al., 2003; Ho et al., 2008), remains to be determined. Recent
data suggested that GRN is needed for a proper functional blood brain barrier (Jackman
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et al., 2013). Therefore, it would be interesting to examine the blood brain barrier
integrity (Nishimura et al., 2013) in grna-/-;grnb-/- double mutant zebrafish.
6.6 Grna;Grnb KO zebrafish lack disease-related phenotypes
After the discovery in 2006 that mutations in GRN are causative for FTLD-TDP (Baker
et al., 2006; Cruts et al., 2006) and in 2012 that a complete absence of GRN leads to
NCL (Smith et al., 2012), the major challenge in the field was and still is to unravel
the underlying pathomechanisms. In the recent years patient material from FTLD-
TDP/GRN patients was analysed in detail and experiments using cell culture systems
as well as animal models were performed. Some of the phenotypes described in GRN
patients and Grn KO mice were addressed in the grna-/-;grnb-/- double mutant zebrafish
and the results are discussed hereafter.
6.6.1 No neurodegeneration in Grna;Grnb KO larvae
Both FTLD-TDP/GRN and NCL/GRN are neurodegenerative diseases and animal
models mimicking these diseases should develop neurodegeneration as well. Interestingly,
neurodegeneration was only reported in one aged Grn KO mouse strain (Ahmed et al.,
2010) but not in others (Ghoshal et al., 2012; Petkau et al., 2012; Wils et al., 2012).
Consistent with the findings in most Grn-deficient mice, also Grna;Grnb KO larvae
lack an increase in neurodegeneration. The dying cells observed in brains of 5dpf
Grna;Grnb KO and wildtype larvae are mostly undergoing programmed cell death
through developmental pruning processes (Eyo and Dailey, 2013). Neurodegeneration
in the brain of adult Grna;Grnb KO fish was not examined, but is rather unlikely
based on the observations in rodents. Why neurodegeneration observed in Grn-deficient
humans is not seen in mice and zebrafish that lack Grn is still elusive. It was postulated
that a longer lifespan in humans might play a role (Götzl et al., 2014). Moreover, it is
possible that characteristics specific to human beings, e.g. human specific sialic acid
biology (Varki, 2009), promote neurodegeneration upon GRN-deficiency in men.
6.6.2 No microgliosis in Grna;Grnb KO larvae
In contrast to FTLD-TDP/GRN patients (Chen-Plotkin et al., 2010; Josephs et al.,
2007; Mackenzie et al., 2006) and homozygous Grn KO mice (Ahmed et al., 2010;
Ghoshal et al., 2012; Petkau et al., 2012; Wils et al., 2012; Yin et al., 2010a,b) the
grna-/-;grnb-/- double mutant zebrafish do not develop microgliosis in the larval brain.
One possible explanation for this finding are the time points of analysis, which might
have been too early. But also preliminary examinations in sections of adult Grna;Grnb
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KO brains were not indicative of microgliosis in grna-/-;grnb-/- double mutant zebrafish.
Moreover, it would be of interest to examine the phagocytic behaviour of microglia in
Grna;Grnb KOs, since it was demonstrated that macrophages and microglia of Grn
KO mice are more active (Kao et al., 2011; Martens et al., 2012; Tanaka et al., 2012,
2013). Heterozygous Grn KO mice also lack gliosis (Ahmed et al., 2010; Filiano et al.,
2013). Similar to the remaining wildtype Grn in heterozygous mice, the presence of
Grn1 as well as Grn2 might be sufficient to prevent microgliosis in Grna;Grnb KOs.
In general, microglia are present in zebrafish (Sieger et al., 2012; Svahn et al., 2013)
and microgliosis including activated microglia, has been detected after an injury in the
adult zebrafish brain (Baumgart et al., 2012). Parenchymal astrocytes are not present
in zebrafish and therefore Grna;Grnb KO zebrafish were not examined for astrogliosis.
Radial ependymoglia located at the ventricle seem to have functions attributed to
parenchymal astrocytes (Baumgart et al., 2012). But after an injury in the adult
zebrafish telencephalon there are for example no or very few cells positive for glial
fibrillary acidic protein (Gfap) detectable in the parenchyma around the injury site.
Instead Gfap-positive radial glia at the ventricle start to proliferate (Baumgart et al.,
2012; März et al., 2011). These data indicate that the cellular response to an injury
in zebrafish is different to the observations made in mammals. This might also be an
explanation for the lack of scar formation and the tremendous regenerative capacity of
the zebrafish brain (Baumgart et al., 2012). To my knowledge, there is no model so far
describing adult onset neurodegeneration in the zebrafish brain. Therefore, it remains
to be seen if microgliosis comparable to that observed in FTLD-TDP/GRN patients
and homozygous Grn KO mice can occur at all in the uninjured adult zebrafish brain.
6.6.3 Are Grna;Grnb KOs devoid of aggregates?
Another hallmark of neurodegenerative diseases including FTLD and NCL are protein
deposits (Kleinberger et al., 2013). FTLD-TDP/GRN patients as well as Grn KO
mice show increased SCMAS and Saposin D staining (Götzl et al., 2014) and FTLD-
TDP/GRN patients do additionally possess ubiquitin-positive TDP-43 deposits (Neu-
mann et al., 2006) of which the latter were not observed in Grn KO mice (Ahmed et al.,
2010; Ghoshal et al., 2012; Petkau et al., 2012; Wils et al., 2012). NCL/GRN patients
and mice lacking Grn have consistently shown an increase in autofluorescent lipofuscin
deposits (Ahmed et al., 2010; Petkau et al., 2012; Smith et al., 2012; Wils et al., 2012).
The "ageing pigment" lipofuscin can be found in postmitotic cells of nearly every ageing
organism (Jung et al., 2010). In zebrafish lipofuscin was demonstrated by PAS stain
in the liver of 3.8 year old animals and autofluorescent material was detected in the
eye after 4.8 years of birth (Kishi et al., 2008). Interestingly, one group mentioned the
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observation of neurolipofuscin in 2.5 year old zebrafish, but did not show images (Rosa
et al., 2010). My collaboration partner Claire Russell has, however, never observed
autofluorescent deposits in zebrafish. Lipofuscin can also be visualized by PAS stain.
Abnormal big dense, pinkish aggregates reminiscent of lipofuscin deposits in zebrafish,
were detectable in CLN2 mutant zebrafish upon PAS staining (C. Russell, personal
communication). The PAS stain in brains of larval and 11mpf adult Grna;Grnb KO
zebrafish were devoid of any obvious abnormalities when compared to wildtype controls
indicating absence of lipofuscin deposits. Whether lipofuscin deposits accumulate in
the brain of Grna;Grnb KO zebrafish and if neurolipofuscin does occur in zebrafish
in general could not be clarified within this study due to a lack of a positive control
for aged brains. Possibly the time points of analysis were scheduled too early, as even
pathological lipofuscin is only accumulating over time (Ahmed et al., 2010; Petkau
et al., 2012; Smith et al., 2012; Wils et al., 2012). Additionally, the high regenerative
capacity of zebrafish might have an influence. Lipofuscin-containing cells are maybe less
functional and therefore quickly removed and replaced (Gemberling et al., 2013). Nev-
ertheless, it was shown before, that protein deposits do form in zebrafish cells and can
be detected before being removed (Paquet et al., 2009; Schiffer et al., 2007). However,
both studies relied on strong overexpression of the aggregating protein. It might be
worth to analyse the brains of more aged Grna;Grnb KO zebrafish with focus on brain
regions that have been reported to contain neurolipofuscin in zebrafish or are primarily
affected in humans and mice. Moreover, it would be interesting to examine the aged
grna-/-;grnb-/- double mutant zebrafish brains for TDP-43- and p62-positive deposits or
elevated Saposin D and SCMAS levels, which have been detected in FTLD-TDP/GRN
patients and/or Grn-deficient mice (Götzl et al., 2014; Neumann et al., 2006), to clarify
if protein deposits do form in zebrafish that lack Grna and Grnb.
6.6.4 No indications for lysosomal dysfunction in Grna;Grnb KOs
NCL is a lysosomal storage disorder (Smith et al., 2012) and there is now increasing
evidence of a lysosomal dysfunction in FTLD-TDP/GRN and Grn KO mice (Götzl et al.,
2014). Consequently, I asked if the lysosomes in Grna;Grnb KO larvae are functional.
Stainings with the in vivo dye LysoTracker that is incorporated in its fluorescent form
in acidic subcellular compartments including lysosomes indicate that grna-/-;grnb-/-
double mutant larvae are able to establish vesicular acidic cell compartments. This
acidic pH is required for an efficient function of lysosomal proteins. LysoTracker
staining was demonstrated to be functional in zebrafish before (Donà et al., 2013;
He et al., 2009; Mahmood et al., 2013a; Peri and Nüsslein-Volhard, 2008), but the
detailed structure and appearance of zebrafish lysosomes is not characterized very
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well. Therefore conclusions regarding the size, number, and localization of lysosomes
in cells of Grna;Grnb KOs cannot be drawn. Additionally, it would be of interest to
examine the lysosomes in the adult brain of grna-/-;grnb-/- double mutants, as aberrant
lysosomal staining becomes more prominent in aged Grn KO mice (Götzl et al., 2014).
Both analyses require a lysosome specific labelling method. This could be realized
either in a transgenic zebrafish line that labels lysosomes selectively and seems to
be available in the laboratory of John Rawls (J. Rawls, personal communication) or
by immunohistochemical stainings on whole larvae or sections using lysosome specific
antibodies like the LAMP1 antibody (Drerup and Nechiporuk, 2013). Unfortunately, the
latter still lacks a detailed validation in zebrafish. Furthermore, it would be interesting
to analyse lysosomal size, number, and localization in sections from Grna;Grnb KO
mutants and controls by electron microscopy best suited for the small size of zebrafish
lysosomes, especially in neurons.
Lysosomal proteins and also some transcripts encoding lysosomal proteins, e.g. CTSD,
accumulate in Grn KO mice and FTLD-TDP/GRN patients (Götzl et al., 2014; Tanaka
et al., 2013; Wils et al., 2012). Unlike CTSD in Grn-deficient men and mammals (Götzl
et al., 2014; Tanaka et al., 2013; Wils et al., 2012), the ctsd mRNA and Ctsd protein
levels are unchanged in grna-/-;grnb-/- double mutant zebrafish. In Grna;Grnb KO
larvae this can be explained by the fact that Ctsd mRNA and Ctsd protein levels
increase with age in Grn-deficent mice (Götzl et al., 2014; Wils et al., 2012) and that
larvae are simply too young to show differences. The factor ageing was considered in
the analysis of aged zebrafish brains from Grna;Grnb KOs and no difference in the Ctsd
mRNA or protein expression levels were detectable. Zebrafish Ctsd and its processing
is slightly different to mammalian CTSD. The zebrafish Ctsd is mono-glycosylated
and matures into a single-chain protein, whereas CTSD is di-glycosylated and cleaved
into light and heavy chain (Follo et al., 2011, 2013). However, both the proprotein
and the heavy chain are increased in Grn KO mice (Götzl et al., 2014), thus the
minor differences between CTSDs should be of no consequence in these experiments.
Another reason for stable Ctsd levels in the Grna;Grnb KOs might be the tremendous
regenerative capacity of the zebrafish even in the adult brain (Gemberling et al., 2013;
Kizil et al., 2012). It is possible that cells with elevated Ctsd levels have a decreased
lysosomal function and are eliminated and replaced. Furthermore, it could be that Ctsd
is unexceptionally not affected but other lysosomal proteins are. Hence, it would be
interesting to analyse other lysosomal proteins that have been reported to be elevated
in Grn KO mice like for example Saposin D or TMEM106B (Götzl et al., 2014). Since
zebrafish regenerate much better than mammals (Gemberling et al., 2013), ageing
in general could be fundamentally distinct precluding the accumulation of lysosomal
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proteins. A higher turnover capacity could also prevent an accumulation of lysosomal
proteins in zebrafish, however there are no indications so far that lysosomal biology in
zebrafish is very different to that in mammals. Nevertheless, it cannot be excluded that
minor differences exist and that these could have had an effect on the analysis of Ctsd
levels in the Grna;Grnb KO zebrafish. To learn more about the lysosomal biology in
zebrafish in general and possible difference in grna-/-;grnb-/- double mutant zebrafish, it
would be of interest to analyse the lysosomal dynamics in zebrafish larvae by in vivo
imaging. It was demonstrated that the lysosomal biogenesis is increased in Grn KO
mice especially after an injury (Götzl et al., 2014; Tanaka et al., 2013) indicating a
decreased lysosomal function upon Grn-deficiency. For the further characterization of
the lysosomal dysfunction, lysosomal dynamics and turnover should be compared in
Grn-deficient and control model systems.
6.6.5 No biochemical alterations in Grna;Grnb KOs
Besides lysosomal proteins that were linked to Grn-deficiency, there are also others e.g.
STAT3 and FLNC that seem to be differentially expressed upon a partial or complete
loss of GRN (J. Janssens and J. Banzhaf-Strathmann, unpublished; Schmid et al.,
2013). In contrast to the increased Stat3 levels in Grn KO mice and FTLD-TDP/GRN
patients, the stat3 levels in all Grna;Grnb KO samples were not statistically significantly
altered. The increase in Stat3 expression was becoming more obvious in aged Grn
KO mice. Therefore, it might be worth to analyse stat3 in aged grna-/-;grnb-/- double
mutant brain samples. The mechanisms that lead to the STAT3 increase in mammals
and the cell types involved are not examined so far. STAT3, which is a transcription
factor, is involved in many processes, amongst others neuroinflammation. Oxidative
stress or anti- and pro-inflammatory cytokines can activate STAT3 and it is discussed
as a factor that promotes on the one hand cell death and on the other hand neuronal
survival (Nicolas et al., 2013). Possibly Stat3 is increased as a result of micro- and
astrogliosis observed in Grn KO mice and FTLD-TDP/GRN patients (Ahmed et al.,
2010; Ghoshal et al., 2012; Petkau et al., 2012; Wils et al., 2012; Yin et al., 2010a,b). If
so, it would explain the lack of a stat3 increase in grna-/-;grnb-/- double mutants which
are devoid of microgliosis.
The expression of the two FLNC orthologues, flnca and flncb, was not changed when
compared to wildtype controls. Interestingly, there is a slight increase in flncb at 22mpf
in grna-/-;grnb-/- double mutant brains. Of the two orthologues flncb is related more
closely to FLNC (Ruparelia et al., 2012) and it would be interesting to see if flncb
expression in even older Grna;Grnb KO brains is further increasing. Mutations in FLNC
are linked to myofibrillar myopathies and flnca and flncb expression in zebrafish embryos
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is mainly observed in the muscle (Ruparelia et al., 2012). Interestingly, there seems to
be one patient with a mutation in FLNC who developed also cerebellar atrophy (Tasca
et al., 2012). But the exact reasons of increased FLNC levels in FTLD-TDP/GRN
remain to be determined. The unaltered expression of stat3, flnca, and flncb in the
grna-/-;grnb-/- double mutants could be based on the presence of Grn1 and Grn2 that
might be sufficient to compensate for the loss of Grna and Grnb. Consequently, it
would be worth to repeat the analysis of stat3, flnca, and flncb expression levels in aged
brains derived from zebrafish mutant that lack all zf-grns. STAT3 and FLNC are also
of interest, since an upregulation of Stat3 and Flnca was originally discovered in the
proteom analysis of the tardbp-/-;tardbpl-/- double mutants (Schmid et al., 2013). Tardbp
and Tardbpl are the orthologues of TDP-43, which is typically found in intracellular
deposits of FTLD-TDP/GRN patients and it is unclear so far if a lack of soluble TDP-43
or a TDP-43-aggregate-mediated toxicity is harmful to neurons. The identification of
increased STAT3 and FLNC levels in Grn-deficient mammals and Tardbp;Tardbpl KO
zebrafish provides now a connection between a loss of GRN and TDP-43 and it is of
great interest to solve the underlying pathomechanisms.
6.6.6 No behavioural phenotypes in Grna;Grnb KO larvae
One of the symptoms in NCL/GRN are epileptic seizures due to massive neurodegener-
ation (Smith et al., 2012). I could show before that Grna;Grnb KO larvae show no signs
of neurodegeneration and I aimed to exclude seizure-like swimming behaviour, as well.
In contrast to PTZ-treated wildtype and CLN2 mutant larvae (Mahmood et al., 2013a)
the grna-/-;grnb-/- double mutants swim like wildtype and do not suffer from seizure-like
swim episodes. NCL/GRN patients became symptomatic in their twenties (Smith
et al., 2012). If Grna;Grnb KOs develop neurodegeneration as aged adults and if this
leads occasionally to seizure-like swim episodes remains to be answered. This could
be addressed by long-term recording of the swimming behaviour of adult zebrafish.
FTLD-TDP/GRN patients develop very diverse phenotypes ranging from behavioural
abnormalities to comprehension and speech problems (Bonvicini et al., 2014) and also
the behavioural analysis of Grn KO mice reveal very diverse results (Kleinberger et al.,
2013). Since FTLD-TDP/GRN typically has an age at onset above 50, it would be
interesting to analyse the Grna;Grnb KO zebrafish for example in a behavioural test
that has been established for the aggression-boldness syndrome (Norton et al., 2011).
The analysis of the motor performance in Grn-deficient mice revealed a reduced swim
speed in some strains (Ghoshal et al., 2012; Wils et al., 2012). Additionally the touch
response and avoidance swimming behaviour was reported to be reduced in Grna KD
embryos (Chitramuthu et al., 2010). On the contrary, the Grna;Grnb KO zebrafish
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larvae did not respond differently in a photomotor response experiment. This demon-
strates that cognition of a stimulus, processing of the information, and response to a
stimulus are similar in grna-/-;grnb-/- double mutant larvae and wildtype controls and
also indicates no motor deficits in the double mutants as suggested by others (Chitra-
muthu et al., 2010). Therefore, it can be concluded that the Grna;Grnb KO larvae
show a normal response to a visual stimulus.
It was demonstrated before that zebrafish larvae can serve as a model for neurodegener-
ative diseases like NCL (Follo et al., 2011; Mahmood et al., 2013a), however zebrafish
larvae that lack Grna and Grnb are clearly devoid of any phenotypic alterations that
were described in Grn-deficient mammals before. First analysis in adult grna-/-;grnb-/-
brains did not provide any indications for disease-associated phenotypes or biochem-
ical alterations. A more detailed examination of aged Grna;Grnb KO zebrafish will
determine if ageing might affect these parameters in mutants. Since for example het-
erozygous Grn KO mice were devoid of signatures of lysosomal impairment (Filiano
et al., 2013; Götzl et al., 2014), it is possible that Grn1 and Grn2 are sufficient to
preclude phenotypes and it would be interesting to analyse if Grna;Grnb KO zebrafish
that additionally lack Grn1 and Grn2 develop disease-related pathologies described in
Grn-deficient men and mice.
6.7 Normal wound healing in Grna and Grnb KO larvae
It was confirmed in this study that especially grna expression is increased after an
injury. Therefore, I asked whether a lack of Grna and Grnb could have an influence
on the inflammatory response or the regeneration in Grna;Grnb KOs revealing a long-
awaited phenotype in the mutants. Tail fin amputations, a well accepted model to
study the inflammatory response and regeneration in the larval zebrafish (Ellett et al.,
2011; Yoshinari and Kawakami, 2011), were performed in grna-/-;grnb-/- double mutant
zebrafish larvae. In the experiments it was shown that the regeneration of the tail fin
is comparable in Grna;Grnb KO and wildtype larvae. The regeneration time and the
morphological shape of the regenerate are not distinguishable. Moreover, the response
of cells of the myeloid lineage to a larval tail fin amputation was similar. There was a
slight reduction of the time the cell spent in the wound but this was not statistically
significant and can be explained by the different cell types, neutrophils and macrophages,
that could have been selected for the single cell tracking (Ellett et al., 2011). As grna
and grn1/grn2 are enriched in macrophages it would be interesting to examine the
response of macrophages to an injury selectively. The transgenic line used in this study,
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Tg(spi1b:Gal4/UAS:EGFP), labels all cell types of myeloid origin, which are at the
developmental stage of analysis mainly macrophages and neutrophils, and it would be
worth to repeat the cell tracking in a transgenic line that labels only macrophages for
example the Tg(mpeg1 :mCherry). Due to the findings that macrophages and microglia
from Grn KO mice have an enhanced phagocytic activity and show an exaggerated
inflammatory response after e.g. a traumatic brain injury (Kao et al., 2011; Martens
et al., 2012; Tanaka et al., 2012), the phagocytic activity would be of special interest.
Additionally, it is possible that Grn1 and Grn2 compensate for the lack of Grna and
Grnb after a tail fin amputation. Unfortunately, the determination of the grn1/grn2
expression levels is challenging at that specific time of development, since they are
close to the detection limit. Already in the expression analysis conducted in tail fin
amputated wildtype larvae, a very high variance between the single experiments was
observed. Consequently, it would be important to use a robust assay, that would allow
to answer the question if Grn1 and Grn2 compensate for the lack of Grna and Grnb after
an injury. One possibility is to compare the response to a stab wound injury in adult
zebrafish telencephali of wildtype and grna-/-;grnb-/- mutant brains. These experiments
could be realized in a collaboration with a group at the Helmholtz Center Munich, which
has extensive experience, performing this kind of injury experiments in adult zebrafish.
In the larval zebrafish, however, there are so far no indications that a loss of Grna and
Grnb leads to an increased inflammatory response after a tail fin amputation. In Grn
KO mice in contrast an exaggerated inflammatory response after a traumatic brain
injury was reported (Tanaka et al., 2012). Cells of the myeloid lineage in Grna;Grnb KO
larvae are responsive to inflammatory cues and show no irregular migration path after
a tail fin amputation. It is possible, that the injury model chosen herein is affecting
the wrong tissue at the wrong developmental stage and that an injury in the (adult)
zebrafish brain would give insights into underlying pathomechanisms. One should also
keep in mind, that the restoration of a fin is different to the replacement of neurons in
the brain and it is quite likely that different signaling pathways and mechanisms are
involved in these two processes (Lenkowski and Raymond, 2014). Moreover, zebrafish
have a high regenerative capacity (Gemberling et al., 2013) and it should be considered
that the pathways that caused an exaggerated inflammatory response in Grn KO mice
might not be conserved in zebrafish.
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So far the examinations of Grna;Grnb KO zebrafish embryos and larvae did not reveal
any phenotypic alterations. Since NCL/GRN and FTLD-TDP/GRN patients as well
as Grn KO mice become symptomatic and develop phenotypes as adults (Fujioka
and Wszolek, 2011; Kleinberger et al., 2013; Smith et al., 2012) it remains to be
answered if Grna;Grnb KO zebrafish develop phenotypic alterations upon ageing. The
disease onset in FTLD-TDP/GRN patients is frequently asymmetric, therefore, it was
hypothesized that a second hit, a small traumatic injury or a microhemorrhage, is
needed to trigger the disease (Hardy and Rogaeva, 2013). To consider such aspects,
one should analyse Grna;Grnb KO zebrafish after a stab wound injury in the adult
telencephalon. Preliminary data already indicate a difference between wildtype and
Grna;Grnb KOs. It is published that an acute inflammation in the adult zebrafish brain
enhances its regenerative capacity after an injury (Kyritsis et al., 2012). Moreover, it was
demonstrated that the inflammatory response after a traumatic brain injury is increased
in Grn KO mice (Tanaka et al., 2012). I hypothesize that Grna;Grnb KO zebrafish,
which provide a unique model to study this issue, respond with increased inflammation
to an injury in the adult telencephalon when compared to wildtype, leading to an
increase in the regenerative response to the injury, indicated by an elevated number of
proliferative cells in the subventricular zone.
Even though grn1/grn2 expression is not increased in Grna;Grnb KO larvae, it is
possible that Grn1 and Grn2 are capable to compensate for the lack of Grna and Grnb,
especially after an injury. To test this hypothesis, either a grn1 and grn2 KD or KO
would be required. A MO KD is easy to perform but would allow only a temporal
analysis in larvae. grn1/grn2 expression becomes first prominent at 3dpf to 4dpf, a time
where a MO is already very diluted. Consequently, a KO would be the better choice.
For a KO the CRISPR/Cas9 system would be used, which is the method-of-choice for
genome editing (Hruscha et al., 2013; Schmid and Haass, 2013). The generation of
grn1 and grn2 mutants was already initiated and is on the way. A special challenge of
this approach is the fact that grn1 and grn2 are in tandem on the same chromosome.
Therefore, either the whole locus needs to be deleted at once or the mutants need to be
generated successively. Once the granulin quadruple mutants are available, it would
be of great interest to analyse them for phenotypic alterations. These models hold the
unique potential to functionally analyse the physiological function of the full-length-like
GRN with the Grna;Grnb KOs and the physiological function of the processed granulin
peptides with the quadruple mutants.
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10 Appendix
Figure 10.1 – grn1 (ENSDART00000051972) and grn2 (ENSDART00000051970) aligned
with CLC Main Workbench. Red: 5’UTR or 3’UTR. Yellow: ORF. Red in conservation
line: bp that are different.
Figure 10.2 – Grn1 (ENSDARP00000051971) and Grn2 (ENSDARP00000051969) aligned
with CLC Main Workbench. Red in conservation line: aa that are different.
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Figure 10.3 – Schematic representation of grna and grnb and the qPCR primer binding
sites. The genomic structures of grna and grnb are depicted.
Figure 10.4 – Schematic representation of Grna and Grnb and the binding sites of the
Grna and Grnb specific mAbs.
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Figure 10.5 – Sequences of ZFN-induced mutations that were detected in the F1 genera-
tion. A: Offsprings from 13 founder injected with ZFNs targeting grna were analysed and
13 different mutations were observed. B: Offsprings from 8 founder injected with ZFN
targeting grnb were analysed and 15 different mutations were observed. ∆: deletion, +:
insertion
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